| 1 | C (migalastat) | [1] Migalastat Migalastat | [2] Migalastat hydrochloride
Migalastat hydrochloride
,
Migalastat
💬
| [1] GLA GLA 💬
| [5] Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 2 | C-028380 | - | - | - | - | [1] 106 106 💬
|
| 3 | C-1-esterase | - | - | - | - | [1] 65 65 💬
|
| 4 | C-11 ER176 | - | - | - | - | [3] 6 6, 17, 127 💬
|
| 5 | C-11 ER176 Radiotracer | - | - | - | - | [1] 13 13 💬
|
| 6 | C-11 PiB | - | - | - | - | [3] 6 6, 17, 127 💬
|
| 7 | C-82 Topical Gel, 1% | - | - | - | - | [1] 51 51 💬
|
| 8 | C-kit+ cells | - | - | - | - | [1] 211 211 💬
|
| 9 | C-Trelin OD Tab(5mg Taltirelin Hydrate) | [1] Taltirelin Taltirelin | - | - | - | [1] 18 18 💬
|
| 10 | C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 276 276 💬
|
| 11 | C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER | [1] Polyethylene glycol Polyethylene glycol | [3] Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | [1] 276 276 💬
|
| 12 | C. albicans | - | - | - | - | [1] 46 46 💬
|
| 13 | C. cicadae | - | - | - | - | [1] 2 2 💬
|
| 14 | C01CA04 - Dopamina | - | - | - | - | [1] 299 299 💬
|
| 15 | C01EB19 | - | - | - | - | [1] 65 65 💬
|
| 16 | C03C | - | - | - | - | [1] 57 57 💬
|
| 17 | C03DB01 | - | - | - | - | [1] 222 222 💬
|
| 18 | C03XA01 | - | - | - | - | [2] 67 67, 72 💬
|
| 19 | C07AB07 | - | - | - | - | [1] 86 86 💬
|
| 20 | C09 | - | - | - | - | [1] 66 66 💬
|
| 21 | C1 ESTERASE INHIBITOR | - | - | - | - | [1] 65 65 💬
|
| 22 | C1 ESTERASE INHIBITOR (HUMAN) | - | - | - | - | [1] 65 65 💬
|
| 23 | C1 esterase inhibitor [human] | - | - | - | - | [1] 65 65 💬
|
| 24 | C1 esterase inhibitor [human] (C1INH-nf) | - | - | - | - | [1] 65 65 💬
|
| 25 | C1 esterase inhibitor [human] liquid | - | - | - | - | [1] 65 65 💬
|
| 26 | C1 esterase inhibitor concentrate | - | - | - | - | [1] 65 65 💬
|
| 27 | C1 esterase inhibitor concentrate, human, pasteurized | - | - | - | - | [1] 65 65 💬
|
| 28 | C1 Esterase Inhibitor Human | - | - | - | - | [1] 65 65 💬
|
| 29 | C1 esterase inhibitor liquid for injection | - | - | - | - | [1] 65 65 💬
|
| 30 | C1 inhibitor (human) [C1 INH] | - | - | - | - | [1] 65 65 💬
|
| 31 | C1 inhibitor concentrate | - | - | - | - | [1] 65 65 💬
|
| 32 | C1-Esterase Inhibitor | - | - | - | - | [1] 65 65 💬
|
| 33 | C1-esterase inhibitor (Cinryze) | - | - | - | - | [1] 13 13 💬
|
| 34 | C1-esterase inhibitor - single intravenous dose | - | - | - | - | [1] 65 65 💬
|
| 35 | C1-esterase inhibitor - subcutaneous high dose | - | - | - | - | [1] 65 65 💬
|
| 36 | C1-esterase inhibitor - subcutaneous low dose | - | - | - | - | [1] 65 65 💬
|
| 37 | C1-esterase inhibitor - subcutaneous medium dose | - | - | - | - | [1] 65 65 💬
|
| 38 | C1-esterase inhibitor [recombinant] (C1-INH-R) | - | - | - | - | [1] 65 65 💬
|
| 39 | C1-Esterase-Inhibitor | - | - | - | - | [1] 65 65 💬
|
| 40 | C105 | - | - | - | - | [1] 13 13 💬
|
| 41 | C106 solution | - | - | - | - | [1] 85 85 💬
|
| 42 | C10AA05 | - | - | - | - | [1] 46 46 💬
|
| 43 | C10AB02 | - | - | - | - | [1] 94 94 💬
|
| 44 | C11 Pittsburgh Compound B | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [1] 13 13 💬
|
| 45 | C11-methionine | [1] Methionine Methionine | [1] Methionine
Methionine
💬
| - | - | [1] 84 84 💬
|
| 46 | C11-SY08 | - | - | - | - | [2] 6 6, 17 💬
|
| 47 | C21 | - | - | - | - | [2] 51 51, 85 💬
|
| 48 | C225 | - | - | - | - | [2] 51 51, 86 💬
|
| 49 | C2L-OCT-01 PR | - | - | - | - | [1] 77 77 💬
|
| 50 | C2L-OCT-01 PR , 10mg | - | - | - | - | [1] 77 77 💬
|
| 51 | C2L-OCT-01 PR , 20mg | - | - | - | - | [1] 77 77 💬
|
| 52 | C2L-OCT-01 PR , 30mg | - | - | - | - | [1] 77 77 💬
|
| 53 | C2L-OCT-01 PR 30 mg | - | - | - | - | [1] 77 77 💬
|
| 54 | C2L-OCT-01 PR, 10 or 20 mg | - | - | - | - | [1] 77 77 💬
|
| 55 | C2L-OCT-01 PR, 20 mg | - | - | - | - | [1] 77 77 💬
|
| 56 | C2L-OCT-01 PR, 30 mg | - | - | - | - | [1] 77 77 💬
|
| 57 | C326 | [1] C326 C326 | - | - | - | [1] 96 96 💬
|
| 58 | C326, IL-6 Inhibitory Avimer protein | [1] C326 C326 | - | - | - | [1] 96 96 💬
|
| 59 | C5 inh MAb, SKY59, RO/CH7092230 | - | - | - | - | [2] 62 62, 109 💬
|
| 60 | C5 Inhibitor | - | - | - | - | [1] 62 62 💬
|
| 61 | CA | - | - | - | - | [1] 234 234 💬
|
| 62 | CA2 | - | - | - | - | [1] 271 271 💬
|
| 63 | CABA-201 | - | - | - | - | [5] 11 11, 13, 35, 49, 51 💬
|
| 64 | CABA-201 following preconditioning with fludarabine and cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 50 50 💬
|
| 65 | Cabaletta | - | - | - | - | [1] 113 113 💬
|
| 66 | Cabaletta for IV infusion once weekly during 24 weeks | - | - | - | - | [1] 18 18 💬
|
| 67 | Cabaser | - | - | - | - | [2] 6 6, 77 💬
|
| 68 | Cabaseril | - | - | - | - | [1] 6 6 💬
|
| 69 | Cabaseril, 1,0 mg Tablette | - | - | - | - | [1] 6 6 💬
|
| 70 | Cabaseril, 2,0 mg Tablette | - | - | - | - | [1] 6 6 💬
|
| 71 | Cabergolin | - | - | - | - | [2] 74 74, 77 💬
|
| 72 | Cabergolin Teva | - | - | - | - | [1] 74 74 💬
|
| 73 | CABERGOLINA | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 6 6, 75 💬
|
| 74 | Cabergoline | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [4] 6 6, 74, 75, 77 💬
|
| 75 | Cabergoline (Dopamine Agonist) | [2] Cabergoline Cabergoline, Dopamine | [3] Dopamine hydrochloride
Dopamine hydrochloride
,
Cabergoline
,
Dopamine
💬
| [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 76 | Cabergoline 1.5-2 mg/week).orally daily for 1 month plus health education | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 77 | Cabergoline 1.5-2 mg/week).orally daily for 1 month without health education | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 78 | Cabergoline tablets | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 79 | Cabergoline tablets reference formulation | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 80 | Cabergoline tablets test formulation | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 74 74 💬
|
| 81 | CABERGOLINE TEVA | [1] Cabergoline Cabergoline | [1] Cabergoline
Cabergoline
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 75 75 💬
|
| 82 | CABLIVI | - | - | - | - | [1] 64 64 💬
|
| 83 | Cablivi® | - | - | - | - | [1] 64 64 💬
|
| 84 | Cablivi®Product Name: Cablivi®Product Code: ALX0081Pharmaceutical Form: Powder and solvent for solution for injectionINN or Proposed INN: CaplacizumabCAS Number: 915810-67-2Current Sponsor code: ALX0081Other descriptive name: Nanobody directed towards the human A1 domain of von Willebrand factorConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 12.5-Trade Name: Cablivi®Product Name: Cablivi®Product Code: ALX0081Pharmaceutical Form: Powder and solvent for solution for injectionINN or Proposed INN: CaplacizumabCAS Number: 915810-67-2Current Sponsor code: ALX0081Other descriptive name: Nanobody directed towards the human A1 domain of von Willebrand factorConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 12.5- | - | - | - | - | [1] 64 64 💬
|
| 85 | Cabozantinib | [1] Cabozantinib Cabozantinib | [2] Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| [3] AXL AXL, KDR, MET 💬
| [28] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [9] 13 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
|
| 86 | Cabozantinib Oral Tablet | [1] Cabozantinib Cabozantinib | [2] Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| [3] AXL AXL, KDR, MET 💬
| [28] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 34 34 💬
|
| 87 | CACIPLIQ20 | - | - | - | - | [1] 36 36 💬
|
| 88 | CACIT D3 effervescent granules, 500 mg/440 IU | - | - | - | - | [1] 97 97 💬
|
| 89 | CAD-1883 | - | - | - | - | [1] 18 18 💬
|
| 90 | CADD-Legacy ambulatory infusion pump | - | - | - | - | [1] 6 6 💬
|
| 91 | CADD-Legacy® 1400 ambulatory infusion pump | - | - | - | - | [1] 6 6 💬
|
| 92 | CAEL-101 | - | - | - | - | [1] 28 28 💬
|
| 93 | Caffeic acid | - | - | - | - | [1] 63 63 💬
|
| 94 | Caffeic acid tablets | - | - | - | - | [1] 63 63 💬
|
| 95 | Caffeine | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
| 96 | Caffeine 100 mg | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 💬
|
| 97 | Caffeine 100-200 mg BID | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 98 | Caffeine alkaloid | [1] Caffeine Caffeine | [2] Caffeine
Caffeine
,
Caffeine citrate
💬
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬
| [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 99 | CAL101 | - | - | - | - | [1] 85 85 💬
|
| 100 | Calcichew D3 | - | - | - | - | [1] 274 274 💬
|
| 101 | Calcichew D3 Forte | - | - | - | - | [1] 113 113 💬
|
| 102 | Calcichew tablets | - | - | - | - | [1] 274 274 💬
|
| 103 | Calcifediol | [1] Calcifediol Calcifediol | [1] Calcifediol
Calcifediol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 86 86, 113 💬
|
| 104 | Calcifediol Oral Capsule | [1] Calcifediol Calcifediol | [1] Calcifediol
Calcifediol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 86 86 💬
|
| 105 | Calcineurin Inhibitors | - | - | - | - | [1] 50 50 💬
|
| 106 | Calcineurin inhibitors maintenance | - | - | - | - | [1] 67 67 💬
|
| 107 | CALCIO CARBONATO/COLECALCIFEROLO | [1] Calcium Calcium | - | - | - | [1] 274 274 💬
|
| 108 | CALCIO FOLINATO DC.IT | [1] Calcium Calcium | - | - | - | [1] 13 13 💬
|
| 109 | Calcipotriene | - | - | - | - | [1] 51 51 💬
|
| 110 | CALCIPOTRIOL | [1] Calcipotriol Calcipotriol | [2] Calcipotriene
Calcipotriene
,
Calcipotriol hydrate
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 36 36 💬
|
| 111 | Calcitonin | - | - | - | - | [1] 225 225 💬
|
| 112 | CALCITONIN (SALMON) | - | - | - | - | [1] 225 225 💬
|
| 113 | Calcitonin nasal spray (salmon) | - | - | - | - | [2] 96 96, 97 💬
|
| 114 | Calcitriol | [1] Calcitriol Calcitriol | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [11] 18 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
|
| 115 | Calcitriol & Calcium | [2] Calcitriol Calcitriol, Calcium | [1] Calcitriol
Calcitriol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 235 235 💬
|
| 116 | Calcium | [1] Calcium Calcium | - | - | - | [39] 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 117 | Calcium and cholecalciferol | [2] Calcium Calcium, Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 46 46 💬
|
| 118 | Calcium and Vit D | [1] Calcium Calcium | - | - | - | [1] 49 49 💬
|
| 119 | Calcium and Vitamin D | [2] Calcium Calcium, Vitamin D | - | - | - | [1] 74 74 💬
|
| 120 | Calcium and Vitamin D combination | [2] Calcium Calcium, Vitamin D | - | - | - | [1] 13 13 💬
|
| 121 | Calcium carbonate | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [10] 13 13, 19, 46, 53, 71, 75, 96, 97, 235, 299 💬
|
| 122 | Calcium carbonate 1250 mg (500 mg elemental calcium) 4 times a day | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 235 235 💬
|
| 123 | Calcium carbonate 1250 mg (500 mg elemental calcium) twice a day | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 235 235 💬
|
| 124 | Calcium carbonate 600 mg once daily | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 97 97 💬
|
| 125 | Calcium carbonate and alphacalcidol | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 235 235 💬
|
| 126 | Calcium carbonate D | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 53 53 💬
|
| 127 | Calcium carbonate tablets | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 46 46 💬
|
| 128 | Calcium Channel Blockers | [1] Calcium Calcium | - | - | - | [1] 51 51 💬
|
| 129 | Calcium citrate | [2] Calcium Calcium, Calcium citrate | [1] Calcium citrate
Calcium citrate
💬
| - | - | [3] 46 46, 84, 235 💬
|
| 130 | Calcium Citrate with Vitamin D2 | [3] Calcium Calcium, Calcium citrate, Ergocalciferol | [2] Ergocalciferol
Ergocalciferol
,
Calcium citrate
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 84 84 💬
|
| 131 | Calcium D3 | [1] Calcium Calcium | - | - | - | [1] 274 274 💬
|
| 132 | CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI | [1] Calcium Calcium | - | - | - | [1] 274 274 💬
|
| 133 | Calcium gluconate | [2] Calcium Calcium, Calcium gluconate | [1] Calcium gluconate
Calcium gluconate
💬
| - | - | [3] 214 214, 215, 235 💬
|
| 134 | Calcium lactate | [2] Calcium Calcium, Calcium lactate | [1] Calcium lactate
Calcium lactate
💬
| - | - | [1] 235 235 💬
|
| 135 | Calcium levofolinate | [1] Calcium Calcium | - | - | - | [1] 13 13 💬
|
| 136 | Calcium Phosphate | [2] Calcium Calcium, Calcium Phosphate | [2] Anhydrous diabasic calcium phosphate
Anhydrous diabasic calcium phosphate
,
Calcium phosphate, tribasic
💬
| - | - | [1] 71 71 💬
|
| 137 | Calcium rosuvastatin | [2] Calcium Calcium, Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 138 | Calcium, Dietary | [1] Calcium Calcium | - | - | - | [1] 298 298 💬
|
| 139 | Calculus bovis sativus (CBS) | - | - | - | - | [1] 13 13 💬
|
| 140 | CALD HR-D (High-Risk, Regimen C) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 141 | CALD HR-D (High-Risk, Regimen D) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 142 | CALD SR-A (Standard-Risk, Regimen A) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 143 | CALD SR-B (Standard-Risk, Regimen B) | - | - | - | - | [5] 19 19, 20, 125, 234, 326 💬
|
| 144 | Calfactant | [1] Calfactant Calfactant | [1] Calfactant
Calfactant
💬
| - | - | [1] 299 299 💬
|
| 145 | Calogen | - | - | - | - | [1] 2 2 💬
|
| 146 | Caltrate | - | - | - | - | [1] 97 97 💬
|
| 147 | Caltrate Pill | - | - | - | - | [1] 96 96 💬
|
| 148 | Calvan (bevantolol hydrochloride) | [1] Bevantolol Bevantolol | [1] Bevantolol hydrochloride
Bevantolol hydrochloride
💬
| [8] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [44] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gap junction, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 8 8 💬
|
| 149 | Calvan Tablets 100 | - | - | - | - | [1] 8 8 💬
|
| 150 | Calvan® 100 mg | - | - | - | - | [1] 8 8 💬
|
| 151 | CALY-002 | [1] CALY-002 CALY-002 | - | - | - | [1] 98 98 💬
|
| 152 | CAM-3001 | [1] Mavrilimumab Mavrilimumab | [1] Mavrilimumab
Mavrilimumab
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 💬
|
| 153 | CAM2029 | - | - | - | - | [1] 77 77 💬
|
| 154 | CAM2029 (Octreotide subcutaneous depot) | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 155 | CAM2029 (Octreotide subcutaneous depot) _prefilled syringe_prefilled syringe | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 156 | CAM2029 (Octreotide subcutaneous depot)_ prefilled pen | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 157 | CAM2029 (Octreotide subcutaneous depot)_ prefilled syringe | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 158 | CAM2029 (Octreotide subcutaneous depot)_pre-filled pen | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 159 | CAM2029 (Octreotide subcutaneous depot)_pre-filled syringe | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 160 | CAM2029 (Octreotide subcutaneous depot)_prefilled pen | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 161 | CAM2029 (Octreotide subcutaneous depot)_prefilled syringe | [1] Octreotide Octreotide | [5] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Octreotide hydrochloride
💬
| [1] SSTR2 SSTR2 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 162 | CAM2029-BR | - | - | - | - | [1] 77 77 💬
|
| 163 | CAM2043 | - | - | - | - | [1] 51 51 💬
|
| 164 | Camoteskimab | [1] Camoteskimab Camoteskimab | - | - | - | [1] 54 54 💬
|
| 165 | Camoteskimab (CERC-007, AVTX-007, AEVI-007) | [1] Camoteskimab Camoteskimab | - | - | - | [1] 54 54 💬
|
| 166 | Campath | - | - | - | - | [3] 49 49, 51, 60 💬
|
| 167 | Campath -1H | - | - | - | - | [1] 65 65 💬
|
| 168 | Campath 1H | - | - | - | - | [4] 60 60, 65, 164, 285 💬
|
| 169 | Campath, Busulfan, Clofarabine | [2] Busulfan Busulfan, Clofarabine | [2] Busulfan
Busulfan
,
Clofarabine
💬
| [3] POLA1 POLA1, POLA2, RRM1 💬
| [5] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 326 326 💬
|
| 170 | Campath, Chemo and/or TBI Allo SCT | - | - | - | - | [3] 60 60, 62, 283 💬
|
| 171 | Campath, Fludarabine, Cyclophosphamide | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [2] 65 65, 284 💬
|
| 172 | Campath-1H | - | - | - | - | [6] 19 19, 20, 60, 65, 234, 326 💬
|
| 173 | CAMPATH-1H (Alemtuzumab) | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [1] 60 60 💬
|
| 174 | Canakinumab | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [11] 46 46, 54, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬
|
| 175 | Canakinumab (ACZ885) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 💬
|
| 176 | Canakinumab (company code: ACZ885D) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 💬
|
| 177 | Canakinumab (investigational) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 46 46 💬
|
| 178 | Canakinumab (proposed) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 46 46 💬
|
| 179 | Canakinumab (WHO approval pending) | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 💬
|
| 180 | Canakinumab - proposed | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 106 106 💬
|
| 181 | Canakinumab Injection | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 46 46 💬
|
| 182 | Canakinumab Injection [Ilaris] | [1] Canakinumab Canakinumab | [1] Canakinumab
Canakinumab
💬
| [1] IL1B IL1B 💬
| [43] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [1] 113 113 💬
|
| 183 | CANDESARTAN | [1] Candesartan Candesartan | [1] Candesartan
Candesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [4] 57 57, 58, 67, 222 💬
|
| 184 | Candesartan and Cilnidipine | [2] Candesartan Candesartan, Cilnidipine | [2] Candesartan
Candesartan
,
Cilnidipine
💬
| [6] AGTR1 AGTR1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [50] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hormone signaling, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬
|
| 185 | Candesartan plus non-CCB agents | [1] Candesartan Candesartan | [1] Candesartan
Candesartan
💬
| [1] AGTR1 AGTR1 💬
| [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬
|
| 186 | Candesartán Kern Pharma 16 mg comprimidos EFG | - | - | - | - | [1] 57 57 💬
|
| 187 | Cannabichromene | [1] Cannabichromene Cannabichromene | - | - | - | [1] 46 46 💬
|
| 188 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [20] 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
| 189 | Cannabidiol (CBD) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [7] 6 6, 13, 140, 144, 145, 156, 158 💬
|
| 190 | Cannabidiol , synthetic form | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 96 96 💬
|
| 191 | Cannabidiol / Dronabinol capsule 5 mg+2,5 mg | [2] Cannabidiol Cannabidiol, Dronabinol | [2] Dronabinol
Dronabinol
,
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬
|
| 192 | Cannabidiol 100 mg/ml | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 6 6 💬
|
| 193 | Cannabidiol 300 mg/ml | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 6 6 💬
|
| 194 | Cannabidiol 400 mg/ml | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 6 6 💬
|
| 195 | Cannabidiol Botanical Drug Substance (CBD BDS) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬
|
| 196 | Cannabidiol capsule 5 mg | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬
|
| 197 | Cannabidiol Oral Solution | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [4] 140 140, 144, 145, 193 💬
|
| 198 | Cannabidiol oral solution (Epidyolex) | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [3] 19 19, 158, 206 💬
|
| 199 | Cannabidiol Oral Solution [Epidiolex] | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 158 158 💬
|
| 200 | Cannabidiol Oral Solution, is known as Epidyolex 100 mg/mL oral solution and is the approved name in the EU. Epidiolex (cannabidiol) oral solution is the approved name in the US. | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 158 158 💬
|
| 201 | Cannabidiol tablet 10 mg | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 46 46, 271 💬
|
| 202 | Cannabidiol vaginal suppository | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 226 226 💬
|
| 203 | Cannabidiolo | - | - | - | - | [1] 156 156 💬
|
| 204 | Cannabidiolo (CBD) | - | - | - | - | [1] 156 156 💬
|
| 205 | Cannabigerol | [1] Cannabigerol Cannabigerol | - | - | - | [1] 46 46 💬
|
| 206 | Cannabigerol (CBG) | [1] Cannabigerol Cannabigerol | - | - | - | [1] 46 46 💬
|
| 207 | CANNABINOL | [1] Cannabinol Cannabinol | - | - | - | [1] 36 36 💬
|
| 208 | Cannabinol (CBN) | [1] Cannabinol Cannabinol | - | - | - | [1] 36 36 💬
|
| 209 | Cannabis | - | - | - | - | [2] 13 13, 90 💬
|
| 210 | Cannabis Based Medicine Extract (Sativex) | - | - | - | - | [1] 13 13 💬
|
| 211 | Cannabis Oil | - | - | - | - | [1] 6 6 💬
|
| 212 | Cannabis Sativa extract Oromucosal spray | - | - | - | - | [1] 2 2 💬
|
| 213 | Cannabis sativa L., folium cum flore | - | - | - | - | [1] 19 19 💬
|
| 214 | Cannabis, Medical | - | - | - | - | [5] 2 2, 6, 13, 96, 97 💬
|
| 215 | Cannador | - | - | - | - | [1] 13 13 💬
|
| 216 | CAP-1002 | - | - | - | - | [1] 113 113 💬
|
| 217 | Capacity of muscular oxygen extraction | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 13 13 💬
|
| 218 | Capecitabine | [1] Capecitabine Capecitabine | [1] Capecitabine
Capecitabine
💬
| [1] TYMS TYMS 💬
| [3] Folate transport and metabolism Folate transport and metabolism, One carbon pool by folate, Pyrimidine metabolism 💬 | [1] 94 94 💬
|
| 219 | CAPILLAREMA | - | - | - | - | [1] 51 51 💬
|
| 220 | Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients. | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [1] 266 266 💬
|
| 221 | Caplacizumab | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [9] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [2] 63 63, 64 💬
|
| 222 | Caplacizumab (ALX-0081) | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [9] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
| 223 | Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [9] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
| 224 | Caplacizumab (an anti-von Willebrand Factor Nanobody) | [1] Caplacizumab Caplacizumab | [1] Caplacizumab
Caplacizumab
💬
| [1] VWF VWF 💬
| [9] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | [1] 64 64 💬
|
| 225 | Caprylic Triglyceride | - | - | - | - | [1] 13 13 💬
|
| 226 | Capsaicin | [1] Capsaicin Capsaicin | [1] Capsaicin
Capsaicin
💬
| [1] TRPV1 TRPV1 💬
| [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [5] 2 2, 6, 19, 86, 226 💬
|
| 227 | Capsaicin Challenge | [1] Capsaicin Capsaicin | [1] Capsaicin
Capsaicin
💬
| [1] TRPV1 TRPV1 💬
| [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 2 2 💬
|
| 228 | Capsaicin vapor | [1] Capsaicin Capsaicin | [1] Capsaicin
Capsaicin
💬
| [1] TRPV1 TRPV1 💬
| [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬
|
| 229 | Capsule di prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 💬
|
| 230 | Capsule endoscopy | - | - | - | - | [1] 96 96 💬
|
| 231 | Capsule fecal microbiota material (cap-FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 96 96 💬
|
| 232 | Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 233 | Capsules with 160 mg Teavigo (at least 94% EGCG) | - | - | - | - | [1] 13 13 💬
|
| 234 | Captafer® | - | - | - | - | [1] 97 97 💬
|
| 235 | Captopril | [1] Captopril Captopril | [1] Captopril
Captopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [3] 17 17, 57, 86 💬
|
| 236 | CAR T cell | - | - | - | - | [1] 50 50 💬
|
| 237 | CAR-DC | - | - | - | - | [1] 85 85 💬
|
| 238 | CAR-NK cell | - | - | - | - | [1] 53 53 💬
|
| 239 | CAR-T cell | - | - | - | - | [1] 49 49 💬
|
| 240 | CAR-T cells | - | - | - | - | [1] 63 63 💬
|
| 241 | CAR-T cells injection | - | - | - | - | [1] 13 13 💬
|
| 242 | CAR-T Therapy | - | - | - | - | [2] 49 49, 51 💬
|
| 243 | Carbaglu | - | - | - | - | [2] 245 245, 246 💬
|
| 244 | Carbamazepine | [1] Carbamazepine Carbamazepine | [1] Carbamazepine
Carbamazepine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [6] 6 6, 13, 137, 145, 158, 231 💬
|
| 245 | Carbetocin | [1] Carbetocin Carbetocin | [1] Carbetocin
Carbetocin
💬
| [1] OXTR OXTR 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 💬
|
| 246 | CARBIDOPA | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [7] 6 6, 13, 17, 90, 140, 164, 201 💬
|
| 247 | CARBIDOPA (CD) | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 248 | CARBIDOPA (FU) | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 249 | Carbidopa 20 mg | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 250 | Carbidopa 200mg oral dose | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 💬
|
| 251 | Carbidopa 25/Levodopa 100Mg Tab | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 252 | Carbidopa 27.5 mg | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 253 | Carbidopa 65 mg capsule | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 254 | Carbidopa and Levodopa Controlled Release Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 255 | Carbidopa and Levodopa Tablets, USP | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 256 | CARBIDOPA ANIDRA | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 257 | CARBIDOPA FU | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 258 | CARBIDOPA INN | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 259 | CARBIDOPA LEVODOPA | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 260 | CARBIDOPA MONOHYDRATE | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 261 | Carbidopa Pill | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 262 | Carbidopa, levodopa, entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 263 | Carbidopa- Levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 264 | Carbidopa-4'-Monophosphate | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 265 | Carbidopa-Levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 266 | Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 267 | Carbidopa/l-dopa | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 268 | Carbidopa/l-dopa/entacapone | [2] Carbidopa Carbidopa, Entacapone | [2] Carbidopa
Carbidopa
,
Entacapone
💬
| [2] COMT COMT, DDC 💬
| [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 269 | Carbidopa/levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 270 | Carbidopa/levodopa, as prescribed by treating physician | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 271 | Carbidopa/Levodopa, immediate release | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 272 | Carbidopa/Levodopa/Entacapone | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] Levodopa
Levodopa
,
Carbidopa
,
Entacapone
💬
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [18] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 273 | Carbidopamonohydraat | - | - | - | - | [1] 6 6 💬
|
| 274 | CARBODOPA LEVADOPA | - | - | - | - | [1] 6 6 💬
|
| 275 | Carbodopa/levadopa | - | - | - | - | [1] 6 6 💬
|
| 276 | Carbohydrates | - | - | - | - | [1] 240 240 💬
|
| 277 | Carbohydrates intake | - | - | - | - | [1] 257 257 💬
|
| 278 | CARBOLITHIUM | - | - | - | - | [1] 2 2 💬
|
| 279 | CARBOLITHIUM*100CPS 150MG | - | - | - | - | [1] 2 2 💬
|
| 280 | Carbomer | [1] Carbomer Carbomer | - | - | - | [1] 53 53 💬
|
| 281 | Carbomer 974P | [1] Carbomer Carbomer | - | - | - | [1] 53 53 💬
|
| 282 | Carbomer Gel/Jelly | [1] Carbomer Carbomer | - | - | - | [1] 53 53 💬
|
| 283 | Carbon dioxide | [1] Carbon dioxide Carbon dioxide | [1] Carbon dioxide
Carbon dioxide
💬
| - | - | [4] 50 50, 51, 97, 158 💬
|
| 284 | Carbon dioxide insufflation | [1] Carbon dioxide Carbon dioxide | [1] Carbon dioxide
Carbon dioxide
💬
| - | - | [1] 97 97 💬
|
| 285 | Carbon Fiber Ankle Foot Orthosis (AFO) | - | - | - | - | [1] 6 6 💬
|
| 286 | Carbon monoxide | [1] Carbon monoxide Carbon monoxide | [1] Carbon monoxide
Carbon monoxide
💬
| - | - | [3] 85 85, 86, 298 💬
|
| 287 | Carbon orthosis (control) | - | - | - | - | [1] 13 13 💬
|
| 288 | Carbon-14 BIA 28-6156 | [1] BIA BIA | - | - | - | [1] 6 6 💬
|
| 289 | Carbon-14 labeled HSK39297 | - | - | - | - | [1] 62 62 💬
|
| 290 | Carbonate de lithium | - | - | - | - | [1] 2 2 💬
|
| 291 | CARBONE VEGETALE | - | - | - | - | [1] 13 13 💬
|
| 292 | Carbone vegetale polvere | - | - | - | - | [1] 13 13 💬
|
| 293 | Carboplatin | [1] Carboplatin Carboplatin | [1] Carboplatin
Carboplatin
💬
| - | - | [4] 28 28, 34, 60, 85 💬
|
| 294 | CARBOSSIMALTOSIO FERRICO | - | - | - | - | [1] 97 97 💬
|
| 295 | Carboxymethylcellulose | [1] Carboxymethylcellulose Carboxymethylcellulose | [2] Carboxymethylcellulose sodium
Carboxymethylcellulose sodium
,
Carmellose
💬
| - | - | [3] 35 35, 70, 162 💬
|
| 296 | Carboxymethylcellulose with ionic silver (Aquacel Ag) | [2] Carboxymethylcellulose Carboxymethylcellulose, Silver | [2] Carboxymethylcellulose sodium
Carboxymethylcellulose sodium
,
Carmellose
💬
| - | - | [2] 35 35, 162 💬
|
| 297 | CardAP-Zellen | - | - | - | - | [1] 57 57 💬
|
| 298 | CardAPcells | - | - | - | - | [1] 57 57 💬
|
| 299 | Cardiac Index-Guided Hemodynamic Management | - | - | - | - | [1] 22 22 💬
|
| 300 | Cardiac Magnetic Resonance Imaging (CMRI) | - | - | - | - | [1] 215 215 💬
|
| 301 | Cardiac monitoring | - | - | - | - | [1] 6 6 💬
|
| 302 | Cardiac MRI (CMR) | - | - | - | - | [2] 215 215, 216 💬
|
| 303 | Cardicor (Merck brand) | - | - | - | - | [1] 113 113 💬
|
| 304 | CardioMEMS pulmonary artery pressure monitor | - | - | - | - | [1] 86 86 💬
|
| 305 | Cardiovascular profile | - | - | - | - | [1] 113 113 💬
|
| 306 | CARDURA | - | - | - | - | [1] 67 67 💬
|
| 307 | CARDYL 10 mg comprimidos recubiertos con película | - | - | - | - | [1] 79 79 💬
|
| 308 | CARDYL 20 mg comprimidos recubiertos con película | - | - | - | - | [1] 79 79 💬
|
| 309 | CARDYL 40 mg comprimidos recubiertos con película | - | - | - | - | [1] 79 79 💬
|
| 310 | Care as usual | - | - | - | - | [1] 15 15 💬
|
| 311 | Carfentanil | [1] Carfentanil Carfentanil | [2] Carfentanil citrate
Carfentanil citrate
,
Carfentanil
💬
| [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 6 6 💬
|
| 312 | Carfilzomib | [1] Carfilzomib Carfilzomib | [1] Carfilzomib
Carfilzomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [2] 16 16, 28 💬
|
| 313 | CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE | [3] Carfilzomib Carfilzomib, Cyclophosphamide, Dexamethasone | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Cyclophosphamide
,
Dexamethasone phosphate
,
Carfilzomib
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 16 16 💬
|
| 314 | Carglumic Acid | [1] Carglumic acid Carglumic acid | [1] Carglumic acid
Carglumic acid
💬
| [1] CPS1 CPS1 💬
| [3] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬 | [3] 245 245, 246, 251 💬
|
| 315 | Carglumic Acid (Carbaglu®) | [1] Carglumic acid Carglumic acid | [1] Carglumic acid
Carglumic acid
💬
| [1] CPS1 CPS1 💬
| [3] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Nitrogen metabolism 💬 | [2] 245 245, 246 💬
|
| 316 | CARISBAMATE | [1] Carisbamate Carisbamate | [1] Carisbamate
Carisbamate
💬
| - | - | [1] 144 144 💬
|
| 317 | Carisbamate (S)-2-O-carbamoyl-1-o-chlorophenyl-ethanol | [2] Carisbamate Carisbamate, Ethanol | [3] Alcohol
Alcohol
,
Ethanol
,
Carisbamate
💬
| - | - | [1] 144 144 💬
|
| 318 | CARMUSTINA | - | - | - | - | [1] 13 13 💬
|
| 319 | Carmustine | [1] Carmustine Carmustine | [1] Carmustine
Carmustine
💬
| - | - | [5] 11 11, 13, 14, 28, 60 💬
|
| 320 | Carmustine, etoposide, cytarabine, and melphalan (BEAM) | [4] Carmustine Carmustine, Cytarabine, Etoposide, Melphalan | [7] Etoposide
Etoposide
,
Cytarabine
,
Carmustine
,
Melphalan
,
Cytarabine hydrochloride
,
Etoposide phosphate
,
Melphalan hydrochloride
💬
| - | - | [1] 13 13 💬
|
| 321 | Carnitine | - | - | - | - | [2] 46 46, 58 💬
|
| 322 | Carnosine | [1] Carnosine Carnosine | - | - | - | [2] 6 6, 13 💬
|
| 323 | Carnosine supplementation | [1] Carnosine Carnosine | - | - | - | [1] 6 6 💬
|
| 324 | Carnosine, capsulle, 2 g/day, 8 weeks | [1] Carnosine Carnosine | - | - | - | [1] 13 13 💬
|
| 325 | Carotegrast methyl | [1] Carotegrast methyl Carotegrast methyl | [1] Carotegrast methyl
Carotegrast methyl
💬
| [3] ITGA4 ITGA4, ITGB1, ITGB7 💬
| [32] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagocytosis, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Transcriptional misregulation in cancer, Virion - Rotavirus, Yersinia infection 💬 | [1] 97 97 💬
|
| 326 | Carotid to femoral PWW measurement | - | - | - | - | [1] 167 167 💬
|
| 327 | Carrageenan | - | - | - | - | [1] 97 97 💬
|
| 328 | CART Infusion | - | - | - | - | [2] 61 61, 63 💬
|
| 329 | CART19 | - | - | - | - | [1] 49 49 💬
|
| 330 | Carvedilol | [1] Carvedilol Carvedilol | [2] Carvedilol
Carvedilol
,
Carvedilol phosphate
💬
| [5] ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
| [15] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 6 6, 46, 57, 58, 86, 113, 210 💬
|
| 331 | CARVI EXTRACTUM FLUIDUM | - | - | - | - | [1] 97 97 💬
|
| 332 | CAS # in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid) | - | - | - | - | [1] 254 254 💬
|
| 333 | CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- | - | - | - | - | [1] 58 58 💬
|
| 334 | CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one | - | - | - | - | [1] 58 58 💬
|
| 335 | CAS Name: 1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] IUPAC Name: 4-(Pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-one | - | - | - | - | [1] 58 58 💬
|
| 336 | CAS No.: 7758-16-9 | - | - | - | - | [1] 166 166 💬
|
| 337 | CAS# in D.3.9.1 for Sodium Salt. CAS number 1639325-43-1 (Parent Acid) | - | - | - | - | [1] 254 254 💬
|
| 338 | Casein | [1] Casein Casein | - | - | - | [1] 97 97 💬
|
| 339 | Casein glycomacropeptide (CGMP) | [1] Casein Casein | - | - | - | [1] 97 97 💬
|
| 340 | CASIMERSEN | [1] Casimersen Casimersen | [1] Casimersen
Casimersen
💬
| [1] DMD DMD 💬
| [5] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | [1] 113 113 💬
|
| 341 | Caspofungin | [1] Caspofungin Caspofungin | [2] Caspofungin acetate
Caspofungin acetate
,
Caspofungin
💬
| - | - | [1] 60 60 💬
|
| 342 | CASPOFUNGIN ACETATE | [2] Acetate Acetate, Caspofungin | [2] Caspofungin acetate
Caspofungin acetate
,
Caspofungin
💬
| - | - | [1] 60 60 💬
|
| 343 | CAT-1004 | - | - | - | - | [1] 113 113 💬
|
| 344 | CAT-354 | - | - | - | - | [1] 97 97 💬
|
| 345 | Catapres ampoules | - | - | - | - | [1] 6 6 💬
|
| 346 | Catapresan 75, Tabletten | - | - | - | - | [1] 65 65 💬
|
| 347 | Cathepsin S | - | - | - | - | [1] 53 53 💬
|
| 348 | Cathepsin S Inhibitor | - | - | - | - | [1] 53 53 💬
|
| 349 | Catheter directed therapy | - | - | - | - | [1] 88 88 💬
|
| 350 | Catridecacog | [1] Catridecacog Catridecacog | [1] Catridecacog
Catridecacog
💬
| - | - | [1] 97 97 💬
|
| 351 | Caudal epidural injection | - | - | - | - | [1] 70 70 💬
|
| 352 | Caudal Epidural Injection with Celestone | - | - | - | - | [1] 70 70 💬
|
| 353 | Caudal Epidural Injection with DepoMedrol | - | - | - | - | [1] 70 70 💬
|
| 354 | Caudal Epidural Injection with generic Celestone | - | - | - | - | [1] 70 70 💬
|
| 355 | Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) | [1] LTI-03 LTI-03 | - | - | - | [1] 85 85 💬
|
| 356 | Cavosonstat | [1] Cavosonstat Cavosonstat | [1] Cavosonstat
Cavosonstat
💬
| - | - | [1] 299 299 💬
|
| 357 | Cayston | - | - | - | - | [1] 299 299 💬
|
| 358 | Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler | - | - | - | - | [1] 299 299 💬
|
| 359 | CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution | [1] Aztreonam Aztreonam | [2] Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | [1] 299 299 💬
|
| 360 | CB-01-02 | - | - | - | - | [1] 97 97 💬
|
| 361 | CB-01-05-MMX | - | - | - | - | [1] 97 97 💬
|
| 362 | CB-010 | [1] CB-010 CB-010 | - | - | - | [1] 49 49 💬
|
| 363 | CB-280 | - | - | - | - | [1] 299 299 💬
|
| 364 | CBD | - | - | - | - | [2] 13 13, 36 💬
|
| 365 | CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA. | - | - | - | - | [2] 140 140, 144 💬
|
| 366 | CBD - Oral Solution, is known as Epidyolex 100 mg/ml oral solution, | - | - | - | - | [1] 158 158 💬
|
| 367 | CBD - Oral Solution, is known as Epidyolex, and is the approved name | - | - | - | - | [1] 156 156 💬
|
| 368 | CBD - Solution Orale, conosciuto come Epidiolex, questo è il nome approvato negli Stati Uniti | - | - | - | - | [1] 156 156 💬
|
| 369 | CBD oil | - | - | - | - | [1] 51 51 💬
|
| 370 | CBD Oral Solution | - | - | - | - | [1] 206 206 💬
|
| 371 | CBD Oral Solution (eCBD system Target) | - | - | - | - | [1] 206 206 💬
|
| 372 | CBD Oral solution, is known as Epidyolex and is the approved name in the EU | - | - | - | - | [1] 156 156 💬
|
| 373 | CBD soluzione orale nota come Epidyolex e con tale nome è stato approvato in UE | - | - | - | - | [1] 156 156 💬
|
| 374 | CBD, synthetic form | - | - | - | - | [1] 97 97 💬
|
| 375 | CBD-Oral Solution, is known as Epidiolex, and is the approved name in the USA. | - | - | - | - | [1] 158 158 💬
|
| 376 | CBD: GT4 Transdermal Delivery System | - | - | - | - | [2] 140 140, 144 💬
|
| 377 | CBDV Compound | - | - | - | - | [1] 193 193 💬
|
| 378 | CBP-307 | - | - | - | - | [1] 97 97 💬
|
| 379 | CBT102-A capsule | - | - | - | - | [1] 240 240 💬
|
| 380 | CC-100004 | - | - | - | - | [1] 84 84 💬
|
| 381 | CC-10004 | - | - | - | - | [5] 46 46, 56, 97, 162, 271 💬
|
| 382 | CC-220 | - | - | - | - | [1] 49 49 💬
|
| 383 | CC-220 0.3 mg Daily | - | - | - | - | [1] 84 84 💬
|
| 384 | CC-220 0.6mg Daily | - | - | - | - | [1] 84 84 💬
|
| 385 | CC-292 | - | - | - | - | [1] 46 46 💬
|
| 386 | CC-4047 | - | - | - | - | [2] 28 28, 51 💬
|
| 387 | CC-5013 | - | - | - | - | [2] 28 28, 96 💬
|
| 388 | CC-90001 | [1] CC-90001 CC-90001 | - | - | - | [1] 85 85 💬
|
| 389 | CC-930 | - | - | - | - | [1] 85 85 💬
|
| 390 | CC-93538 | - | - | - | - | [1] 98 98 💬
|
| 391 | CC-97540 | - | - | - | - | [5] 11 11, 13, 46, 49, 51 💬
|
| 392 | CC-97540 (BMS-986353) | - | - | - | - | [1] 13 13 💬
|
| 393 | CC-99677 | - | - | - | - | [1] 271 271 💬
|
| 394 | CC-99677 30mg Capsule | - | - | - | - | [1] 271 271 💬
|
| 395 | CC-99677 60mg Capsule | - | - | - | - | [1] 271 271 💬
|
| 396 | CC100 | - | - | - | - | [1] 2 2 💬
|
| 397 | CC312 | - | - | - | - | [5] 46 46, 49, 51, 61, 63 💬
|
| 398 | CCD 1042 | - | - | - | - | [1] 152 152 💬
|
| 399 | CCD 1042, MD 9150000, Mepalon 1042, SPT316 | - | - | - | - | [2] 152 152, 206 💬
|
| 400 | CCD 1042, MD 9150000, Mepalon 1042, SPT3162 | - | - | - | - | [1] 152 152 💬
|
| 401 | CCI-779 | - | - | - | - | [2] 13 13, 46 💬
|
| 402 | CCP-020 | - | - | - | - | [1] 36 36 💬
|
| 403 | CCR1 Antagonist | - | - | - | - | [1] 46 46 💬
|
| 404 | CCX 354 | - | - | - | - | [1] 46 46 💬
|
| 405 | CCX 354-C | - | - | - | - | [1] 46 46 💬
|
| 406 | CCX-354 | [1] CCX-354 CCX-354 | - | - | - | [1] 46 46 💬
|
| 407 | CCX-354-C | [1] CCX-354 CCX-354 | - | - | - | [1] 46 46 💬
|
| 408 | CCX140-B | - | - | - | - | [1] 222 222 💬
|
| 409 | CCX168 | - | - | - | - | [6] 43 43, 44, 49, 66, 109, 223 💬
|
| 410 | CCX282-B | - | - | - | - | [1] 96 96 💬
|
| 411 | CCX354 | - | - | - | - | [1] 46 46 💬
|
| 412 | CCX354-C | - | - | - | - | [1] 46 46 💬
|
| 413 | CD-4 guided therapy interruption | - | - | - | - | [1] 265 265 💬
|
| 414 | CD-C-Food | - | - | - | - | [1] 96 96 💬
|
| 415 | CD-LD CR | - | - | - | - | [1] 6 6 💬
|
| 416 | CD-LD IR | - | - | - | - | [1] 6 6 💬
|
| 417 | CD19 CAR T Arm | - | - | - | - | [1] 51 51 💬
|
| 418 | CD19 CAR-?d T cell | - | - | - | - | [2] 66 66, 222 💬
|
| 419 | CD19 CAR-T cell infusion | - | - | - | - | [1] 49 49 💬
|
| 420 | CD19 CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 421 | CD19 or CD19-BCMA CAR-T | - | - | - | - | [2] 51 51, 53 💬
|
| 422 | CD19 targeted CAR-T cells | - | - | - | - | [3] 50 50, 51, 53 💬
|
| 423 | CD19 UCAR-T cells | - | - | - | - | [5] 48 48, 49, 51, 53, 63 💬
|
| 424 | CD19 Universal CAR-?d T Cells | - | - | - | - | [1] 49 49 💬
|
| 425 | CD19 Universal CAR-T cells | - | - | - | - | [1] 49 49 💬
|
| 426 | CD19- BCMA CAR-T cells | - | - | - | - | [4] 43 43, 49, 51, 53 💬
|
| 427 | CD19-BCMA CAR-T cells infusion | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 428 | CD19-BCMA Targeted CAR-T Dose 1 | - | - | - | - | [1] 11 11 💬
|
| 429 | CD19-BCMA Targeted CAR-T Dose 2 | - | - | - | - | [1] 11 11 💬
|
| 430 | CD19-CAR-DNT cells | - | - | - | - | [2] 49 49, 51 💬
|
| 431 | CD19-CAR-NK Cells Injection | - | - | - | - | [1] 11 11 💬
|
| 432 | CD19-directed humanised afucosylated monoclonal antibody | - | - | - | - | [1] 11 11 💬
|
| 433 | CD19-targetd CAR-T | - | - | - | - | [1] 50 50 💬
|
| 434 | CD19-targeted iNKT Cell Injection | - | - | - | - | [3] 66 66, 222, 223 💬
|
| 435 | CD19/BCMA CAR NK | - | - | - | - | [1] 300 300 💬
|
| 436 | CD19/BCMA CAR T-cells | - | - | - | - | [3] 16 16, 49, 61 💬
|
| 437 | CD19/BCMA CAR-T cell therapy | - | - | - | - | [1] 49 49 💬
|
| 438 | CD19/BCMA-targeted CAR-T cells | - | - | - | - | [3] 11 11, 13, 14 💬
|
| 439 | CD19/BCMA-Targeted Universal Chimeric Antigen Receptor T Cells (UCAR-T) infusing | - | - | - | - | [1] 222 222 💬
|
| 440 | CD19/CD22/BCMA CAR-T cells(BZE2204) | - | - | - | - | [2] 49 49, 63 💬
|
| 441 | CD20/BCMA-directed CAR-T cells | - | - | - | - | [4] 11 11, 13, 49, 51 💬
|
| 442 | CD3-depleted hematopoietic cell transplantation | - | - | - | - | [1] 60 60 💬
|
| 443 | CD3/CD19 depleted leukocytes | - | - | - | - | [1] 284 284 💬
|
| 444 | CD3/CD19 neg allogeneic BMT | - | - | - | - | [1] 65 65 💬
|
| 445 | CD3/CD19 negative allogeneic hematopoietic stem cells | - | - | - | - | [1] 65 65 💬
|
| 446 | CD3/CD19 negative hematopoietic stem cells | - | - | - | - | [1] 85 85 💬
|
| 447 | CD34 selected autologous hematopoietic cells | - | - | - | - | [1] 51 51 💬
|
| 448 | CD34 selected haploidentical PBSCT | - | - | - | - | [1] 285 285 💬
|
| 449 | CD34 Stem Cell Selection Therapy | - | - | - | - | [3] 60 60, 65, 284 💬
|
| 450 | CD34+ | - | - | - | - | [1] 65 65 💬
|
| 451 | CD34+ autologous stem cell transplantation | - | - | - | - | [1] 57 57 💬
|
| 452 | CD34+ bone marrow stem cells intravitreal | - | - | - | - | [1] 90 90 💬
|
| 453 | CD34+ cell enriched stem cell graft | - | - | - | - | [2] 65 65, 285 💬
|
| 454 | CD34+ CELLS | - | - | - | - | [1] 285 285 💬
|
| 455 | CD34+ cells enriched with MNV-BLD | - | - | - | - | [1] 21 21 💬
|
| 456 | CD34+ enriched, T Cell Depleted donor stem cell product | - | - | - | - | [1] 326 326 💬
|
| 457 | CD34+ HSCs transduced with the lentivirus vector, VSV-G pseudotyped CL20-4i-EF1a-h?c-OPT | - | - | - | - | [1] 65 65 💬
|
| 458 | CD34+ Peripheral Blood Stem Cell Reinfusion | - | - | - | - | [1] 49 49 💬
|
| 459 | CD34+ selected cells | - | - | - | - | [1] 285 285 💬
|
| 460 | CD34+CELLS | - | - | - | - | [2] 65 65, 285 💬
|
| 461 | CD34+SC | - | - | - | - | [1] 51 51 💬
|
| 462 | CD3±CD19 depleted hematopoietic stem cell transplantation | - | - | - | - | [1] 60 60 💬
|
| 463 | CD4-IgG | - | - | - | - | [1] 63 63 💬
|
| 464 | CD45RA depleted leukocytes | - | - | - | - | [1] 284 284 💬
|
| 465 | CD45RA-depleted DLI | - | - | - | - | [1] 60 60 💬
|
| 466 | CD62L- Tem | - | - | - | - | [1] 60 60 💬
|
| 467 | CD7 CAR T-cells | - | - | - | - | [3] 50 50, 96, 97 💬
|
| 468 | CD7 CAR-T cells infusion | - | - | - | - | [1] 60 60 💬
|
| 469 | CD7 CAR-T cells injection | - | - | - | - | [1] 60 60 💬
|
| 470 | CDC infusion | - | - | - | - | [1] 57 57 💬
|
| 471 | CDCA Weight-Based Dose TID | - | - | - | - | [1] 263 263 💬
|
| 472 | CDED+dairy | - | - | - | - | [1] 96 96 💬
|
| 473 | CDED+PEN | - | - | - | - | [1] 96 96 💬
|
| 474 | CDMARD | - | - | - | - | [1] 46 46 💬
|
| 475 | CDNF | - | - | - | - | [1] 6 6 💬
|
| 476 | CDP 6038 SC | - | - | - | - | [1] 46 46 💬
|
| 477 | CDP3194 | - | - | - | - | [1] 49 49 💬
|
| 478 | CDP323 | [1] CDP323 CDP323 | - | - | - | [1] 13 13 💬
|
| 479 | CDP6038 | - | - | - | - | [2] 46 46, 96 💬
|
| 480 | CDP6038 (olokizumab) | [1] Olokizumab Olokizumab | [1] Olokizumab
Olokizumab
💬
| [1] IL6 IL6 💬
| [49] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 💬
|
| 481 | CDP7657 | - | - | - | - | [1] 49 49 💬
|
| 482 | CDP870 | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 483 | CDP870 100mg | - | - | - | - | [1] 46 46 💬
|
| 484 | CDP870 200mg | - | - | - | - | [1] 46 46 💬
|
| 485 | CDP870 400mg | - | - | - | - | [1] 46 46 💬
|
| 486 | CDP870 Fab'-PEG | - | - | - | - | [1] 46 46 💬
|
| 487 | CDX 6114 | - | - | - | - | [1] 240 240 💬
|
| 488 | CDX-0159 | - | - | - | - | [1] 98 98 💬
|
| 489 | CDX-1135 | [1] CDX-1135 CDX-1135 | - | - | - | [1] 223 223 💬
|
| 490 | CDZ173 | - | - | - | - | [2] 53 53, 65 💬
|
| 491 | CE 224,535 | - | - | - | - | [1] 46 46 💬
|
| 492 | CE-224,535 | - | - | - | - | [1] 46 46 💬
|
| 493 | CE-VST01-JC | [1] CE-VST01-JC CE-VST01-JC | - | - | - | [1] 25 25 💬
|
| 494 | CE1145 | - | - | - | - | [1] 65 65 💬
|
| 495 | CE211NS21 | - | - | - | - | [1] 13 13 💬
|
| 496 | CEBION 500*20CPR MAST 500MG | - | - | - | - | [1] 10 10 💬
|
| 497 | CEBION 500MG 20CPR MAST.ARAN | - | - | - | - | [1] 10 10 💬
|
| 498 | Cebsulfase alfa | - | - | - | - | [1] 19 19 💬
|
| 499 | Cediranib | [1] Cediranib Cediranib | [2] Cediranib
Cediranib
,
Cediranib maleate
💬
| [3] FLT1 FLT1, FLT4, KDR 💬
| [17] Breast cancer Breast cancer, Cadherin signaling, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 34 34 💬
|
| 500 | Cediranib Maleate | [1] Cediranib Cediranib | [2] Cediranib
Cediranib
,
Cediranib maleate
💬
| [3] FLT1 FLT1, FLT4, KDR 💬
| [17] Breast cancer Breast cancer, Cadherin signaling, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 34 34 💬
|
| 501 | Cefaclor | [1] Cefaclor Cefaclor | [2] Cefaclor
Cefaclor
,
Cefaclor
💬
| - | - | [1] 296 296 💬
|
| 502 | CEFALEXIN | - | - | - | - | [1] 299 299 💬
|
| 503 | Cefazolin | [1] Cefazolin Cefazolin | [2] Cefazolin sodium
Cefazolin sodium
,
Cefazolin
💬
| - | - | [1] 291 291 💬
|
| 504 | CEFAZOLINA | - | - | - | - | [1] 90 90 💬
|
| 505 | Cefazolina Qilu | - | - | - | - | [1] 90 90 💬
|
| 506 | Cefepime | [1] Cefepime Cefepime | [2] Cefepime hydrochloride
Cefepime hydrochloride
,
Cefepime
💬
| - | - | [2] 60 60, 299 💬
|
| 507 | CEFEPIME DIHYDROCHLORIDE MONOHYDRATE | [1] Cefepime Cefepime | [2] Cefepime hydrochloride
Cefepime hydrochloride
,
Cefepime
💬
| - | - | [1] 60 60 💬
|
| 508 | Cefiderocol | [1] Cefiderocol Cefiderocol | [2] Cefiderocol sulfate tosylate
Cefiderocol sulfate tosylate
,
Cefiderocol
💬
| - | - | [3] 96 96, 97, 299 💬
|
| 509 | Cefmetazole | [1] Cefmetazole Cefmetazole | [2] Cefmetazole
Cefmetazole
,
Cefmetazole sodium
💬
| - | - | [2] 96 96, 97 💬
|
| 510 | Cefoperazone | [1] Cefoperazone Cefoperazone | [2] Cefoperazone sodium
Cefoperazone sodium
,
Cefoperazone
💬
| - | - | [1] 296 296 💬
|
| 511 | Cefoxitin | [1] Cefoxitin Cefoxitin | [2] Cefoxitin sodium
Cefoxitin sodium
,
Cefoxitin
💬
| - | - | [1] 299 299 💬
|
| 512 | Ceftaroline | - | - | - | - | [1] 299 299 💬
|
| 513 | Ceftazidim Fresenius Kabi | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 514 | Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 515 | CEFTAZIDIMA PENTAIDRATO | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 516 | CEFTAZIDIME | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 517 | Ceftazidime and tobramycin | [2] Ceftazidime Ceftazidime, Tobramycin | [4] Tobramycin
Tobramycin
,
Ceftazidime
,
Tobramycin sulfate
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 518 | CEFTAZIDIME PENTAHYDRATE | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 519 | Ceftazidime/avibactam | [2] Avibactam Avibactam, Ceftazidime | [3] Ceftazidime
Ceftazidime
,
Ceftazidime
,
Avibactam sodium
💬
| - | - | [1] 299 299 💬
|
| 520 | Ceftolozane | [1] Ceftolozane Ceftolozane | [2] Ceftolozane
Ceftolozane
,
Ceftolozane sulfate
💬
| - | - | [1] 299 299 💬
|
| 521 | Ceftolozane/Tazobactam | [2] Ceftolozane Ceftolozane, Tazobactam | [4] Tazobactam
Tazobactam
,
Tazobactam sodium
,
Ceftolozane
,
Ceftolozane sulfate
💬
| - | - | [1] 299 299 💬
|
| 522 | Ceftriaxone | [1] Ceftriaxone Ceftriaxone | [2] Ceftriaxone sodium
Ceftriaxone sodium
,
Ceftriaxone
💬
| - | - | [4] 2 2, 6, 97, 299 💬
|
| 523 | Ceftriaxone for Injection | [1] Ceftriaxone Ceftriaxone | [2] Ceftriaxone sodium
Ceftriaxone sodium
,
Ceftriaxone
💬
| - | - | [1] 299 299 💬
|
| 524 | Cefuroxim | [1] Cefuroxime Cefuroxime | [3] Cefuroxime
Cefuroxime
,
Cefuroxime axetil
,
Cefuroxime sodium
💬
| - | - | [1] 299 299 💬
|
| 525 | CEFUROXIMA | - | - | - | - | [1] 90 90 💬
|
| 526 | Cefuroxime | [1] Cefuroxime Cefuroxime | [3] Cefuroxime
Cefuroxime
,
Cefuroxime axetil
,
Cefuroxime sodium
💬
| - | - | [2] 97 97, 299 💬
|
| 527 | CELBESTA® | - | - | - | - | [1] 46 46 💬
|
| 528 | Celebra | - | - | - | - | [1] 46 46 💬
|
| 529 | Celebra (celecoxib) | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 530 | CELEBREX | - | - | - | - | [4] 46 46, 96, 107, 271 💬
|
| 531 | Celebrex 200 mg | - | - | - | - | [1] 46 46 💬
|
| 532 | Celebrex 200 mg capsule, hard | - | - | - | - | [1] 46 46 💬
|
| 533 | Celebrex 200 mg Hartkapseln | - | - | - | - | [1] 46 46 💬
|
| 534 | CELEBREX 200MG 20CPS | - | - | - | - | [1] 46 46 💬
|
| 535 | Celebrex 200Mg Capsule | - | - | - | - | [1] 70 70 💬
|
| 536 | Celebrex, Celcox | - | - | - | - | [1] 2 2 💬
|
| 537 | CELEBREX® | - | - | - | - | [1] 46 46 💬
|
| 538 | CELECOXIB | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [14] 2 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
| 539 | Celecoxib (Celebrex) | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 34 34 💬
|
| 540 | Celecoxib 200 milligrams | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 541 | Celecoxib 200mg | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 6 6 💬
|
| 542 | Celecoxib 200mg capsule | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 543 | Celecoxib 400 milligrams | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 544 | Celecoxib, Celebrex® | [1] Celecoxib Celecoxib | [1] Celecoxib
Celecoxib
💬
| [1] PTGS2 PTGS2 💬
| [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 💬
|
| 545 | Celiac Block with triamcinolone and bupivicaine | [1] Triamcinolone Triamcinolone | [4] Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 298 298 💬
|
| 546 | Celiprolol | [1] Celiprolol Celiprolol | [2] Celiprolol hydrochloride
Celiprolol hydrochloride
,
Celiprolol
💬
| [1] ADRB1 ADRB1 💬
| [13] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 168 168 💬
|
| 547 | Cell | - | - | - | - | [1] 57 57 💬
|
| 548 | Cell Infusion | - | - | - | - | [3] 60 60, 62, 283 💬
|
| 549 | Cell suspension containing dendritic cells | - | - | - | - | [1] 13 13 💬
|
| 550 | Cell transplantation | - | - | - | - | [1] 36 36 💬
|
| 551 | Cell-based therapeutics | - | - | - | - | [1] 2 2 💬
|
| 552 | Cell-based therapy | - | - | - | - | [1] 2 2 💬
|
| 553 | Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients | - | - | - | - | [1] 2 2 💬
|
| 554 | Cellavita HD Higher dose | - | - | - | - | [1] 8 8 💬
|
| 555 | Cellavita HD Lower Dose | - | - | - | - | [1] 8 8 💬
|
| 556 | Cellavita-HD | - | - | - | - | [1] 8 8 💬
|
| 557 | CELLCEPT | - | - | - | - | [7] 11 11, 13, 42, 43, 49, 222, 223 💬
|
| 558 | CellCept (Mycophenolate Mofetil) | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 42 42, 43 💬
|
| 559 | CellCept 500 mg | - | - | - | - | [1] 11 11 💬
|
| 560 | CellCept 500 mg comprimidos recubiertos | - | - | - | - | [1] 35 35 💬
|
| 561 | CellCept 500 mg film-coated tablets | - | - | - | - | [1] 11 11 💬
|
| 562 | CellCept 500 mg tablets | - | - | - | - | [1] 11 11 💬
|
| 563 | CELLCEPT® | - | - | - | - | [1] 35 35 💬
|
| 564 | Cellcept® in autoimmune bullous dermatoses | - | - | - | - | [2] 35 35, 162 💬
|
| 565 | CellCept®500 mg comprimidos | - | - | - | - | [1] 35 35 💬
|
| 566 | CellCept®500 mg tablets | - | - | - | - | [1] 11 11 💬
|
| 567 | Cellular therapy with EBV specific autologous CTL infusion | - | - | - | - | [1] 13 13 💬
|
| 568 | Cellule CD34+ autologhe trasdotte con IDUA LV codificante per il cDNA dell'alfa-L-iduronidasi | - | - | - | - | [1] 19 19 💬
|
| 569 | Cellule mesenchimali stromali di origine cordonale (CB-MSC) per uso allogenico) | - | - | - | - | [1] 222 222 💬
|
| 570 | Cellulose | - | - | - | - | [1] 84 84 💬
|
| 571 | Cellulose acetate with petrolatum | [2] Acetate Acetate, Petrolatum | [2] Petrolatum, white
Petrolatum, white
,
Petrolatum
💬
| - | - | [2] 35 35, 162 💬
|
| 572 | Cellvizio 100 Series System with Confocal Miniprobes | - | - | - | - | [1] 215 215 💬
|
| 573 | Celulas hepatocitos troncales adultas alogenicas de higado expandidas | - | - | - | - | [1] 251 251 💬
|
| 574 | Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida | - | - | - | - | [1] 274 274 💬
|
| 575 | Cemdisiran | [1] Cemdisiran Cemdisiran | - | - | - | [6] 11 11, 15, 62, 66, 109, 223 💬
|
| 576 | Cendakimab | [1] Cendakimab Cendakimab | [1] Cendakimab
Cendakimab
💬
| [1] IL13 IL13 💬
| [8] Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | [1] 98 98 💬
|
| 577 | Cenegermin | [1] Cenegermin Cenegermin | [1] Cenegermin
Cenegermin
💬
| [1] NGFR NGFR 💬
| [9] Apoptosis - multiple species Apoptosis - multiple species, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬 | [1] 53 53 💬
|
| 578 | Cenerimod | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 579 | Cenerimod 0.5 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 580 | Cenerimod 1 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 581 | Cenerimod 2 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 582 | Cenerimod 2 mg (ex-4 mg) | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 583 | Cenerimod 4 mg | [1] Cenerimod Cenerimod | [1] Cenerimod
Cenerimod
💬
| [1] S1PR1 S1PR1 💬
| [4] Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 49 49 💬
|
| 584 | Cenicriviroc | [1] Cenicriviroc Cenicriviroc | [2] Cenicriviroc
Cenicriviroc
,
Cenicriviroc mesylate
💬
| [2] CCR2 CCR2, CCR5 💬
| [11] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 94 94 💬
|
| 585 | Cenicriviroc 150 mg | [1] Cenicriviroc Cenicriviroc | [2] Cenicriviroc
Cenicriviroc
,
Cenicriviroc mesylate
💬
| [2] CCR2 CCR2, CCR5 💬
| [11] Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [1] 94 94 💬
|
| 586 | Cenplacel-L | [1] Cenplacel-L Cenplacel-L | [1] Cenplacel-L
Cenplacel-L
💬
| - | - | [1] 84 84 💬
|
| 587 | CENSAVUDINE | [1] Censavudine Censavudine | [1] Censavudine
Censavudine
💬
| - | - | [3] 2 2, 127, 325 💬
|
| 588 | Centerpiece titanium plate | [1] Titanium Titanium | - | - | - | [1] 70 70 💬
|
| 589 | Central venous line placement | - | - | - | - | [1] 215 215 💬
|
| 590 | Centricyte 1000 | - | - | - | - | [2] 85 85, 229 💬
|
| 591 | CEP-1347 | [1] CEP-1347 CEP-1347 | - | - | - | [1] 6 6 💬
|
| 592 | CEP-1347 10mg | [1] CEP-1347 CEP-1347 | - | - | - | [1] 6 6 💬
|
| 593 | CEP-1347 50mg | [1] CEP-1347 CEP-1347 | - | - | - | [1] 6 6 💬
|
| 594 | CEP-33457 | - | - | - | - | [1] 49 49 💬
|
| 595 | CEP1347 | - | - | - | - | [1] 6 6 💬
|
| 596 | CEP1347 25mg | - | - | - | - | [1] 6 6 💬
|
| 597 | Cephalexin | [1] Cephalexin Cephalexin | [2] Cefalexin
Cefalexin
,
Cephalexin
💬
| - | - | [1] 299 299 💬
|
| 598 | Cepharanthine | [1] Cepharanthine Cepharanthine | [1] Cepharanthine
Cepharanthine
💬
| - | - | [1] 53 53 💬
|
| 599 | CER-001 | [1] CER-001 CER-001 | - | - | - | [1] 79 79 💬
|
| 600 | Ceralifimod | [1] Ceralifimod Ceralifimod | - | - | - | [1] 13 13 💬
|
| 601 | Ceralifmod | - | - | - | - | [1] 13 13 💬
|
| 602 | Cerazette | - | - | - | - | [1] 230 230 💬
|
| 603 | CERC-006 | - | - | - | - | [1] 278 278 💬
|
| 604 | Cerdelga | - | - | - | - | [1] 19 19 💬
|
| 605 | CERE-120 | [1] CERE-120 CERE-120 | - | - | - | [1] 6 6 💬
|
| 606 | CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) | [1] CERE-120 CERE-120 | - | - | - | [1] 6 6 💬
|
| 607 | CERE-120: Adeno-Associated Virus Delivery of Neurturin | [1] CERE-120 CERE-120 | - | - | - | [1] 6 6 💬
|
| 608 | Cerebral Dopamine Neurotrophic Factor | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 609 | Cerebro-spinal fluid | - | - | - | - | [1] 13 13 💬
|
| 610 | Cerebrolysin | [1] Cerebrolysin Cerebrolysin | - | - | - | [1] 124 124 💬
|
| 611 | CEREDASE™ | - | - | - | - | [1] 19 19 💬
|
| 612 | Ceretec | - | - | - | - | [1] 6 6 💬
|
| 613 | CERETEC (TM) Estabilizado | - | - | - | - | [1] 6 6 💬
|
| 614 | CEREZYME | - | - | - | - | [1] 19 19 💬
|
| 615 | Cerezyme (imiglucerase for injection) | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 616 | Cerezyme 400 Units Powder for concentrate for solution for infusion | - | - | - | - | [1] 19 19 💬
|
| 617 | Cerezyme 400 Units Powder for concentrate for solution for infusionPharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: ImigluceraseCAS Number: 154248-97-2Concentration unit: U unit(s)Concentration type: equalConcentration number: 400-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 19 19 💬
|
| 618 | Cerezyme 400 Unità Polvere per concentrato per soluzione per infusione | - | - | - | - | [1] 19 19 💬
|
| 619 | Cerezyme® | - | - | - | - | [1] 19 19 💬
|
| 620 | Cerezyme® / Imiglucerase | [1] Imiglucerase Imiglucerase | [2] Alglucerase
Alglucerase
,
Imiglucerase
💬
| [1] GBA1 GBA1 💬
| [4] Cornified envelope formation Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬 | [1] 19 19 💬
|
| 621 | Cerliponase Alfa | [1] Cerliponase alfa Cerliponase alfa | [1] Cerliponase alfa
Cerliponase alfa
💬
| [1] TPP1 TPP1 💬
| [1] Lysosome biogenesis Lysosome biogenesis 💬 | [1] 19 19 💬
|
| 622 | Certican | - | - | - | - | [3] 67 67, 96, 228 💬
|
| 623 | Certican 0,5 | - | - | - | - | [1] 228 228 💬
|
| 624 | Certican 0,5 mg Tabletten | - | - | - | - | [1] 228 228 💬
|
| 625 | Certican 0,75mg | - | - | - | - | [1] 228 228 💬
|
| 626 | Certican 0,75mg Tabletten | - | - | - | - | [1] 228 228 💬
|
| 627 | Certican 1 mg tablets | - | - | - | - | [1] 158 158 💬
|
| 628 | Certican Tabletten | - | - | - | - | [1] 67 67 💬
|
| 629 | Certolizumab | - | - | - | - | [6] 46 46, 48, 49, 96, 270, 271 💬
|
| 630 | Certolizumab Pegol | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [10] 37 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
|
| 631 | Certolizumab pegol (CDP870) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 96 💬
|
| 632 | Certolizumab pegol (CDP870, CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 633 | Certolizumab pegol (CDP870, tradename Cimzia) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 634 | Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 635 | Certolizumab Pegol (CZP) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 96, 107, 271 💬
|
| 636 | Certolizumab Pegol (CZP) 200 mg | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 637 | Certolizumab Pegol (CZP) 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 638 | Certolizumab pegol (rINN) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 639 | Certolizumab Pegol + Methotrexate (MTX) | [2] Certolizumab pegol Certolizumab pegol, Methotrexate | [3] Methotrexate
Methotrexate
,
Methotrexate sodium
,
Certolizumab pegol
💬
| [3] DHFR DHFR, DHFR2, TNF 💬
| [69] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 640 | Certolizumab pegol / CIMZIA | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 641 | Certolizumab Pegol /Cimzia | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 642 | Certolizumab Pegol 200 MG/ML [Cimzia] | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 643 | Certolizumab pegol 400 mg | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 💬
|
| 644 | CertolizumabPegol injection | - | - | - | - | [1] 46 46 💬
|
| 645 | CERTOLUZIMAB PEGOL | - | - | - | - | [1] 46 46 💬
|
| 646 | Cervarix suspensie voor injectie | - | - | - | - | [3] 49 49, 50, 107 💬
|
| 647 | Cervical interbody fusion | - | - | - | - | [1] 70 70 💬
|
| 648 | Cervical spinal cord and brain MRI | - | - | - | - | [1] 2 2 💬
|
| 649 | Cesamet™ (nabilone) | [1] Nabilone Nabilone | [1] Nabilone
Nabilone
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 💬
|
| 650 | Ceterizine | - | - | - | - | [1] 13 13 💬
|
| 651 | Cetirizina | [1] Cetirizine Cetirizine | [2] Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 300, 309 💬
|
| 652 | CETIRIZINA DICLORIDRATO | - | - | - | - | [1] 28 28 💬
|
| 653 | Cetirizina Mylan Generics | [1] Cetirizine Cetirizine | [2] Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 654 | CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU | - | - | - | - | [1] 300 300 💬
|
| 655 | Cetirizine | [1] Cetirizine Cetirizine | [2] Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [3] 13 13, 19, 35 💬
|
| 656 | CETIRIZINE HYDROCHLORIDE | [1] Cetirizine Cetirizine | [2] Cetirizine hydrochloride
Cetirizine hydrochloride
,
Cetirizine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 657 | Cetrizine | - | - | - | - | [1] 13 13 💬
|
| 658 | Cetrorelix | [1] Cetrorelix Cetrorelix | [2] Cetrorelix acetate
Cetrorelix acetate
,
Cetrorelix
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 659 | Cetuximab | [1] Cetuximab Cetuximab | [1] Cetuximab
Cetuximab
💬
| [1] EGFR EGFR 💬
| [49] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬 | [5] 34 34, 51, 86, 89, 331 💬
|
| 660 | Cevidoplenib | [1] Cevidoplenib Cevidoplenib | - | - | - | [2] 46 46, 63 💬
|
| 661 | Cevimeline | [1] Cevimeline Cevimeline | [2] Cevimeline hydrochloride
Cevimeline hydrochloride
,
Cevimeline
💬
| [1] CHRM3 CHRM3 💬
| [12] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 53 53 💬
|
| 662 | Cevostamab | [1] Cevostamab Cevostamab | [1] Cevostamab
Cevostamab
💬
| [1] CD3E CD3E 💬
| [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 49 49 💬
|
| 663 | CF patients with a G551D mutation and treated with Ivacaftor | [1] Ivacaftor Ivacaftor | [1] Ivacaftor
Ivacaftor
💬
| [1] CFTR CFTR 💬
| [9] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 💬
|
| 664 | CF-CB-MSC | - | - | - | - | [1] 222 222 💬
|
| 665 | CF101 | - | - | - | - | [1] 46 46 💬
|
| 666 | CF101 1 mg | - | - | - | - | [1] 46 46 💬
|
| 667 | CF101 2 mg | - | - | - | - | [1] 46 46 💬
|
| 668 | CFTR Modulators | - | - | - | - | [1] 299 299 💬
|
| 669 | CFTR potentiator | - | - | - | - | [1] 299 299 💬
|
| 670 | CFZ533 | - | - | - | - | [4] 11 11, 46, 49, 53 💬
|
| 671 | CFZ533 active - Cohort 1 | - | - | - | - | [1] 53 53 💬
|
| 672 | CFZ533 active - Cohort 2 | - | - | - | - | [1] 53 53 💬
|
| 673 | CFZ533 active - Cohort 3 | - | - | - | - | [1] 53 53 💬
|
| 674 | CFZ533 active -Cohort 3 | - | - | - | - | [1] 53 53 💬
|
| 675 | CG-BM1 | - | - | - | - | [1] 271 271 💬
|
| 676 | CGM/CKM | - | - | - | - | [1] 67 67 💬
|
| 677 | CGMP protein | - | - | - | - | [1] 97 97 💬
|
| 678 | CGP 77116 | - | - | - | - | [1] 13 13 💬
|
| 679 | CH-1504 | - | - | - | - | [1] 46 46 💬
|
| 680 | CH-4051 | - | - | - | - | [1] 46 46 💬
|
| 681 | Ch11-1F4 (NSC-711516) | - | - | - | - | [1] 28 28 💬
|
| 682 | ChAdOx2 HAV | - | - | - | - | [1] 96 96 💬
|
| 683 | Chamomile | [1] Chamomile Chamomile | [1] German chamomile flower
German chamomile flower
💬
| - | - | [1] 6 6 💬
|
| 684 | Champix | - | - | - | - | [1] 6 6 💬
|
| 685 | Characterization of carotenoid status and plasma levels of oxidative stress markers in patients (case group only) | - | - | - | - | [1] 264 264 💬
|
| 686 | Charcoal | - | - | - | - | [1] 13 13 💬
|
| 687 | Chelation | - | - | - | - | [1] 60 60 💬
|
| 688 | Chemical name: [R-(R*, R*)]-2-(4-fluorophenyl)-beta, ?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenyl | - | - | - | - | [1] 79 79 💬
|
| 689 | Chemical name: [R-(R*, R*)]-2-(4-fluorophenyl)-ß, ?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenyl | - | - | - | - | [1] 79 79 💬
|
| 690 | CHEMICALLY MODIFIED RECOMBINANT HUMAN SULFAMIDASE | - | - | - | - | [1] 19 19 💬
|
| 691 | Chemotherapy | - | - | - | - | [3] 28 28, 60, 285 💬
|
| 692 | Chemotherapy Agents | - | - | - | - | [1] 51 51 💬
|
| 693 | Chemotherapy, intrathecal chemotherapy, steroid therapy | - | - | - | - | [1] 65 65 💬
|
| 694 | Chemotherapy: cyclophosphamide (CYC) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
| 695 | Chemotherapy: fludarabine (FLU) | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 696 | Chenodeoxycholic acid | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [5] 20 20, 86, 96, 234, 263 💬
|
| 697 | Chenodeoxycholic acid leadiant | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 263 263 💬
|
| 698 | Chenodiol | [1] Chenodeoxycholic acid Chenodeoxycholic acid | [1] Chenodiol
Chenodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 96 96 💬
|
| 699 | Chenofalk | - | - | - | - | [1] 96 96 💬
|
| 700 | Cherry | [1] Cherry Cherry | - | - | - | [1] 97 97 💬
|
| 701 | Chest X-ray | - | - | - | - | [1] 215 215 💬
|
| 702 | CHF 6333 | - | - | - | - | [1] 299 299 💬
|
| 703 | CHF10067 | - | - | - | - | [1] 85 85 💬
|
| 704 | CHF10067 high dose -- 3000mg (Cohort C) | - | - | - | - | [1] 85 85 💬
|
| 705 | CHF10067 intermediate dose -- 2000mg (Cohort B) | - | - | - | - | [1] 85 85 💬
|
| 706 | CHF10067 starting dose -- 1000mg (Cohort A) | - | - | - | - | [1] 85 85 💬
|
| 707 | CHF6333 | - | - | - | - | [1] 299 299 💬
|
| 708 | CHF6333 (Part 1 - SAD) | - | - | - | - | [1] 299 299 💬
|
| 709 | CHF6333 (Part 2 - MAD) | - | - | - | - | [1] 299 299 💬
|
| 710 | CHF6657 | - | - | - | - | [1] 19 19 💬
|
| 711 | Chicken | [1] Chicken Chicken | - | - | - | [1] 46 46 💬
|
| 712 | Chicken type II collagen | [1] Chicken Chicken | - | - | - | [1] 46 46 💬
|
| 713 | Chidamide | - | - | - | - | [1] 63 63 💬
|
| 714 | CHIMERIC FIBRIL-REACTIVE IGG1K MONOCLONAL ANTIBODY 11-1F4 | - | - | - | - | [1] 28 28 💬
|
| 715 | Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4 | - | - | - | - | [1] 28 28 💬
|
| 716 | Chimeric Human-Murine IgG1 | - | - | - | - | [1] 46 46 💬
|
| 717 | Chimeric human/mouse anti-CD-20 monoclonal antibody | - | - | - | - | [1] 46 46 💬
|
| 718 | Chimeric IgG1 monoclonal antibody | - | - | - | - | [1] 96 96 💬
|
| 719 | Chimeric monoclonal antibody, IgG4 subtype | - | - | - | - | [2] 43 43, 44 💬
|
| 720 | Chimeric murine human anti-IL-6 monoclonal antibody | - | - | - | - | [1] 331 331 💬
|
| 721 | Chinese Herb Prescription Granule plus prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 💬
|
| 722 | Chinese herbal concoction twice a day for 6 months | - | - | - | - | [1] 60 60 💬
|
| 723 | Chinese herbal medicine treatment | - | - | - | - | [1] 6 6 💬
|
| 724 | Chinese herbal tea TBDESJS | - | - | - | - | [1] 53 53 💬
|
| 725 | Chinese herbs based on syndrome differentiation | - | - | - | - | [1] 224 224 💬
|
| 726 | Chinese medicine WT | - | - | - | - | [1] 18 18 💬
|
| 727 | Chlorambucil | [1] Chlorambucil Chlorambucil | [1] Chlorambucil
Chlorambucil
💬
| - | - | [2] 222 222, 223 💬
|
| 728 | Chlorhexidine | [1] Chlorhexidine Chlorhexidine | [4] Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
💬
| - | - | [2] 86 86, 299 💬
|
| 729 | Chlorhexidine Gluconate | [1] Chlorhexidine Chlorhexidine | [4] Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
💬
| - | - | [1] 299 299 💬
|
| 730 | Chlorhexidine gluconate oral rinse | [1] Chlorhexidine Chlorhexidine | [4] Chlorhexidine gluconate
Chlorhexidine gluconate
,
Chlorhexidine hydrochloride
,
Chlorhexidine
,
Chlorhexidine acetate
💬
| - | - | [1] 299 299 💬
|
| 731 | Chloride ion | [1] Chloride ion Chloride ion | - | - | - | [1] 299 299 💬
|
| 732 | Chlorogenic Acid | [1] Chlorogenic Acid Chlorogenic Acid | - | - | - | [1] 97 97 💬
|
| 733 | Chloroquine | [1] Chloroquine Chloroquine | [4] Chloroquine phosphate
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
💬
| - | - | [3] 46 46, 49, 95 💬
|
| 734 | Chloroquine diphosphate | [1] Chloroquine Chloroquine | [4] Chloroquine phosphate
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
💬
| - | - | [1] 95 95 💬
|
| 735 | Chloroquine diphosphate 250mg | [1] Chloroquine Chloroquine | [4] Chloroquine phosphate
Chloroquine phosphate
,
Chloroquine
,
Chloroquine hydrochloride
,
Chloroquine sulfate
💬
| - | - | [1] 95 95 💬
|
| 736 | Chlorothiazide | [1] Chlorothiazide Chlorothiazide | [2] Chlorothiazide
Chlorothiazide
,
Chlorothiazide sodium
💬
| [1] SLC12A3 SLC12A3 💬
| [1] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action 💬 | [1] 225 225 💬
|
| 737 | Chlorpromazine | [1] Chlorpromazine Chlorpromazine | [2] Chlorpromazine
Chlorpromazine
,
Chlorpromazine hydrochloride
💬
| [13] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 120 120, 254 💬
|
| 738 | Chlorpromazine Hydrochloride | [1] Chlorpromazine Chlorpromazine | [2] Chlorpromazine
Chlorpromazine
,
Chlorpromazine hydrochloride
💬
| [13] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2B, HTR2C 💬
| [24] Alcoholism Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 254 254 💬
|
| 739 | CHLORURE DE SODIUM | - | - | - | - | [1] 96 96 💬
|
| 740 | Chocolate | - | - | - | - | [1] 6 6 💬
|
| 741 | CHOLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [10] 13 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
|
| 742 | Cholecalciferol (Vitamin D3) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [2] 13 13, 299 💬
|
| 743 | Cholecalciferol (vitaminD3) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 299 299 💬
|
| 744 | Cholecalciferol 10,000 IU | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 745 | Cholecalciferol 400 IU | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 746 | Cholecalciferol and C. Xanthorrhiza | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 49 49 💬
|
| 747 | CHOLECALCIFEROL CONCENTRATE | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 748 | CHOLECALCIFEROL CONCENTRATE (WATER-DISPERSIBLE FORM) | [2] Cholecalciferol Cholecalciferol, Water | [2] Water
Water
,
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 💬
|
| 749 | Cholecalciferol Pill | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 299 299 💬
|
| 750 | Cholecalciferol vial (100 000 UI) | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 222 222 💬
|
| 751 | Cholecalciferol, Vitamin D3 | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 13 13 💬
|
| 752 | Cholestagel | - | - | - | - | [2] 79 79, 96 💬
|
| 753 | Cholesterol | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [10] 8 8, 19, 71, 79, 90, 160, 222, 259, 261, 310 💬
|
| 754 | Cholesterol supplementation | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 310 310 💬
|
| 755 | Cholesterol Suspension | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 310 310 💬
|
| 756 | Cholestyramine | [1] Cholestyramine Cholestyramine | [1] Cholestyramine resin
Cholestyramine resin
💬
| - | - | [2] 13 13, 79 💬
|
| 757 | Cholic Acid | [1] Cholic Acid Cholic Acid | [1] Cholic acid
Cholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [4] 20 20, 234, 265, 310 💬
|
| 758 | Cholic Acids | - | - | - | - | [2] 20 20, 234 💬
|
| 759 | Choline | [1] Choline Choline | [1] Choline
Choline
💬
| - | - | [4] 93 93, 171, 193, 299 💬
|
| 760 | Choline Chloride | [1] Choline Choline | [1] Choline
Choline
💬
| - | - | [1] 299 299 💬
|
| 761 | Choline supplementation | [1] Choline Choline | [1] Choline
Choline
💬
| - | - | [1] 299 299 💬
|
| 762 | Chondroitin sulfate | [1] Chondroitin sulfate Chondroitin sulfate | [1] Chondroitin sulfate A
Chondroitin sulfate A
💬
| - | - | [2] 96 96, 226 💬
|
| 763 | Chong Kun Dang Tofacitinib Tablet | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 💬
|
| 764 | CHOP-daclizumab | [1] Daclizumab Daclizumab | [1] Daclizumab
Daclizumab
💬
| [1] IL2RA IL2RA 💬
| [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 26 26 💬
|
| 765 | CHR-1103 / GBR500 | - | - | - | - | [1] 13 13 💬
|
| 766 | Chromium | [1] Chromium Chromium | - | - | - | [1] 46 46 💬
|
| 767 | Chronic Antioxidant | - | - | - | - | [1] 299 299 💬
|
| 768 | Chronic Corticosteroid Therapy | - | - | - | - | [1] 113 113 💬
|
| 769 | Chronic- PF-06480605 150 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 770 | Chronic- PF-06480605 450 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 771 | Chronic- PF-06480605 50 mg SC Q4W | - | - | - | - | [1] 97 97 💬
|
| 772 | Chronocort | - | - | - | - | [1] 81 81 💬
|
| 773 | Chronocort 10mg | - | - | - | - | [1] 81 81 💬
|
| 774 | Chronocort 5mg | - | - | - | - | [1] 81 81 💬
|
| 775 | Chronocort® | - | - | - | - | [1] 81 81 💬
|
| 776 | Chronocort® 10 mg | - | - | - | - | [1] 81 81 💬
|
| 777 | Chronocort® 20 mg | - | - | - | - | [1] 81 81 💬
|
| 778 | Chronocort® 5 mg | - | - | - | - | [1] 81 81 💬
|
| 779 | CHS-0214 | - | - | - | - | [1] 46 46 💬
|
| 780 | Chuna manipulation | - | - | - | - | [1] 70 70 💬
|
| 781 | Chuna manual medicine | - | - | - | - | [1] 70 70 💬
|
| 782 | CHX A-DTPA anti-CD66 antibody | - | - | - | - | [1] 28 28 💬
|
| 783 | CHX-A-DTPA-Anti-CD66 | - | - | - | - | [1] 28 28 💬
|
| 784 | CI-984 | - | - | - | - | [1] 75 75 💬
|
| 785 | CI-984, 17AA70, PD 132301-2 | - | - | - | - | [1] 81 81 💬
|
| 786 | Cialis | - | - | - | - | [2] 51 51, 86 💬
|
| 787 | CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE | - | - | - | - | [2] 75 75, 77 💬
|
| 788 | Cialis 10 mg film-coated tablets | - | - | - | - | [2] 86 86, 113 💬
|
| 789 | Cialis 2.5 mg film-coated tablets | - | - | - | - | [2] 86 86, 113 💬
|
| 790 | CIALIS 20 mg comprimidos recubiertos con película | - | - | - | - | [1] 86 86 💬
|
| 791 | Cialis 20 mg film-coated tablets | - | - | - | - | [2] 86 86, 113 💬
|
| 792 | Cialis 5 mg film-coated tablets | - | - | - | - | [2] 86 86, 113 💬
|
| 793 | CIANOCOBALAMINA FU DC.IT | - | - | - | - | [1] 13 13 💬
|
| 794 | CIC | - | - | - | - | [1] 118 118 💬
|
| 795 | CIC using LoFric Primo | - | - | - | - | [1] 13 13 💬
|
| 796 | Ciclesonide | [1] Ciclesonide Ciclesonide | [1] Ciclesonide
Ciclesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 💬
|
| 797 | Cicletanine | [1] Cicletanine Cicletanine | [2] Cicletanine
Cicletanine
,
Cicletanine hydrochloride
💬
| - | - | [1] 86 86 💬
|
| 798 | Cicletanine hydrochloride | [1] Cicletanine Cicletanine | [2] Cicletanine
Cicletanine
,
Cicletanine hydrochloride
💬
| - | - | [1] 86 86 💬
|
| 799 | Ciclofosfamida | - | - | - | - | [1] 222 222 💬
|
| 800 | CICLOFOSFAMIDE | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 49 49, 51 💬
|
| 801 | Ciclopirox | [1] Ciclopirox Ciclopirox | [2] Ciclopirox olamine
Ciclopirox olamine
,
Ciclopirox
💬
| - | - | [1] 254 254 💬
|
| 802 | Ciclosporin | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [10] 26 26, 46, 49, 50, 53, 60, 97, 226, 228, 269 💬
|
| 803 | Ciclosporin (Ciclosporinium) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 804 | CICLOSPORIN A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 805 | Ciclosporin Soft Capsule | - | - | - | - | [1] 60 60 💬
|
| 806 | Ciclosporin soft capsules | - | - | - | - | [1] 222 222 💬
|
| 807 | CICLOSPORINA | - | - | - | - | [3] 49 49, 60, 97 💬
|
| 808 | Ciclosporina / Ciclosporin | - | - | - | - | [1] 228 228 💬
|
| 809 | Ciclosporina A Liposomica Aerolised Liposomal Ciclosporin A | - | - | - | - | [1] 228 228 💬
|
| 810 | Ciclosporina Generis 100 mg Cápsulas moles | - | - | - | - | [1] 222 222 💬
|
| 811 | Ciclosporina/ Ciclosporin | - | - | - | - | [1] 228 228 💬
|
| 812 | Ciclosporine | - | - | - | - | [1] 60 60 💬
|
| 813 | Ciclosporine A | - | - | - | - | [1] 228 228 💬
|
| 814 | Ciclosporine, Ciclosporina | - | - | - | - | [1] 228 228 💬
|
| 815 | CID-103 | - | - | - | - | [1] 63 63 💬
|
| 816 | Cidofovir | [1] Cidofovir Cidofovir | [1] Cidofovir
Cidofovir
💬
| - | - | [1] 25 25 💬
|
| 817 | CIGB-814 (multiple-dose group) | - | - | - | - | [1] 46 46 💬
|
| 818 | CIGB-814 (single-dose group) | - | - | - | - | [1] 46 46 💬
|
| 819 | CIK cells | - | - | - | - | [1] 118 118 💬
|
| 820 | Ciklosporin | - | - | - | - | [1] 226 226 💬
|
| 821 | CILASTATIN | [1] Cilastatin Cilastatin | [2] Cilastatin sodium
Cilastatin sodium
,
Cilastatin
💬
| - | - | [2] 60 60, 299 💬
|
| 822 | Cilazapril | [1] Cilazapril Cilazapril | [2] Cilazapril
Cilazapril
,
Cilazapril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 66 66 💬
|
| 823 | Ciliary Neurotrophic Factor Implant NT-501 | - | - | - | - | [1] 90 90 💬
|
| 824 | Cilnidipine | [1] Cilnidipine Cilnidipine | [1] Cilnidipine
Cilnidipine
💬
| [5] CACNA1B CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [41] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Nicotine addiction, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬
|
| 825 | CILO | - | - | - | - | [1] 94 94 💬
|
| 826 | Cilofexor | [1] Cilofexor Cilofexor | - | - | - | [2] 93 93, 94 💬
|
| 827 | Cilostazol | [1] Cilostazol Cilostazol | [1] Cilostazol
Cilostazol
💬
| [3] PDE3A PDE3A, PDE3B, TBXA2R 💬
| [13] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 6 6, 13, 46, 48, 51, 70, 124 💬
|
| 828 | Cilostazol 100 MG | [1] Cilostazol Cilostazol | [1] Cilostazol
Cilostazol
💬
| [3] PDE3A PDE3A, PDE3B, TBXA2R 💬
| [13] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 💬
|
| 829 | Ciltacabtagene Autoleucel | [1] Ciltacabtagene autoleucel Ciltacabtagene autoleucel | [1] Ciltacabtagene autoleucel
Ciltacabtagene autoleucel
💬
| [2] CD38 CD38, TNFRSF17 💬
| [8] Calcium signaling pathway Calcium signaling pathway, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1] 28 28 💬
|
| 830 | Cimetidine | [1] Cimetidine Cimetidine | [2] Cimetidine
Cimetidine
,
Cimetidine hydrochloride
💬
| [1] HRH2 HRH2 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [2] 2 2, 254 💬
|
| 831 | Cimetidine plus Dexpramipexole | [2] Cimetidine Cimetidine, Dexpramipexole | [4] Cimetidine
Cimetidine
,
Cimetidine hydrochloride
,
Dexpramipexole
,
Dexpramipexole dihydrochloride
💬
| [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, HRH2 💬
| [14] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 2 2 💬
|
| 832 | CIMZIA | - | - | - | - | [7] 46 46, 48, 49, 96, 97, 107, 271 💬
|
| 833 | CIMZIA (Certolizumab Pegol) | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 834 | CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI | - | - | - | - | [1] 46 46 💬
|
| 835 | CIMZIA - 200MG-SOLUZIONE INIETTABILE-USO SOTTOCUTANEO-SIRINGA PRERIEMPITA(VETRO) 1ML 6(3X2) SIRINGHE PRERIEMPITE+6(3X2) SALVIETTINE IMBEVUTE DI ALCOOL | - | - | - | - | [1] 46 46 💬
|
| 836 | Cimzia 200 mg injeksjonsvæske, oppløsning | - | - | - | - | [1] 46 46 💬
|
| 837 | Cimzia 200 mg solution for injection | - | - | - | - | [3] 46 46, 96, 271 💬
|
| 838 | CIMZIA certolizumab pegol 200 mg/ml solution for injection | [1] Certolizumab pegol Certolizumab pegol | [1] Certolizumab pegol
Certolizumab pegol
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 839 | Cimzia® | - | - | - | - | [2] 46 46, 271 💬
|
| 840 | Cinacalcet | [1] Cinacalcet Cinacalcet | [2] Cinacalcet
Cinacalcet
,
Cinacalcet hydrochloride
💬
| [1] CASR CASR 💬
| [2] NOD-like receptor signaling pathway NOD-like receptor signaling pathway, Parathyroid hormone synthesis, secretion and action 💬 | [1] 238 238 💬
|
| 841 | Cinnamyl alcohol | [1] Cinnamyl alcohol Cinnamyl alcohol | - | - | - | [1] 279 279 💬
|
| 842 | CINRYZE | - | - | - | - | [1] 65 65 💬
|
| 843 | CINRYZE 1000 | - | - | - | - | [1] 65 65 💬
|
| 844 | CINRYZE 1000 U | - | - | - | - | [1] 65 65 💬
|
| 845 | CINRYZE 500 | - | - | - | - | [1] 65 65 💬
|
| 846 | CINRYZE 500 U | - | - | - | - | [1] 65 65 💬
|
| 847 | CINRYZE with rHuPH20 | - | - | - | - | [1] 65 65 💬
|
| 848 | CINRYZE® | - | - | - | - | [1] 65 65 💬
|
| 849 | CINRYZE® (C1 esterase inhibitor [human]) | - | - | - | - | [1] 61 61 💬
|
| 850 | CION-08 Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 60-Product Name: bempedoic acidPharmaceutical Form: Suspension for oral suspensionINN or Proposed INN: Bempedoic acidCAS Number: 738606-46-7 Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20- | - | - | - | - | [1] 79 79 💬
|
| 851 | CION-08 Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 90-Trade Name: Nilemdo Product Name: bempedoic acidPharmaceutical Form: TabletINN or Proposed INN: Bempedoic acidCAS Number: 738606-46-7 Current Sponsor code: ETC-1002 | - | - | - | - | [1] 79 79 💬
|
| 852 | Cipaglucosidase Alfa | [1] Cipaglucosidase alfa Cipaglucosidase alfa | [1] Cipaglucosidase alfa
Cipaglucosidase alfa
💬
| [1] GAA GAA 💬
| [3] Galactose metabolism Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 256 256 💬
|
| 853 | Cipaglucosidasi alfa | - | - | - | - | [1] 256 256 💬
|
| 854 | CIPRALEX | - | - | - | - | [1] 6 6 💬
|
| 855 | Cipro (Ciprofloxacin, BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 856 | Cipro Inhale | - | - | - | - | [1] 299 299 💬
|
| 857 | Cipro, Ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 2 2 💬
|
| 858 | Ciprofloxacin | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [6] 2 2, 46, 60, 96, 97, 299 💬
|
| 859 | Ciprofloxacin (BAYQ3939) dry powder for inhalation | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 860 | Ciprofloxacin (Cipro Inhale, BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 861 | Ciprofloxacin (Cipro, BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 862 | Ciprofloxacin (ciproxin) | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 863 | Ciprofloxacin dispersion for inhalation | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 864 | Ciprofloxacin DPI | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 865 | Ciprofloxacin DPI (BAYQ3939) | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 866 | Ciprofloxacin for Inhalation | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 867 | Ciprofloxacin hydrochloride | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [2] 96 96, 299 💬
|
| 868 | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 869 | Ciprofloxacin Inhale | [1] Ciprofloxacin Ciprofloxacin | [3] Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | [1] 299 299 💬
|
| 870 | Ciprofloxacina | - | - | - | - | [1] 299 299 💬
|
| 871 | CIPROFLOXACINA CLORIDRATO | - | - | - | - | [2] 2 2, 299 💬
|
| 872 | Ciproxin | - | - | - | - | [1] 299 299 💬
|
| 873 | CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE | - | - | - | - | [1] 299 299 💬
|
| 874 | Ciproxin Suspension | - | - | - | - | [1] 299 299 💬
|
| 875 | CIPROXIN*6CPR RIV 500MG | - | - | - | - | [1] 299 299 💬
|
| 876 | Circadian rhythm measurement | - | - | - | - | [1] 106 106 💬
|
| 877 | Circadin | - | - | - | - | [1] 13 13 💬
|
| 878 | Circadin ( INN= Melatonin) | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬
| [2] MTNR1A MTNR1A, MTNR1B 💬
| [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 879 | Circadin 2 mg | - | - | - | - | [1] 90 90 💬
|
| 880 | CIRCADIN 2 mg comprimidos de liberación prolongada | - | - | - | - | [1] 90 90 💬
|
| 881 | Circadin® | - | - | - | - | [1] 6 6 💬
|
| 882 | Cis-4-Hydroxy-L-Proline | [1] Proline Proline | [1] Proline
Proline
💬
| - | - | [1] 94 94 💬
|
| 883 | CISAPRIDE | [1] Cisapride Cisapride | [2] Cisapride
Cisapride
,
Cisapride
💬
| [3] HTR2A HTR2A, HTR3A, HTR4 💬
| [8] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 💬
|
| 884 | Cisplatin | [1] Cisplatin Cisplatin | [1] Cisplatin
Cisplatin
💬
| - | - | [1] 28 28 💬
|
| 885 | Cistanche Total Glycosides | - | - | - | - | [1] 2 2 💬
|
| 886 | CIT-013 high dose | - | - | - | - | [1] 46 46 💬
|
| 887 | CIT-013 low dose | - | - | - | - | [1] 46 46 💬
|
| 888 | CIT-013 medium dose | - | - | - | - | [1] 46 46 💬
|
| 889 | Citalopram | [1] Citalopram Citalopram | [2] Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| [1] SLC6A4 SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [7] 6 6, 8, 13, 18, 46, 98, 127 💬
|
| 890 | Citalopram 20mg | [1] Citalopram Citalopram | [2] Citalopram hydrobromide
Citalopram hydrobromide
,
Citalopram
💬
| [1] SLC6A4 SLC6A4 💬
| [3] Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 6 6 💬
|
| 891 | CITARABINA | - | - | - | - | [1] 13 13 💬
|
| 892 | CITICOLIN*1G/4ML IM IV 5 F | - | - | - | - | [1] 6 6 💬
|
| 893 | Citicolina 1000 mg/die | - | - | - | - | [1] 6 6 💬
|
| 894 | CITICOLINA SODICA | - | - | - | - | [1] 6 6 💬
|
| 895 | CITOCHINE ED IMMUNOMODULATORI | - | - | - | - | [1] 13 13 💬
|
| 896 | Citocoline | - | - | - | - | [1] 205 205 💬
|
| 897 | Citric acid | [1] Citric acid Citric acid | [2] Citric acid, anhydrous
Citric acid, anhydrous
,
Citric acid monohydrate
💬
| - | - | [2] 53 53, 291 💬
|
| 898 | Citric Acid based Mouthwash | [1] Citric acid Citric acid | [2] Citric acid, anhydrous
Citric acid, anhydrous
,
Citric acid monohydrate
💬
| - | - | [1] 53 53 💬
|
| 899 | Citrulline | [1] Citrulline Citrulline | [2] L-Citrulline
L-Citrulline
,
Citrulline malate
💬
| - | - | [3] 21 21, 86, 113 💬
|
| 900 | Cizutamig | - | - | - | - | [4] 11 11, 46, 49, 97 💬
|
| 901 | CJH1 (CLR4001) | - | - | - | - | [1] 6 6 💬
|
| 902 | CJNJ-68150420-ZZZ-G001 (ACT- 064992D) | - | - | - | - | [1] 86 86 💬
|
| 903 | CJNJ-68150420-ZZZ-G001 (ACT-064992D) | - | - | - | - | [1] 86 86 💬
|
| 904 | CJNJ-68150420-ZZZ-G001(ACT-064992D) | - | - | - | - | [1] 86 86 💬
|
| 905 | CK-2017357 | - | - | - | - | [1] 2 2 💬
|
| 906 | CK-2017357 (Part A) | - | - | - | - | [1] 2 2 💬
|
| 907 | CK-2017357 (Part B) | - | - | - | - | [1] 2 2 💬
|
| 908 | CK-2127107 | [1] Reldesemtiv Reldesemtiv | [1] Reldesemtiv
Reldesemtiv
💬
| [3] TNNC2 TNNC2, TNNI2, TNNT3 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬 | [1] 2 2 💬
|
| 909 | CK-3773274 | - | - | - | - | [1] 58 58 💬
|
| 910 | CK-3773274 (10 - 30 mg) | - | - | - | - | [1] 58 58 💬
|
| 911 | CK-3773274 (5 - 15 mg) | - | - | - | - | [1] 58 58 💬
|
| 912 | CK-3773274 - Granules in Capsule | - | - | - | - | [1] 58 58 💬
|
| 913 | CK-3773274 - Tablets | - | - | - | - | [1] 58 58 💬
|
| 914 | CK0801 | - | - | - | - | [1] 60 60 💬
|
| 915 | CK0803 | - | - | - | - | [1] 2 2 💬
|
| 916 | CK2017357 | - | - | - | - | [1] 2 2 💬
|
| 917 | CKD-374 5mg Tab. | - | - | - | - | [1] 46 46 💬
|
| 918 | CKD-504 | [1] CKD-504 CKD-504 | - | - | - | [1] 8 8 💬
|
| 919 | CKD-506 | - | - | - | - | [1] 46 46 💬
|
| 920 | CLA (Chlorogenic acid) | [1] Chlorogenic Acid Chlorogenic Acid | - | - | - | [1] 97 97 💬
|
| 921 | CLADRIBINA | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 922 | Cladribina oral | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 923 | CLADRIBINE | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [3] 11 11, 13, 94 💬
|
| 924 | Cladribine (MAVENCLAD®) | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 925 | Cladribine 10 mg oral tablet | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 926 | Cladribine 3.5 mg/kg | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 927 | Cladribine 5.25 mg/kg | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 928 | Cladribine High Dose | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 11 11 💬
|
| 929 | Cladribine Low Dose | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 11 11 💬
|
| 930 | Cladribine Oral Tablet | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 931 | Cladribine Pill | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 932 | Cladribine Subcutaneous Injection | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 933 | Cladribine Tablet | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 934 | Cladribine Tablets | [1] Cladribine Cladribine | [1] Cladribine
Cladribine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 13 13 💬
|
| 935 | Cladrybine | - | - | - | - | [1] 11 11 💬
|
| 936 | CLAIRYG 50 mg/ml | - | - | - | - | [1] 14 14 💬
|
| 937 | CLAIRYG 50mg/ml | - | - | - | - | [1] 14 14 💬
|
| 938 | Clarithromycin | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬
| - | - | [10] 6 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
|
| 939 | Clarithromycin (Not used as of 4/2020) | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬
| - | - | [1] 6 6 💬
|
| 940 | Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days. | [1] Clarithromycin Clarithromycin | [1] Clarithromycin
Clarithromycin
💬
| - | - | [1] 63 63 💬
|
| 941 | Claritromycin | - | - | - | - | [1] 299 299 💬
|
| 942 | Claritromycin 500mg film coated tablets | - | - | - | - | [1] 299 299 💬
|
| 943 | Clarium 50 mg Retardtabletten | - | - | - | - | [1] 6 6 💬
|
| 944 | Clarix Flo | - | - | - | - | [1] 226 226 💬
|
| 945 | Clartihromycin, amoxicillin, and omeprazole | [2] Amoxicillin Amoxicillin, Omeprazole | [6] Amoxicillin
Amoxicillin
,
Omeprazole
,
Omeprazole sodium
,
Amoxicillin sodium
,
Omeprazole magnesium
,
Amoxicillin
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 6 6 💬
|
| 946 | Claseprubart | [1] Claseprubart Claseprubart | - | - | - | [2] 11 11, 14 💬
|
| 947 | Classic DMARDs treatment group | - | - | - | - | [1] 46 46 💬
|
| 948 | Classical ketogenic diet | - | - | - | - | [1] 137 137 💬
|
| 949 | Clasteon | - | - | - | - | [1] 274 274 💬
|
| 950 | ClaversalPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ClaversalPharmaceutical Form: Rectal foamINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Gastro-resistant granules for oral suspension in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: TabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: PentasaPharmaceutical Form: Granules for oral solution in sachetINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: MezavantPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: Mesalazine TevaPharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: SuppositoryINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: ColitofalkPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-6Trade Name: SalazopyrinePharmaceutical Form: Gastro-resistant tabletINN or Proposed INN: SulfasalazineCAS Number: 599-79-1Trade Name: PentasaPharmaceutical Form: Rectal suspensionINN or Proposed INN: MesalazineCAS Number: 89-57-6 | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 951 | CLAVULANIC ACID | [1] Clavulanic acid Clavulanic acid | [2] Clavulanate potassium
Clavulanate potassium
,
Clavulanic acid
💬
| - | - | [1] 299 299 💬
|
| 952 | CLAZAKIZUMAB | [1] Clazakizumab Clazakizumab | [1] Clazakizumab
Clazakizumab
💬
| - | - | [1] 46 46 💬
|
| 953 | CLBS12 | [1] CLBS12 CLBS12 | - | - | - | [1] 47 47 💬
|
| 954 | CLE | - | - | - | - | [1] 6 6 💬
|
| 955 | Clemastine | [1] Clemastine Clemastine | [2] Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 179 💬
|
| 956 | CLEMASTINE FUMARATE | [1] Clemastine Clemastine | [2] Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 957 | Clemastine Fumarate Tablets | [1] Clemastine Clemastine | [2] Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 179 179 💬
|
| 958 | Clemastine Milstein 1 mg, tabletten | [1] Clemastine Clemastine | [2] Clemastine fumarate
Clemastine fumarate
,
Clemastine
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 💬
|
| 959 | Clemizole | [1] Clemizole Clemizole | [2] Clemizole hydrochloride
Clemizole hydrochloride
,
Clemizole
💬
| [1] TRPC5 TRPC5 💬
| [2] Axon guidance Axon guidance, GnRH secretion 💬 | [2] 140 140, 144 💬
|
| 960 | Clemizole HCl | [1] Clemizole Clemizole | [2] Clemizole hydrochloride
Clemizole hydrochloride
,
Clemizole
💬
| [1] TRPC5 TRPC5 💬
| [2] Axon guidance Axon guidance, GnRH secretion 💬 | [2] 140 140, 144 💬
|
| 961 | CLEMIZOLE HYDROCHLORIDE | [1] Clemizole Clemizole | [2] Clemizole hydrochloride
Clemizole hydrochloride
,
Clemizole
💬
| [1] TRPC5 TRPC5 💬
| [2] Axon guidance Axon guidance, GnRH secretion 💬 | [1] 140 140 💬
|
| 962 | Clenbuterol | [1] Clenbuterol Clenbuterol | [2] Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 1 1, 2, 6, 57, 113, 256 💬
|
| 963 | Clenbuterol HCl | [1] Clenbuterol Clenbuterol | [2] Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 964 | CLENBUTEROL HYDROCHLORIDE | [1] Clenbuterol Clenbuterol | [2] Clenbuterol hydrochloride
Clenbuterol hydrochloride
,
Clenbuterol
💬
| [1] ADRB2 ADRB2 💬
| [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 965 | CLENBUTEROLO | - | - | - | - | [1] 1 1 💬
|
| 966 | Clervonafusp alfa | [1] Clervonafusp alfa Clervonafusp alfa | [1] Clervonafusp alfa
Clervonafusp alfa
💬
| [2] GAA GAA, SLC29A2 💬
| [4] Alcoholism Alcoholism, Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬 | [1] 309 309 💬
|
| 967 | Clexane | - | - | - | - | [2] 223 223, 327 💬
|
| 968 | Clexane (40 mg) | - | - | - | - | [1] 223 223 💬
|
| 969 | Clexane/Lovenox | - | - | - | - | [1] 327 327 💬
|
| 970 | Clindamycin | [1] Clindamycin Clindamycin | [4] Clindamycin
Clindamycin
,
Clindamycin phosphate
,
Clindamycin palmitate hydrochloride
,
Clindamycin hydrochloride
💬
| - | - | [2] 46 46, 299 💬
|
| 971 | Clinical DBS Setting | - | - | - | - | [1] 6 6 💬
|
| 972 | Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT group. | - | - | - | - | [1] 60 60 💬
|
| 973 | Clinican CBD 10% oil | - | - | - | - | [1] 13 13 💬
|
| 974 | CliniMACS | - | - | - | - | [2] 60 60, 65 💬
|
| 975 | CliniMACS device | - | - | - | - | [2] 60 60, 285 💬
|
| 976 | CliniMACS Prodigy System | - | - | - | - | [1] 285 285 💬
|
| 977 | CliniMACS® TCR a/beta Reagent Kit and CliniMACS® CD19 System | - | - | - | - | [3] 19 19, 96, 222 💬
|
| 978 | CliniMACS® TCR a/ß Reagent Kit and CliniMACS® CD19 System | - | - | - | - | [3] 19 19, 96, 222 💬
|
| 979 | Clipper | - | - | - | - | [1] 97 97 💬
|
| 980 | Clipper 30 cpr 5mg R.M. | - | - | - | - | [1] 97 97 💬
|
| 981 | CLIPPER*30CPR 5MG R.M. | - | - | - | - | [1] 97 97 💬
|
| 982 | CLN-978 | - | - | - | - | [3] 46 46, 49, 53 💬
|
| 983 | Clobazam | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 140 140, 144 💬
|
| 984 | Clobazam High Dose | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 985 | Clobazam Low Dose | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 986 | Clobazam Medium Dose | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 987 | Clobazam PhEur | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 988 | Clobazam Tablets | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 989 | Clobazam Tablets 10mg | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 990 | Clobazam Tablets 20mg | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 991 | Clobazam Tablets 5mg | [1] Clobazam Clobazam | [1] Clobazam
Clobazam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 💬
|
| 992 | Clobetasol | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [5] 35 35, 39, 46, 51, 162 💬
|
| 993 | Clobetasol 0.05% ointment | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 39 39 💬
|
| 994 | Clobetasol 0.05% Topical Ointment | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 995 | Clobetasol propionate | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 35 35, 46, 162 💬
|
| 996 | Clobetasol propionate + Methotrexate | [3] Clobetasol Clobetasol, Clobetasol propionate, Methotrexate | [4] Methotrexate
Methotrexate
,
Clobetasol propionate
,
Methotrexate sodium
,
Clobetasol
💬
| [3] DHFR DHFR, DHFR2, NR3C1 💬
| [4] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | [1] 162 162 💬
|
| 997 | Clobetasol propionate 0.05% Mouthwash | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 998 | Clobetasol propionate 0.05% mouthwash + photobiomodulation | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 999 | Clobetasol propionate alone | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 1000 | Clobetasol Propionate cream treatment | [2] Clobetasol Clobetasol, Clobetasol propionate | [2] Clobetasol propionate
Clobetasol propionate
,
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 162 162 💬
|
| 1001 | Clobetasolo propionato | - | - | - | - | [1] 162 162 💬
|
| 1002 | Clofarabine | [1] Clofarabine Clofarabine | [1] Clofarabine
Clofarabine
💬
| [3] POLA1 POLA1, POLA2, RRM1 💬
| [5] DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [9] 19 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
|
| 1003 | CLOFAZIMINE | [1] Clofazimine Clofazimine | [1] Clofazimine
Clofazimine
💬
| - | - | [2] 96 96, 299 💬
|
| 1004 | Clomiphene citrate | - | - | - | - | [2] 74 74, 77 💬
|
| 1005 | Clonazepam | [1] Clonazepam Clonazepam | [1] Clonazepam
Clonazepam
💬
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬
| [9] Cadherin signaling Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 6 6 💬
|
| 1006 | Clonidine | [1] Clonidine Clonidine | [2] Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [3] 6 6, 65, 70 💬
|
| 1007 | Clonidine hydrochloride | [1] Clonidine Clonidine | [2] Clonidine
Clonidine
,
Clonidine hydrochloride
💬
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1008 | Clonidinhydrochlorid | - | - | - | - | [1] 65 65 💬
|
| 1009 | Clopidogrel | [1] Clopidogrel Clopidogrel | [4] Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| [1] P2RY12 P2RY12 💬
| [3] Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | [7] 40 40, 49, 51, 62, 71, 86, 222 💬
|
| 1010 | Clopidogrel treatment | [1] Clopidogrel Clopidogrel | [4] Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| [1] P2RY12 P2RY12 💬
| [3] Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | [1] 51 51 💬
|
| 1011 | CLORAMFENICOLO | - | - | - | - | [1] 90 90 💬
|
| 1012 | Cloramfenicolo Fisiopharma | - | - | - | - | [1] 90 90 💬
|
| 1013 | CLORAMFENICOLO FISIOPHARMA - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE DA 10 ML | - | - | - | - | [1] 90 90 💬
|
| 1014 | CLORFENAMINA MALEATO | - | - | - | - | [1] 14 14 💬
|
| 1015 | Cloruro de Sodio | - | - | - | - | [1] 228 228 💬
|
| 1016 | CLORURO DI POTASSIO | - | - | - | - | [1] 97 97 💬
|
| 1017 | CLORURO DI SODIO | - | - | - | - | [1] 97 97 💬
|
| 1018 | CLORURO SODICO 7% | - | - | - | - | [1] 299 299 💬
|
| 1019 | Clostridium botulinum | [1] Clostridium botulinum Clostridium botulinum | - | - | - | [1] 13 13 💬
|
| 1020 | CLOSTRIDIUM BOTULINUM TOXIN TYPE A | [2] Botulinum toxin type A Botulinum toxin type A, Clostridium botulinum | [4] Botulinum toxin type A
Botulinum toxin type A
,
OnabotulinumtoxinA
,
AbobotulinumtoxinA
,
Incobotulinumtoxin A
💬
| [1] SNAP25 SNAP25 💬
| [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 1021 | Clotrimazole | [1] Clotrimazole Clotrimazole | [1] Clotrimazole
Clotrimazole
💬
| - | - | [1] 97 97 💬
|
| 1022 | CLOZAPINE | [1] Clozapine Clozapine | [1] Clozapine
Clozapine
💬
| [11] ADRA2A ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
| 1023 | CLS12311 | - | - | - | - | [1] 13 13 💬
|
| 1024 | CLS12311 high | - | - | - | - | [1] 13 13 💬
|
| 1025 | CLS12311 low | - | - | - | - | [1] 13 13 💬
|
| 1026 | CLS12311 medium | - | - | - | - | [1] 13 13 💬
|
| 1027 | CLS12311Pharmaceutical Form: Dispersion for infusionINN or Proposed INN: not applicableCurrent Sponsor code: CLS12311Other descriptive name: Peptid coupled red blood cellsConcentration unit: OtherConcentration type: rangeConcentration number: 2.2E11-3.5E11Pharmaceutical form of the placebo: InfusionRoute of administration of the placebo: Intravenous use | - | - | - | - | [1] 13 13 💬
|
| 1028 | CLTX-305 | - | - | - | - | [1] 235 235 💬
|
| 1029 | CLZ-2002 | [1] CLZ-2002 CLZ-2002 | - | - | - | [1] 10 10 💬
|
| 1030 | CM-101 | [1] CM-101 CM-101 | - | - | - | [2] 51 51, 94 💬
|
| 1031 | CM-336 BCMA/CD3 bispecific antibody | - | - | - | - | [1] 28 28 💬
|
| 1032 | CM310 | - | - | - | - | [1] 300 300 💬
|
| 1033 | CM313 | - | - | - | - | [1] 66 66 💬
|
| 1034 | CM313 (SC) | - | - | - | - | [1] 35 35 💬
|
| 1035 | CM313 injection | - | - | - | - | [3] 35 35, 49, 63 💬
|
| 1036 | CM313(SC) injection | - | - | - | - | [1] 60 60 💬
|
| 1037 | CM336 | - | - | - | - | [1] 53 53 💬
|
| 1038 | CM336 (BCMA/CD3 bispecific antibody) | - | - | - | - | [1] 16 16 💬
|
| 1039 | CM336 Injection | - | - | - | - | [2] 61 61, 63 💬
|
| 1040 | CM338 | - | - | - | - | [1] 66 66 💬
|
| 1041 | CM355 | - | - | - | - | [1] 49 49 💬
|
| 1042 | CMAB008 | - | - | - | - | [1] 46 46 💬
|
| 1043 | CME-LEM4 | - | - | - | - | [1] 117 117 💬
|
| 1044 | CMK389 | - | - | - | - | [1] 84 84 💬
|
| 1045 | CMP-CPS-001 | - | - | - | - | [1] 251 251 💬
|
| 1046 | CMR316 | - | - | - | - | [1] 85 85 💬
|
| 1047 | CMRI | - | - | - | - | [1] 77 77 💬
|
| 1048 | CMS | - | - | - | - | [1] 299 299 💬
|
| 1049 | CMS-D017 Capsule | - | - | - | - | [1] 62 62 💬
|
| 1050 | CMTS0929 | - | - | - | - | [1] 97 97 💬
|
| 1051 | CMTX-101 | - | - | - | - | [1] 299 299 💬
|
| 1052 | CMV IgM, IgG in blood real time PCR for serum CMV DNA . | - | - | - | - | [1] 97 97 💬
|
| 1053 | CMV-VST | - | - | - | - | [1] 65 65 💬
|
| 1054 | CNCT19 CAR-T cell therapy | - | - | - | - | [1] 61 61 💬
|
| 1055 | CNCT19 cell injection | - | - | - | - | [2] 49 49, 63 💬
|
| 1056 | CND261 | - | - | - | - | [1] 46 46 💬
|
| 1057 | CNM-Au8 | [1] CNM-Au8 CNM-Au8 | - | - | - | [2] 2 2, 13 💬
|
| 1058 | CNMAu8 | - | - | - | - | [1] 2 2 💬
|
| 1059 | CNP-104 | - | - | - | - | [1] 93 93 💬
|
| 1060 | CNP-106 | - | - | - | - | [1] 11 11 💬
|
| 1061 | Cnp-MS-0601 | - | - | - | - | [1] 13 13 💬
|
| 1062 | CNS10-NPC implantation | - | - | - | - | [1] 90 90 💬
|
| 1063 | CNS10-NPC-GDNF | - | - | - | - | [1] 2 2 💬
|
| 1064 | CNSA-001 | - | - | - | - | [1] 240 240 💬
|
| 1065 | CNT-02 | - | - | - | - | [1] 160 160 💬
|
| 1066 | CNTO 1275 | - | - | - | - | [2] 13 13, 96 💬
|
| 1067 | CNTO 136 | - | - | - | - | [2] 41 41, 46 💬
|
| 1068 | CNTO 136 100 mg | - | - | - | - | [1] 46 46 💬
|
| 1069 | CNTO 136 25 mg | - | - | - | - | [1] 46 46 💬
|
| 1070 | CNTO 136 50 mg | - | - | - | - | [1] 46 46 💬
|
| 1071 | CNTO 136 IgG | - | - | - | - | [1] 46 46 💬
|
| 1072 | CNTO 148 | - | - | - | - | [4] 46 46, 84, 97, 271 💬
|
| 1073 | CNTO 148 (Golimumab) | [1] Golimumab Golimumab | [1] Golimumab
Golimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 💬
|
| 1074 | CNTO 1959 | - | - | - | - | [1] 46 46 💬
|
| 1075 | CNTO 1959 + MTX (Group 4) | - | - | - | - | [1] 46 46 💬
|
| 1076 | CNTO 1959 + MTX (Group 5) | - | - | - | - | [1] 46 46 💬
|
| 1077 | CNTO 1959 IgG | - | - | - | - | [1] 46 46 💬
|
| 1078 | CNTO 2476 | - | - | - | - | [1] 90 90 💬
|
| 1079 | CNTO 328 | - | - | - | - | [1] 331 331 💬
|
| 1080 | CNTO 6785 100 mg | - | - | - | - | [1] 46 46 💬
|
| 1081 | CNTO 6785 15 mg | - | - | - | - | [1] 46 46 💬
|
| 1082 | CNTO 6785 200 mg | - | - | - | - | [1] 46 46 💬
|
| 1083 | CNTO 6785 50 mg | - | - | - | - | [1] 46 46 💬
|
| 1084 | CNTO 888 1 mg/kg | - | - | - | - | [1] 85 85 💬
|
| 1085 | CNTO 888 15 mg/kg | - | - | - | - | [1] 85 85 💬
|
| 1086 | CNTO 888 5 mg/kg | - | - | - | - | [1] 85 85 💬
|
| 1087 | CNTO-148 | - | - | - | - | [1] 97 97 💬
|
| 1088 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 💬
|
| 1089 | CNTO136 | - | - | - | - | [1] 46 46 💬
|
| 1090 | CNTO148 | - | - | - | - | [5] 46 46, 84, 96, 97, 107 💬
|
| 1091 | CNTO1959 | - | - | - | - | [4] 37 37, 41, 96, 97 💬
|
| 1092 | CNTO312 | - | - | - | - | [1] 97 97 💬
|
| 1093 | CNTO328 | - | - | - | - | [1] 331 331 💬
|
| 1094 | CNTO6785 | - | - | - | - | [1] 46 46 💬
|
| 1095 | CNTO888 | - | - | - | - | [1] 85 85 💬
|
| 1096 | CNTY-101 | - | - | - | - | [2] 49 49, 51 💬
|
| 1097 | CO-14 | - | - | - | - | [1] 13 13 💬
|
| 1098 | Co-intervention of Prednisolone wean during open label extension phase | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1099 | Co-intervention of Prednisolone wean during randomised controlled phase | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 💬
|
| 1100 | Co-medication: Synthetic DMARDs | - | - | - | - | [1] 46 46 💬
|
| 1101 | CO-TRIMOXAZOLE | - | - | - | - | [1] 85 85 💬
|
| 1102 | CO2 laser | - | - | - | - | [1] 51 51 💬
|
| 1103 | Coagadex(R) | - | - | - | - | [2] 28 28, 288 💬
|
| 1104 | Coagulation factor XIII | - | - | - | - | [1] 288 288 💬
|
| 1105 | Coamoxiclav | - | - | - | - | [1] 97 97 💬
|
| 1106 | Coarse wheat bran | [2] Wheat Wheat, Wheat bran | [1] Wheat
Wheat
💬
| - | - | [1] 6 6 💬
|
| 1107 | Cobalt | [1] Cobalt Cobalt | - | - | - | [1] 46 46 💬
|
| 1108 | Cobalt™ Bone Cement | [1] Cobalt Cobalt | - | - | - | [1] 46 46 💬
|
| 1109 | Cobamamide | [1] Cobamamide Cobamamide | [1] Cobamamide
Cobamamide
💬
| - | - | [1] 299 299 💬
|
| 1110 | Cobiprostone | [1] Cobiprostone Cobiprostone | [1] Cobiprostone
Cobiprostone
💬
| - | - | [1] 46 46 💬
|
| 1111 | COBITOLIMOD | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 1112 | Cobitolimod 250 mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 1113 | Cobitolimod 500 mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 1114 | Cobitolimod 500mg | [1] Cobitolimod Cobitolimod | [1] Cobitolimod
Cobitolimod
💬
| [1] TLR9 TLR9 💬
| [10] African trypanosomiasis African trypanosomiasis, Chagas disease, Herpes simplex virus 1 infection, Lysosome biogenesis, Malaria, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Salmonella infection, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 97 97 💬
|
| 1115 | Cocktail Substrates (Midazolam Oral Solution, Rosuvastatin Calcium Tablets, and Digoxin Tablets) | [4] Calcium Calcium, Digoxin, Midazolam, Rosuvastatin | [6] Digoxin
Digoxin
,
Midazolam
,
Midazolam hydrochloride
,
Rosuvastatin calcium
,
Midazolam maleate
,
Rosuvastatin
💬
| [21] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR 💬
| [30] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Cadherin signaling, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cytoskeleton in muscle cells, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Insulin secretion, Mineral absorption, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬
|
| 1116 | Cocoa | [1] Cocoa Cocoa | - | - | - | [1] 6 6 💬
|
| 1117 | Coconut | [1] Coconut Coconut | - | - | - | [2] 13 13, 53 💬
|
| 1118 | Coconut oil | [2] Coconut Coconut, Coconut oil | [1] Coconut oil
Coconut oil
💬
| - | - | [1] 13 13 💬
|
| 1119 | Coconut oil and epigallocatechin gallate | [4] Coconut Coconut, Coconut oil, Epigallocatechin, Epigallocatechin gallate | [1] Coconut oil
Coconut oil
💬
| - | - | [1] 13 13 💬
|
| 1120 | Cod liver oil | [1] Cod liver oil Cod liver oil | [1] Cod liver oil
Cod liver oil
💬
| - | - | [1] 46 46 💬
|
| 1121 | Code ATC:L01XC04 | - | - | - | - | [1] 65 65 💬
|
| 1122 | Coenzym Q10 Nanodispersion | - | - | - | - | [2] 5 5, 6 💬
|
| 1123 | Coenzym Q10, Ubiquinon, Ubichinon | - | - | - | - | [2] 5 5, 6 💬
|
| 1124 | Coenzyme A | [1] Coenzyme A Coenzyme A | - | - | - | [1] 246 246 💬
|
| 1125 | Coenzyme Q | - | - | - | - | [1] 13 13 💬
|
| 1126 | Coenzyme Q-10 in Normal Control subjects | - | - | - | - | [1] 86 86 💬
|
| 1127 | Coenzyme Q-10 in Pulmonary Hypertension subjects | - | - | - | - | [1] 86 86 💬
|
| 1128 | Coenzyme Q10 | - | - | - | - | [11] 2 2, 5, 6, 8, 10, 18, 49, 57, 107, 113, 193 💬
|
| 1129 | Coenzyme Q10 and Lisinopril | [1] Lisinopril Lisinopril | [2] Lisinopril
Lisinopril
,
Lisinopril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 113 113 💬
|
| 1130 | Coenzyme Q10 Nanodispersion (Nanoquinone) | - | - | - | - | [1] 6 6 💬
|
| 1131 | Coenzyme Q10 with vitamin E | [1] Vitamin E Vitamin E | [1] Vitamin E
Vitamin E
💬
| - | - | [1] 6 6 💬
|
| 1132 | CoenzymeQ10 | - | - | - | - | [1] 21 21 💬
|
| 1133 | Cofactor supplementation (thiamine, riboflavin, L-carnitine) | [2] Riboflavin Riboflavin, Thiamine | [4] Riboflavin
Riboflavin
,
Thiamine hydrochloride
,
Thiamine mononitrate
,
Thiamine
💬
| - | - | [1] 265 265 💬
|
| 1134 | COFFEE COAL | - | - | - | - | [1] 97 97 💬
|
| 1135 | Cogane™ (PYM50028) | - | - | - | - | [1] 6 6 💬
|
| 1136 | Cognixion + Apple Vision Pro | [1] Apple Apple | - | - | - | [1] 2 2 💬
|
| 1137 | Cohort 1 0.225g | - | - | - | - | [1] 240 240 💬
|
| 1138 | Cohort 1: 1.0 x 10^8 PolyTregs | - | - | - | - | [1] 35 35 💬
|
| 1139 | Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 | - | - | - | - | [1] 60 60 💬
|
| 1140 | Cohort 1: JMKX003142 and itraconazole | [1] Itraconazole Itraconazole | [1] Itraconazole
Itraconazole
💬
| - | - | [1] 67 67 💬
|
| 1141 | Cohort 1:Nilotinib Oral Capsules (150mg or 300mg) | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 6 6 💬
|
| 1142 | Cohort 2 0.75g | - | - | - | - | [1] 240 240 💬
|
| 1143 | Cohort 2: 2.5x10^8 PolyTregs | - | - | - | - | [1] 35 35 💬
|
| 1144 | Cohort 2: hATG, CsA, EPAG Day 14 to Month 3 | - | - | - | - | [1] 60 60 💬
|
| 1145 | Cohort 2: JMKX003142 and rifampicin | - | - | - | - | [1] 67 67 💬
|
| 1146 | Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1) | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 6 6 💬
|
| 1147 | Cohort 3 2.25 g | - | - | - | - | [1] 240 240 💬
|
| 1148 | Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6 | - | - | - | - | [1] 60 60 💬
|
| 1149 | COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin | - | - | - | - | [1] 36 36 💬
|
| 1150 | COLAL PRED | - | - | - | - | [1] 97 97 💬
|
| 1151 | COLAL-PRED | - | - | - | - | [1] 97 97 💬
|
| 1152 | COLAL-PRED® | - | - | - | - | [1] 97 97 💬
|
| 1153 | COLCHICINA | - | - | - | - | [1] 2 2 💬
|
| 1154 | COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE | - | - | - | - | [1] 2 2 💬
|
| 1155 | Colchicine | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [9] 2 2, 42, 46, 50, 56, 93, 97, 210, 266 💬
|
| 1156 | Colchicine 1 MG Oral Tablet | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [1] 2 2 💬
|
| 1157 | Colchicine sprinkle capsules | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [12] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [1] 266 266 💬
|
| 1158 | Cold Cadioplegia | - | - | - | - | [1] 215 215 💬
|
| 1159 | COLECALCIFEROL | [1] Cholecalciferol Cholecalciferol | [1] Cholecalciferol
Cholecalciferol
💬
| [1] VDR VDR 💬
| [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [4] 13 13, 46, 96, 228 💬
|
| 1160 | COLECALCIFEROL CONCENTRATE (OILY FORM) | - | - | - | - | [1] 13 13 💬
|
| 1161 | Colecalciferol D3 (Vigantol Oil) | - | - | - | - | [2] 96 96, 97 💬
|
| 1162 | Colectomy | - | - | - | - | [1] 97 97 💬
|
| 1163 | Colesevelam | [1] Colesevelam Colesevelam | [2] Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | [3] 79 79, 96, 260 💬
|
| 1164 | Colesevelam HCl | [1] Colesevelam Colesevelam | [2] Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | [1] 79 79 💬
|
| 1165 | Colesevelam hydrochloride | [1] Colesevelam Colesevelam | [2] Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | [1] 79 79 💬
|
| 1166 | Colesevelam hydrochloride film-coated tablets | [1] Colesevelam Colesevelam | [2] Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | [1] 79 79 💬
|
| 1167 | Colestipol | [1] Colestipol Colestipol | [2] Colestipol hydrochloride
Colestipol hydrochloride
,
Colestipol
💬
| - | - | [1] 254 254 💬
|
| 1168 | COLESTIRAMINA | - | - | - | - | [1] 13 13 💬
|
| 1169 | COLESTYRAMINE | - | - | - | - | [1] 254 254 💬
|
| 1170 | Colfinair 2 MIU Powder for Nebuliser Solution | - | - | - | - | [1] 299 299 💬
|
| 1171 | COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML | - | - | - | - | [1] 299 299 💬
|
| 1172 | COLIMYCINE inhalation | - | - | - | - | [1] 299 299 💬
|
| 1173 | COLIMYCINE injectable | - | - | - | - | [1] 299 299 💬
|
| 1174 | COLISTIMETATO SODICO | - | - | - | - | [1] 299 299 💬
|
| 1175 | Colistimethat-Natrium | - | - | - | - | [1] 299 299 💬
|
| 1176 | COLISTIMETHATE | [1] Colistimethate Colistimethate | [1] Colistimethate sodium
Colistimethate sodium
💬
| - | - | [1] 299 299 💬
|
| 1177 | Colistimethate 75 mg inhaled two times daily | [1] Colistimethate Colistimethate | [1] Colistimethate sodium
Colistimethate sodium
💬
| - | - | [1] 299 299 💬
|
| 1178 | COLISTIMETHATE SODIUM | [1] Colistimethate Colistimethate | [1] Colistimethate sodium
Colistimethate sodium
💬
| - | - | [1] 299 299 💬
|
| 1179 | COLISTIMETHATE SODIUM (A COMPONENT) | [1] Colistimethate Colistimethate | [1] Colistimethate sodium
Colistimethate sodium
💬
| - | - | [1] 299 299 💬
|
| 1180 | Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate | [2] Colistimethate Colistimethate, Colistin | [3] Colistimethate sodium
Colistimethate sodium
,
Colistin sulfate
,
Colistin
💬
| - | - | [1] 299 299 💬
|
| 1181 | Colistimethate sodium (CMS) | [1] Colistimethate Colistimethate | [1] Colistimethate sodium
Colistimethate sodium
💬
| - | - | [1] 299 299 💬
|
| 1182 | Colistimethate sodium (promixin) | [1] Colistimethate Colistimethate | [1] Colistimethate sodium
Colistimethate sodium
💬
| - | - | [1] 299 299 💬
|
| 1183 | COLISTIN | [1] Colistin Colistin | [2] Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | [1] 299 299 💬
|
| 1184 | Colistin CF | [1] Colistin Colistin | [2] Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | [1] 299 299 💬
|
| 1185 | Colistin Forest - Trockenstechampullen mit Lösungsmittel | [1] Colistin Colistin | [2] Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | [1] 299 299 💬
|
| 1186 | COLISTIN MESILATE SODIUM | [1] Colistin Colistin | [2] Colistin sulfate
Colistin sulfate
,
Colistin
💬
| - | - | [1] 299 299 💬
|
| 1187 | Colistineb | - | - | - | - | [1] 299 299 💬
|
| 1188 | COLISTINEB 2MUI | - | - | - | - | [1] 299 299 💬
|
| 1189 | Collagen-based adhesion barrier | - | - | - | - | [1] 70 70 💬
|
| 1190 | Collagenase | - | - | - | - | [1] 162 162 💬
|
| 1191 | Collect of 10 ml of peripheric blood for DNA extraction | - | - | - | - | [1] 46 46 💬
|
| 1192 | Collection of Arterial pressure, metabolic data, kidney function, proteinuria and hematuria before and after KATRIO initiation | - | - | - | - | [1] 299 299 💬
|
| 1193 | Collection of biological sample (blood and/or CSF) | - | - | - | - | [2] 2 2, 6 💬
|
| 1194 | Collection of biological samples | - | - | - | - | [1] 63 63 💬
|
| 1195 | Collection of blood and urine | - | - | - | - | [1] 25 25 💬
|
| 1196 | Collection of blood, feces and urine. For UC: collection of 8 additional biopsies | - | - | - | - | [1] 97 97 💬
|
| 1197 | Collection of samples | - | - | - | - | [4] 49 49, 65, 95, 107 💬
|
| 1198 | Collection of samples of blood and urine | - | - | - | - | [1] 167 167 💬
|
| 1199 | Colobreathe | - | - | - | - | [1] 299 299 💬
|
| 1200 | Colomycin | - | - | - | - | [1] 299 299 💬
|
| 1201 | Colon Endoscopy Procedure | - | - | - | - | [1] 97 97 💬
|
| 1202 | Colon KCC Heptapeptide | - | - | - | - | [1] 97 97 💬
|
| 1203 | Colon preparation for colonoscopy | - | - | - | - | [1] 97 97 💬
|
| 1204 | Colonoscopic fecal microbiota material (colo-FMT) | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 96 96 💬
|
| 1205 | Colonoscopy | - | - | - | - | [2] 96 96, 97 💬
|
| 1206 | Colonoscopy after bowel cleansing | - | - | - | - | [1] 97 97 💬
|
| 1207 | Colonoscopy with Indigo-Carmine chromoendoscopy | [1] Indigo Indigo | - | - | - | [1] 97 97 💬
|
| 1208 | Colony-purified Bacteroides thetaiotaomicron (B.theta) | [1] Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron | - | - | - | [1] 96 96 💬
|
| 1209 | Colorectal biopsies | - | - | - | - | [1] 97 97 💬
|
| 1210 | ColoVit capsule | - | - | - | - | [1] 96 96 💬
|
| 1211 | Coltect | - | - | - | - | [1] 97 97 💬
|
| 1212 | Combination | - | - | - | - | [1] 46 46 💬
|
| 1213 | Combination antiviral therapy | - | - | - | - | [1] 93 93 💬
|
| 1214 | Combination fish oil and borage seed oil | [1] Fish oil Fish oil | - | - | - | [1] 46 46 💬
|
| 1215 | Combination injection of EPO and G-CSF | - | - | - | - | [1] 6 6 💬
|
| 1216 | Combination of a single dose anti-CD20 antibody and bortezomib | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 61 61 💬
|
| 1217 | Combination of DMARDs | - | - | - | - | [1] 107 107 💬
|
| 1218 | Combination of fish oil and colesevelam | [2] Colesevelam Colesevelam, Fish oil | [2] Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | [1] 260 260 💬
|
| 1219 | Combination of Minocycline and MTX or MTX alone | [1] Minocycline Minocycline | [2] Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | [1] 46 46 💬
|
| 1220 | Combination of Navepegritide and Lonapegsomatropin administered as two separate s.c. injections | [2] Lonapegsomatropin Lonapegsomatropin, Navepegritide | [2] Lonapegsomatropin
Lonapegsomatropin
,
Navepegritide
💬
| [2] GHR GHR, NPR2 💬
| [10] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 276 276 💬
|
| 1221 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine | [3] Azathioprine Azathioprine, Dexamethasone, Rituximab | [6] Azathioprine
Azathioprine
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Rituximab
,
Azathioprine sodium
,
Dexamethasone phosphate
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬
|
| 1222 | Combination of Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 63 63 💬
|
| 1223 | Combination of Rituximab with subcutaneous belimumab | [2] Belimumab Belimumab, Rituximab | [2] Rituximab
Rituximab
,
Belimumab
💬
| [2] MS4A1 MS4A1, TNFSF13B 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 63 63 💬
|
| 1224 | Combination of thrombopoietin mimetic and cyclosporin A | [1] Thrombopoietin Thrombopoietin | - | - | - | [1] 60 60 💬
|
| 1225 | Combination Oral Budesonide and Rectal Hydrocortisone | [2] Budesonide Budesonide, Hydrocortisone | [2] Hydrocortisone
Hydrocortisone
,
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1226 | Combination Product: | - | - | - | - | [1] 86 86 💬
|
| 1227 | Combination Product: 1.5g enriched pomegranate muffins | [1] Pomegranate Pomegranate | - | - | - | [1] 97 97 💬
|
| 1228 | Combination Product: 3g enriched pomegranate muffins | [1] Pomegranate Pomegranate | - | - | - | [1] 97 97 💬
|
| 1229 | Combination Product: 68Ga-DOTATATE PET/CT | [1] Dotatate Dotatate | - | - | - | [1] 238 238 💬
|
| 1230 | Combination Product: Active treatment with dual therapy | - | - | - | - | [1] 2 2 💬
|
| 1231 | Combination Product: Anifrolumab (blinded) | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 50 50, 51 💬
|
| 1232 | Combination Product: Anifrolumab (unblinded, open label) | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 50 50, 51 💬
|
| 1233 | Combination Product: Anifrolumab + APFS | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 49 49 💬
|
| 1234 | Combination Product: Beclomethasone dipropionate in addition to MC-EVOO | [1] Beclomethasone dipropionate Beclomethasone dipropionate | [3] Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1235 | Combination Product: Beclomethasone dipropionate in addition to refined oil | [1] Beclomethasone dipropionate Beclomethasone dipropionate | [3] Beclomethasone dipropionate
Beclomethasone dipropionate
,
Beclometasone
,
Beclomethasone dipropionate monohydrate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1236 | Combination Product: Belimumab | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 💬
|
| 1237 | Combination Product: BMN 111 administration via Injector Pen | - | - | - | - | [1] 276 276 💬
|
| 1238 | Combination Product: CDED (Crohn's Disease Exclusion Diet) in addition to anti-TNF therapy | - | - | - | - | [2] 96 96, 97 💬
|
| 1239 | Combination Product: Claseprubart | [1] Claseprubart Claseprubart | - | - | - | [1] 11 11 💬
|
| 1240 | Combination Product: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection | [2] Dolutegravir Dolutegravir, Tenofovir | [3] Tenofovir
Tenofovir
,
Dolutegravir
,
Dolutegravir sodium
💬
| - | - | [1] 26 26 💬
|
| 1241 | Combination Product: Combination Therapy | - | - | - | - | [1] 79 79 💬
|
| 1242 | Combination Product: Diosmin | [1] Diosmin Diosmin | [1] Diosmin
Diosmin
💬
| - | - | [1] 51 51 💬
|
| 1243 | Combination Product: Efgartigimod + Thymectomy | - | - | - | - | [1] 11 11 💬
|
| 1244 | Combination Product: Efgartigimod PH20 SC | - | - | - | - | [2] 11 11, 51 💬
|
| 1245 | Combination Product: EGCG 300 mg + Nintedanib | [1] Nintedanib Nintedanib | [2] Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| [36] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬
|
| 1246 | Combination Product: EGCG 300 mg + Pirfenidone | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 1247 | Combination Product: EGCG 600 mg + Nintedanib | [1] Nintedanib Nintedanib | [2] Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| [36] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 💬
|
| 1248 | Combination Product: EGCG 600 mg + Pirfenidone | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 💬
|
| 1249 | Combination Product: eneboparatide | [1] Eneboparatide Eneboparatide | [1] Eneboparatide
Eneboparatide
💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 1250 | Combination Product: Exercise, and methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 1251 | Combination Product: Fecal Microbiota Transplant | [1] Fecal microbiota Fecal microbiota | - | - | - | [1] 6 6 💬
|
| 1252 | Combination Product: Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration of unlabeled vedolizumab | [1] Vedolizumab Vedolizumab | [1] Vedolizumab
Vedolizumab
💬
| [2] ITGA4 ITGA4, ITGB7 💬
| [18] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | [2] 96 96, 97 💬
|
| 1253 | Combination Product: Gefurulimab | [1] Gefurulimab Gefurulimab | [1] Gefurulimab
Gefurulimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 11 11 💬
|
| 1254 | Combination Product: Gene therapy: GS030-DP AND Medical device: GS030-MD | [1] GS030-DP GS030-DP | - | - | - | [1] 90 90 💬
|
| 1255 | Combination Product: Goldic serum | - | - | - | - | [1] 70 70 💬
|
| 1256 | Combination Product: Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001) | - | - | - | - | [1] 6 6 💬
|
| 1257 | Combination Product: Humira (adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1258 | Combination Product: Implantable System for Remodulin (treprostinil) | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 1259 | Combination Product: INBRIJA® | - | - | - | - | [1] 6 6 💬
|
| 1260 | Combination Product: Intravenous immunglobulin + Thymectomy | - | - | - | - | [1] 11 11 💬
|
| 1261 | Combination Product: L-dopa 140 mg | - | - | - | - | [1] 6 6 💬
|
| 1262 | Combination Product: L-dopa 35 mg | - | - | - | - | [1] 6 6 💬
|
| 1263 | Combination Product: L-dopa 70mg | - | - | - | - | [1] 6 6 💬
|
| 1264 | Combination Product: L-dopa 70mg/carbidopa 7mg | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 1265 | Combination Product: Laser, exercise, and methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 1266 | Combination Product: Levodopa Cyclops® | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1267 | Combination Product: lipid injectable emulsion with Fish oil | [1] Fish oil Fish oil | - | - | - | [1] 294 294 💬
|
| 1268 | Combination Product: mavrilimumab | [1] Mavrilimumab Mavrilimumab | [1] Mavrilimumab
Mavrilimumab
💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 41 41 💬
|
| 1269 | Combination Product: Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 1270 | Combination Product: mirdametinib with radiation | [1] Mirdametinib Mirdametinib | [1] Mirdametinib
Mirdametinib
💬
| [2] MAP2K1 MAP2K1, MAP2K2 💬
| [90] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cadherin signaling, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, Efferocytosis, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 💬
|
| 1271 | Combination Product: ND0612 Solution for SC infusion | - | - | - | - | [1] 6 6 💬
|
| 1272 | Combination Product: ofatumumab with AI | [1] Ofatumumab Ofatumumab | [1] Ofatumumab
Ofatumumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 1273 | Combination Product: ofatumumab with PRF | [1] Ofatumumab Ofatumumab | [1] Ofatumumab
Ofatumumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 1274 | Combination Product: Osteoplastic material based on octacalcium phosphate and biologically active nucleic acids for bone tissue regeneration Nucleostim-VEGF (Histograft) | - | - | - | - | [1] 70 70 💬
|
| 1275 | Combination Product: Palopegteriparatide Control Arm | [1] Palopegteriparatide Palopegteriparatide | [1] Palopegteriparatide
Palopegteriparatide
💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 1276 | Combination Product: Palopegteriparatide Experimental Arm | [1] Palopegteriparatide Palopegteriparatide | [1] Palopegteriparatide
Palopegteriparatide
💬
| [1] PTH1R PTH1R 💬
| [4] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 💬
|
| 1277 | Combination Product: Pozelimab/Cemdisiran | [2] Cemdisiran Cemdisiran, Pozelimab | [1] Pozelimab
Pozelimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 15 15 💬
|
| 1278 | Combination Product: PRP combined Magnovision | - | - | - | - | [1] 90 90 💬
|
| 1279 | Combination Product: Ravulizumab OBDS | [1] Ravulizumab Ravulizumab | [1] Ravulizumab
Ravulizumab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 💬
|
| 1280 | Combination Product: Ripertamab/Eltrombopag | [2] Eltrombopag Eltrombopag, Ripertamab | [2] Eltrombopag olamine
Eltrombopag olamine
,
Eltrombopag choline
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 1281 | Combination Product: SP-101 and doxorubicin Cohort 1 | [2] Doxorubicin Doxorubicin, SP-101 | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | [1] 299 299 💬
|
| 1282 | Combination Product: SP-101 and doxorubicin Cohort 2 | [2] Doxorubicin Doxorubicin, SP-101 | [2] Doxorubicin hydrochloride
Doxorubicin hydrochloride
,
Doxorubicin
💬
| - | - | [1] 299 299 💬
|
| 1283 | Combination Product: Standard of Care | - | - | - | - | [1] 62 62 💬
|
| 1284 | Combination Product: The addition of sodium hyaluronate to poly (cinnamyl alcohol-RRB- produces a more stable foam | [2] Cinnamyl alcohol Cinnamyl alcohol, Hyaluronic acid | [2] Hyaluronate sodium
Hyaluronate sodium
,
Hyaluronic acid
💬
| - | - | [1] 279 279 💬
|
| 1285 | Combination Product: TransCon PTH | - | - | - | - | [1] 235 235 💬
|
| 1286 | Combination Product: Treprostinil via implanted pump | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 1287 | Combination Product: Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator | [3] Acetate Acetate, Hydrocortisone, Hydrocortisone acetate | [2] Hydrocortisone
Hydrocortisone
,
Hydrocortisone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 💬
|
| 1288 | Combination Product: Yu-Tone Music Intervention | - | - | - | - | [1] 49 49 💬
|
| 1289 | Combination Steroid | - | - | - | - | [1] 46 46 💬
|
| 1290 | Combination therapy with vigabatrin and prednisolone | [2] Prednisolone Prednisolone, Vigabatrin | [2] Prednisolone
Prednisolone
,
Vigabatrin
💬
| [2] ABAT ABAT, NR3C1 💬
| [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 💬
|
| 1291 | Combination with dopamine agonist cabergoline | [2] Cabergoline Cabergoline, Dopamine | [3] Dopamine hydrochloride
Dopamine hydrochloride
,
Cabergoline
,
Dopamine
💬
| [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1292 | Combination with somatostatin analogue octreotide | [2] Octreotide Octreotide, Somatostatin | [6] Octreotide
Octreotide
,
Octreotide acetate
,
Octreotide pamoate
,
Octreotide acetate
,
Somatostatin
,
Octreotide hydrochloride
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1293 | Combined antithrombotic therapy | - | - | - | - | [1] 48 48 💬
|
| 1294 | Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 85 85 💬
|
| 1295 | Combined therapy of Iguratimod and tofacitinib | [2] Iguratimod Iguratimod, Tofacitinib | [3] Iguratimod
Iguratimod
,
Tofacitinib citrate
,
Tofacitinib
💬
| [5] JAK1 JAK1, JAK2, JAK3, NFKB1, TYK2 💬
| [85] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | [1] 46 46 💬
|
| 1296 | Combined use of TPO-RAs with low-dose anti-CD20 antibody | - | - | - | - | [1] 63 63 💬
|
| 1297 | COMBIVIR | - | - | - | - | [1] 265 265 💬
|
| 1298 | Combivir (zidovudine [AZT] / lamivudine [3TC]) | [2] Lamivudine Lamivudine, Zidovudine | [2] Lamivudine
Lamivudine
,
Zidovudine
💬
| - | - | [1] 265 265 💬
|
| 1299 | Comirnaty | - | - | - | - | [3] 46 46, 51, 299 💬
|
| 1300 | Comirnaty concentrate for dispersion for injection | - | - | - | - | [2] 53 53, 299 💬
|
| 1301 | Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion | - | - | - | - | [1] 13 13 💬
|
| 1302 | Commercial Formulation Etanercept | [1] Etanercept Etanercept | [1] Etanercept
Etanercept
💬
| [2] LTA LTA, TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 1303 | Commercial Ventavis® (iloprost) | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 1304 | Common form supplementation | - | - | - | - | [1] 299 299 💬
|
| 1305 | Common Name: Sialic Acid | - | - | - | - | [1] 30 30 💬
|
| 1306 | Companion blood samples with procedure | - | - | - | - | [4] 13 13, 51, 97, 271 💬
|
| 1307 | Companion diagnostic (CDx) | - | - | - | - | [1] 96 96 💬
|
| 1308 | Companion Diagnostic (CDx) Testing | - | - | - | - | [1] 97 97 💬
|
| 1309 | Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study from Bangladesh | [2] Sulfasalazine Sulfasalazine, Thalidomide | [2] Sulfasalazine
Sulfasalazine
,
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 💬
|
| 1310 | Comparator | - | - | - | - | [1] 96 96 💬
|
| 1311 | Comparator: carbidopa | [1] Carbidopa Carbidopa | [1] Carbidopa
Carbidopa
💬
| [1] DDC DDC 💬
| [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 💬
|
| 1312 | Comparator: diclofenac | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 1313 | Comparator: Diclofenac sodium | [1] Diclofenac Diclofenac | [5] Diclofenac potassium
Diclofenac potassium
,
Diclofenac sodium
,
Diclofenac
,
Diclofenac diethylamine
,
Diclofenac epolamine
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 1314 | Comparator: ezetimibe | [1] Ezetimibe Ezetimibe | [1] Ezetimibe
Ezetimibe
💬
| [1] NPC1L1 NPC1L1 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [2] 79 79, 260 💬
|
| 1315 | Comparator: levodopa | [1] Levodopa Levodopa | [1] Levodopa
Levodopa
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1316 | Comparator: naproxen tablet 500 mg | [1] Naproxen Naproxen | [2] Naproxen
Naproxen
,
Naproxen sodium
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 💬
|
| 1317 | Comparator: niacin (+) laropiprant (MK0524A) | [2] Laropiprant Laropiprant, Niacin | [2] Niacin
Niacin
,
Laropiprant
💬
| [1] PTGDR PTGDR 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 79 79 💬
|
| 1318 | Comparators | - | - | - | - | [1] 54 54 💬
|
| 1319 | Complarate® | - | - | - | - | [1] 46 46 💬
|
| 1320 | COMPLEMENT C1 ESTERASE INHIBITOR | - | - | - | - | [2] 61 61, 65 💬
|
| 1321 | Complement protein C5 inhibitor | - | - | - | - | [1] 13 13 💬
|
| 1322 | Complete, polymeric formula, fiber, lactose and gluten free | [1] Lactose Lactose | [2] Anhydrous lactose
Anhydrous lactose
,
Lactose hydrate
💬
| - | - | [1] 107 107 💬
|
| 1323 | Compound 1a | - | - | - | - | [2] 246 246, 299 💬
|
| 1324 | COMPOUND 21 | - | - | - | - | [1] 85 85 💬
|
| 1325 | Compound thrombosis capsule sig: 1.5g/tid | - | - | - | - | [1] 90 90 💬
|
| 1326 | Compressa effervescente 0,5 mg di budesonide per uso orodispersibile | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬
|
| 1327 | Compressa effervescente 1 mg di budesonide per uso orodispersibile | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 💬
|
| 1328 | Compressed oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 97 97 💬
|
| 1329 | Computed Tomography | - | - | - | - | [13] 26 26, 28, 34, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
| 1330 | COMTAN | - | - | - | - | [1] 6 6 💬
|
| 1331 | COMTAN 200* 60 CPR 200 MG | - | - | - | - | [1] 6 6 💬
|
| 1332 | COMTAN® | - | - | - | - | [1] 6 6 💬
|
| 1333 | Comtan® | - | - | - | - | [1] 6 6 💬
|
| 1334 | Comtess | - | - | - | - | [1] 6 6 💬
|
| 1335 | Comtess® | - | - | - | - | [1] 6 6 💬
|
| 1336 | Concentration unit: mg milligram(s) | - | - | - | - | [1] 254 254 💬
|
| 1337 | Concerta | - | - | - | - | [1] 203 203 💬
|
| 1338 | CONCOR MITE*28CPR 5MG | - | - | - | - | [1] 57 57 💬
|
| 1339 | Conditioned Medium (CM) | - | - | - | - | [1] 90 90 💬
|
| 1340 | Conditioning Regimen | - | - | - | - | [1] 2 2 💬
|
| 1341 | CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium® | [1] Titanium Titanium | - | - | - | [1] 70 70 💬
|
| 1342 | CONESTAT ALFA | [1] Conestat alfa Conestat alfa | [1] Conestat alfa
Conestat alfa
💬
| [3] C1R C1R, C1S, KLKB1 💬
| [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 65 65 💬
|
| 1343 | Confirm Rx | - | - | - | - | [1] 86 86 💬
|
| 1344 | Confocal laser endomicroscopy | - | - | - | - | [1] 96 96 💬
|
| 1345 | Confortid | - | - | - | - | [1] 225 225 💬
|
| 1346 | Conivaptan | [1] Conivaptan Conivaptan | [2] Conivaptan hydrochloride
Conivaptan hydrochloride
,
Conivaptan
💬
| [2] AVPR1A AVPR1A, AVPR2 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 86 86 💬
|
| 1347 | Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d | - | - | - | - | [1] 49 49 💬
|
| 1348 | Conjugated linoleic acid (CLA/Tonalin® FFA 80) | [1] Linoleic acid Linoleic acid | - | - | - | [1] 13 13 💬
|
| 1349 | Conjugated pneumococcal vaccine (Prevenar) | - | - | - | - | [1] 65 65 💬
|
| 1350 | Conjunctival impression | - | - | - | - | [1] 329 329 💬
|
| 1351 | Conscious sedation | - | - | - | - | [1] 6 6 💬
|
| 1352 | Continuation of azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [1] 49 49 💬
|
| 1353 | Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs) | - | - | - | - | [1] 265 265 💬
|
| 1354 | Continue IS (B cell depletion therapy) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1355 | Continue IS (MMF or MPA) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1356 | Continue IS (MTX) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 1357 | CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID | - | - | - | - | [1] 299 299 💬
|
| 1358 | Continued Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] Ocrelizumab
Ocrelizumab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 1359 | Continuous Apomorphine infusion | [1] Apomorphine Apomorphine | [2] Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| [2] DRD1 DRD1, DRD2 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1360 | Continuous Glucose Monitor | - | - | - | - | [2] 65 65, 298 💬
|
| 1361 | Continuous glucose monitor (CGM) | - | - | - | - | [1] 299 299 💬
|
| 1362 | Continuous Glucose Monitoring | - | - | - | - | [3] 70 70, 75, 299 💬
|
| 1363 | Continuous glucose monitoring (CGM) | - | - | - | - | [1] 299 299 💬
|
| 1364 | Continuous Glucose Monitoring System (CGMS) | - | - | - | - | [1] 299 299 💬
|
| 1365 | Continuous infusion Cefepime | [1] Cefepime Cefepime | [2] Cefepime hydrochloride
Cefepime hydrochloride
,
Cefepime
💬
| - | - | [1] 299 299 💬
|
| 1366 | Continuous infusion Ceftazidime | [1] Ceftazidime Ceftazidime | [2] Ceftazidime
Ceftazidime
,
Ceftazidime
💬
| - | - | [1] 299 299 💬
|
| 1367 | Continuous infusion Meropenem | [1] Meropenem Meropenem | [2] Meropenem
Meropenem
,
Meropenem
💬
| - | - | [1] 299 299 💬
|
| 1368 | Continuous infusion Piperacillin tazobactam | [2] Piperacillin Piperacillin, Tazobactam | [5] Piperacillin sodium
Piperacillin sodium
,
Tazobactam
,
Piperacillin
,
Tazobactam sodium
,
Piperacillin
💬
| - | - | [1] 299 299 💬
|
| 1369 | Continuous infusion Ticarcillin-clavulanate | [1] Ticarcillin Ticarcillin | [2] Ticarcillin disodium
Ticarcillin disodium
,
Ticarcillin
💬
| - | - | [1] 299 299 💬
|
| 1370 | Continuous intrajejunal infusion of levodopa-carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1371 | Continuous Mononuclear Cell Collection (CMNC) | - | - | - | - | [1] 96 96 💬
|
| 1372 | Continuous oxygen | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 90 90 💬
|
| 1373 | Continuous Release Dopamine Agonists | [1] Dopamine Dopamine | [2] Dopamine hydrochloride
Dopamine hydrochloride
,
Dopamine
💬
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [13] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1374 | Continuous Subcutaneous Lisuride Infusion | [1] Lisuride Lisuride | [1] Lisuride
Lisuride
💬
| [3] DRD2 DRD2, DRD3, DRD4 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1375 | Contrast Enhanced Ultrasound | - | - | - | - | [1] 96 96 💬
|
| 1376 | Contrast Enhanced Voiding Urosonography with Urodynamic Testing | - | - | - | - | [1] 118 118 💬
|
| 1377 | Contrast Media, Magnetic Resonance | - | - | - | - | [2] 94 94, 96 💬
|
| 1378 | Contrast sensitivity measurement | - | - | - | - | [1] 19 19 💬
|
| 1379 | Control | - | - | - | - | [8] 2 2, 6, 46, 51, 90, 97, 168, 299 💬
|
| 1380 | Control gel | - | - | - | - | [1] 36 36 💬
|
| 1381 | Control group | - | - | - | - | [6] 2 2, 13, 46, 70, 235, 240 💬
|
| 1382 | Control Group 0.9% Isotonic Saline | - | - | - | - | [1] 299 299 💬
|
| 1383 | Control group: Clomiphene Citrate Tablets | - | - | - | - | [1] 74 74 💬
|
| 1384 | Control group: Mesalazine enema treatment | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [1] 97 97 💬
|
| 1385 | Control intervention (no dexamethasone) | [1] Dexamethasone Dexamethasone | [3] Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬
|
| 1386 | Control multivitamin | - | - | - | - | [1] 299 299 💬
|
| 1387 | Control surgery | - | - | - | - | [1] 6 6 💬
|
| 1388 | Controlled-ileocolonic-release nicotinamide (CICR-NAM): 1000 mg/d | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 97 97 💬
|
| 1389 | Controlled-ileocolonic-release nicotinamide (CICR-NAM): 500 mg/d | [1] Nicotinamide Nicotinamide | [1] Niacinamide
Niacinamide
💬
| - | - | [1] 97 97 💬
|
| 1390 | Controlled-release levodopa / carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] Levodopa
Levodopa
,
Carbidopa
💬
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 💬
|
| 1391 | Conventional | - | - | - | - | [1] 63 63 💬
|
| 1392 | Conventional 24-week glucocorticoid regimen | - | - | - | - | [1] 222 222 💬
|
| 1393 | Conventional DMARD combination | - | - | - | - | [1] 46 46 💬
|
| 1394 | Conventional DMARDs | - | - | - | - | [1] 46 46 💬
|
| 1395 | Conventional drug therapy(expectorant,bronchodilator) | - | - | - | - | [1] 86 86 💬
|
| 1396 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) | [7] Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone | [8] Hydrocortisone
Hydrocortisone
,
Dexamethasone
,
Prednisolone
,
Prednisone
,
Cortisone acetate
,
Dexamethasone sodium phosphate
,
Cortisone
,
Dexamethasone phosphate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 1397 | Conventional ibd medical treatment | - | - | - | - | [1] 97 97 💬
|
| 1398 | Conventional medical treatment | - | - | - | - | [1] 22 22 💬
|
| 1399 | Conventional medication | - | - | - | - | [1] 6 6 💬
|
| 1400 | Conventional medicine | - | - | - | - | [1] 18 18 💬
|
| 1401 | Conventional pharmacotherapy | - | - | - | - | [1] 49 49 💬
|
| 1402 | Conventional surgery | - | - | - | - | [1] 34 34 💬
|
| 1403 | Conventional synthetic antirheumatic drugs | - | - | - | - | [1] 46 46 💬
|
| 1404 | Conventional Synthetic DMARD | - | - | - | - | [1] 46 46 💬
|
| 1405 | Conventional Therapy | - | - | - | - | [5] 14 14, 49, 67, 97, 222 💬
|
| 1406 | Conventional therapy of antiphospholipis syndrome | - | - | - | - | [1] 48 48 💬
|
| 1407 | Conventional therapy users for the last 5 years | - | - | - | - | [1] 271 271 💬
|
| 1408 | Conventional treatment | - | - | - | - | [1] 97 97 💬
|
| 1409 | Conventional treatment (glucocoticoid, immunosupressive drugs and/or mesalazine) | [1] Mesalazine Mesalazine | [1] Mesalamine
Mesalamine
💬
| - | - | [2] 96 96, 97 💬
|
| 1410 | Conventional white-light colonoscopy | - | - | - | - | [1] 97 97 💬
|
| 1411 | Coolonic biopsies | - | - | - | - | [2] 96 96, 97 💬
|
| 1412 | Coozar | - | - | - | - | [1] 167 167 💬
|
| 1413 | COP-1/Copolymer-1 | [1] Glatiramer Glatiramer | [1] Glatiramer acetate
Glatiramer acetate
💬
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
| 1414 | Copanlisib | [1] Copanlisib Copanlisib | [1] Copanlisib
Copanlisib
💬
| [2] PIK3CA PIK3CA, PIK3CD 💬
| [106] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phagocytosis, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | [1] 121 121 💬
|
| 1415 | COPAXONE | - | - | - | - | [1] 13 13 💬
|
| 1416 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE | - | - | - | - | [1] 13 13 💬
|
| 1417 | COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE | - | - | - | - | [1] 13 13 💬
|
| 1418 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN | - | - | - | - | [1] 13 13 💬
|
| 1419 | COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO | - | - | - | - | [1] 13 13 💬
|
| 1420 | Copaxone 20 mg | - | - | - | - | [1] 13 13 💬
|
| 1421 | Copaxone 20 mg/ml | - | - | - | - | [1] 13 13 💬
|
| 1422 | COPAXONE 20 mg/ml solución inyectable en jeringa precargada | - | - | - | - | [1] 13 13 💬
|
| 1423 | Copaxone 20 mg/ml solución para inyección en jeringa precargada | - | - | - | - | [1] 13 13 💬
|
| 1424 | Copaxone 20 mg/ml Solution for Injection, pre-filled syringe | - | - | - | - | [1] 13 13 💬
|
| 1425 | Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes | - | - | - | - | [1] 13 13 💬
|
| 1426 | Copaxone 20mg/ml Solution for Injection, pre-filled syringe | - | - | - | - | [1] 13 13 💬
|
| 1427 | Copaxone 40 mg/ml | - | - | - | - | [1] 13 13 💬
|
| 1428 | Copaxone 40 mg/ml solution for injection, pre-filled syringe | - | - | - | - | [1] 13 13 💬
|
| 1429 | COPAXONE*SC 28SIR 20MG/ML | - | - | - | - | [1] 13 13 💬
|
| 1430 | Copaxone-Teva | - | - | - | - | [1] 13 13 💬
|
| 1431 | Copaxone® | - | - | - | - | [1] 13 13 💬
|
| 1432 | Copegus | - | - | - | - | [1] 2 2 💬
|
| 1433 | Copolymer 1 | - | - | - | - | [1] 13 13 💬
|
| 1434 | Copper | [1] Copper Copper | - | - | - | [4] 2 2, 169, 170, 171 💬
|
| 1435 | COPPER (64CU) CHLORIDE | [1] Copper Copper | - | - | - | [1] 171 171 💬
|
| 1436 | Copper histidinate | [1] Copper Copper | - | - | - | [1] 169 169 💬
|
| 1437 | Copper Histidine | [2] Copper Copper, Histidine | [1] Histidine
Histidine
💬
| - | - | [2] 169 169, 170 💬
|
| 1438 | CoQ10 | - | - | - | - | [4] 5 5, 6, 8, 96 💬
|
| 1439 | COQUN | - | - | - | - | [1] 90 90 💬
|
| 1440 | COR-003 | - | - | - | - | [1] 75 75 💬
|
| 1441 | COR-1 | - | - | - | - | [1] 57 57 💬
|
| 1442 | Coramitug | [1] Coramitug Coramitug | [1] Coramitug
Coramitug
💬
| [1] TTR TTR 💬
| [1] Thyroid hormone synthesis Thyroid hormone synthesis 💬 | [1] 28 28 💬
|
| 1443 | Cord blood | - | - | - | - | [1] 60 60 💬
|
| 1444 | Cord Blood Infusion | - | - | - | - | [1] 60 60 💬
|
| 1445 | Cord blood sampling | - | - | - | - | [1] 227 227 💬
|
| 1446 | Cord Blood Stem Cell Transplantation | - | - | - | - | [1] 97 97 💬
|
| 1447 | Cord Blood Transplant | - | - | - | - | [1] 60 60 💬
|
| 1448 | Cord Blood Transplantation | - | - | - | - | [1] 60 60 💬
|
| 1449 | Cord Blood Units | - | - | - | - | [1] 60 60 💬
|
| 1450 | Cord sampling | - | - | - | - | [1] 227 227 💬
|
| 1451 | Core decompression | - | - | - | - | [1] 71 71 💬
|
| 1452 | Core decompression/BMC implantation | - | - | - | - | [1] 71 71 💬
|
| 1453 | Core decompression/PREOB® implantation | - | - | - | - | [1] 71 71 💬
|
| 1454 | Corlanor | - | - | - | - | [1] 57 57 💬
|
| 1455 | CORMETO | - | - | - | - | [1] 75 75 💬
|
| 1456 | CORMETO - 250 MG CAPSULE MOLLI 50 CAPSULE IN FLACONE HDPE | - | - | - | - | [1] 75 75 💬
|
| 1457 | Corn | [1] Corn Corn | - | - | - | [2] 46 46, 240 💬
|
| 1458 | Corn oil capsules | [1] Corn Corn | - | - | - | [1] 46 46 💬
|
| 1459 | Corn starch tablets | - | - | - | - | [1] 179 179 💬
|
| 1460 | Corn/soy oil | [1] Corn Corn | - | - | - | [1] 240 240 💬
|
| 1461 | Cornstarch | - | - | - | - | [1] 257 257 💬
|
| 1462 | Cornstarch control | - | - | - | - | [1] 90 90 💬
|
| 1463 | CORT113176 | - | - | - | - | [1] 2 2 💬
|
| 1464 | CORT125134 | [1] Relacorilant Relacorilant | [1] Relacorilant
Relacorilant
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 💬
|
| 1465 | CORT125134Pharmaceutical Form: Capsule, soft | - | - | - | - | [1] 75 75 💬
|
| 1466 | CORTANCYL | - | - | - | - | [1] 41 41 💬
|
| 1467 | CORTANCYL 20 mg | - | - | - | - | [2] 35 35, 162 💬
|
| 1468 | Cortancyl ® 1 mg | - | - | - | - | [1] 41 41 💬
|
| 1469 | Cortancyl ® 20 mg | - | - | - | - | [1] 41 41 💬
|
| 1470 | Cortancyl ® 5 mg | - | - | - | - | [1] 41 41 💬
|
| 1471 | Cortecosteroid | - | - | - | - | [1] 96 96 💬
|
| 1472 | Cortef | - | - | - | - | [2] 81 81, 83 💬
|
| 1473 | Cortef (hydrocortisone) | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 💬
|
| 1474 | Cortef 10mg | - | - | - | - | [1] 81 81 💬
|
| 1475 | Cortef 5 mg | - | - | - | - | [1] 83 83 💬
|
| 1476 | Cortef 5mg | - | - | - | - | [1] 81 81 💬
|
| 1477 | Corticoids+ tocilizumab 8mg/Kg/4 weeks | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 1478 | Corticosteriod for treated patients | - | - | - | - | [1] 63 63 💬
|
| 1479 | Corticosteroid | - | - | - | - | [12] 13 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
|
| 1480 | Corticosteroid (CS) | - | - | - | - | [1] 41 41 💬
|
| 1481 | Corticosteroid and azathioprine | [1] Azathioprine Azathioprine | [2] Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | [4] 42 42, 43, 44, 45 💬
|
| 1482 | Corticosteroid and non-biological agents. | - | - | - | - | [1] 46 46 💬
|
| 1483 | Corticosteroid injection | - | - | - | - | [1] 46 46 💬
|
| 1484 | Corticosteroid or NSAID | - | - | - | - | [1] 46 46 💬
|
| 1485 | Corticosteroid treatment (Methylprednisolone or prednisolone) | [2] Methylprednisolone Methylprednisolone, Prednisolone | [3] Methylprednisolone
Methylprednisolone
,
Prednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 64 64 💬
|
| 1486 | Corticosteroide | - | - | - | - | [1] 113 113 💬
|
| 1487 | Corticosteroids | - | - | - | - | [13] 41 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
|
| 1488 | Corticosteroids & tanCART19/20 | - | - | - | - | [1] 13 13 💬
|
| 1489 | Corticosteroids (Aprednislon) | - | - | - | - | [1] 63 63 💬
|
| 1490 | Corticosteroids (prednisone or prednisolone) | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 49 49, 223 💬
|
| 1491 | Corticosteroids + Rivaroxaban | [1] Rivaroxaban Rivaroxaban | [1] Rivaroxaban
Rivaroxaban
💬
| [1] F10 F10 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 56 56 💬
|
| 1492 | Corticosteroids alone | - | - | - | - | [1] 56 56 💬
|
| 1493 | Corticosteroids and immunosuppressants | - | - | - | - | [1] 55 55 💬
|
| 1494 | Corticosteroids combined with immunoglobulin and romiplostim | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 1495 | Corticosteroids for Systemic Use | - | - | - | - | [1] 41 41 💬
|
| 1496 | Corticosteroids only | - | - | - | - | [1] 97 97 💬
|
| 1497 | Corticosteroids'therapy | - | - | - | - | [1] 35 35 💬
|
| 1498 | Corticotherapy | - | - | - | - | [1] 66 66 💬
|
| 1499 | Corticotrophin 80 units | - | - | - | - | [1] 46 46 💬
|
| 1500 | Corticotropin | [1] Corticotropin Corticotropin | [2] Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [10] 2 2, 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
|
| 1501 | Corticotropin-Releasing Hormone | [1] Corticotropin Corticotropin | [2] Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 205 205 💬
|
| 1502 | CortimentMMX 9 mg | - | - | - | - | [1] 97 97 💬
|
| 1503 | Cortisol | [1] Hydrocortisone Hydrocortisone | [1] Hydrocortisone
Hydrocortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 1504 | Cortison | - | - | - | - | [1] 81 81 💬
|
| 1505 | Cortisone | [1] Cortisone Cortisone | [1] Cortisone
Cortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 1506 | Cortisone acetate | [3] Acetate Acetate, Cortisone, Cortisone acetate | [2] Cortisone acetate
Cortisone acetate
,
Cortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 1507 | Corynebacterium diphtheriae | [1] Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | [1] 11 11 💬
|
| 1508 | Cosentyx | - | - | - | - | [4] 41 41, 107, 269, 271 💬
|
| 1509 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 1 SIRINGA PRERIEMPITA | - | - | - | - | [1] 107 107 💬
|
| 1510 | COSENTYX - 150 MG - SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA -USO SOTTOCUTANEO - SIRINGA (VETRO) 1 ML (150MG/ML)- 2 SIRINGHE PRERIEMPITE | - | - | - | - | [1] 107 107 💬
|
| 1511 | Cosentyx 300 mg solution for injection in pre-filled syringe | - | - | - | - | [1] 41 41 💬
|
| 1512 | Cosentyx 300mg solution for injection in pre-filled syringe | - | - | - | - | [1] 41 41 💬
|
| 1513 | Cosentyx® | - | - | - | - | [1] 269 269 💬
|
| 1514 | Cosintropina acetato | - | - | - | - | [1] 113 113 💬
|
| 1515 | CosmoFer | - | - | - | - | [2] 96 96, 97 💬
|
| 1516 | CosmoFer 50mg/ml solution for infusion or injection | - | - | - | - | [2] 96 96, 97 💬
|
| 1517 | Costicosteroids | - | - | - | - | [1] 26 26 💬
|
| 1518 | Cosyntropin | - | - | - | - | [1] 113 113 💬
|
| 1519 | Cosyntropin acetate | [2] Acetate Acetate, Tetracosactide | [2] Cosyntropin
Cosyntropin
,
Tetracosactide acetate
💬
| [1] MC2R MC2R 💬
| [6] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 113 113 💬
|
| 1520 | Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin | [1] Vigabatrin Vigabatrin | [1] Vigabatrin
Vigabatrin
💬
| [1] ABAT ABAT 💬
| [6] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 💬
|
| 1521 | Cosyntropin Injectable Suspension, 1 mg/mL | - | - | - | - | [1] 145 145 💬
|
| 1522 | Cotoretigene Toliparvovec | [1] Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | [1] 90 90 💬
|
| 1523 | Cotrimoxazole | - | - | - | - | [2] 85 85, 97 💬
|
| 1524 | Cotton | [1] Cotton Cotton | - | - | - | [2] 35 35, 162 💬
|
| 1525 | Cotton gauze with petrolatum | [2] Cotton Cotton, Petrolatum | [2] Petrolatum, white
Petrolatum, white
,
Petrolatum
💬
| - | - | [2] 35 35, 162 💬
|
| 1526 | COUMADIN | - | - | - | - | [1] 48 48 💬
|
| 1527 | COVERSIN | - | - | - | - | [2] 62 62, 109 💬
|
| 1528 | Coversyl | - | - | - | - | [2] 19 19, 167 💬
|
| 1529 | Coversyl (perindopril) | [1] Perindopril Perindopril | [3] Perindopril erbumine
Perindopril erbumine
,
Perindopril
,
Perindopril arginine
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 167 167 💬
|
| 1530 | Coversyl 5mg | - | - | - | - | [1] 57 57 💬
|
| 1531 | Coversyl PLUS | - | - | - | - | [1] 19 19 💬
|
| 1532 | COVID-19 mRNA Vaccine (nucleoside modified) | - | - | - | - | [3] 13 13, 46, 51 💬
|
| 1533 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | [4] 13 13, 46, 51, 299 💬
|
| 1534 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | [4] 13 13, 46, 51, 299 💬
|
| 1535 | COVID-19 vaccination | - | - | - | - | [1] 13 13 💬
|
| 1536 | COVID-19 vaccine | - | - | - | - | [4] 46 46, 49, 51, 97 💬
|
| 1537 | COVID-19 vaccine (Ad26.COV2-S [recombinant]) | - | - | - | - | [1] 299 299 💬
|
| 1538 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | [3] 46 46, 51, 299 💬
|
| 1539 | COVID-19 Vaccine AstraZeneca | - | - | - | - | [2] 46 46, 51 💬
|
| 1540 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | - | - | - | - | [3] 46 46, 51, 299 💬
|
| 1541 | COVID-19 Vaccine AstraZeneca suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | [1] 53 53 💬
|
| 1542 | COVID-19 Vaccine Janssen suspension for injection | - | - | - | - | [1] 299 299 💬
|
| 1543 | COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant]) | - | - | - | - | [2] 53 53, 299 💬
|
| 1544 | COVID-19 Vaccine Moderna | - | - | - | - | [5] 46 46, 51, 65, 272, 299 💬
|
| 1545 | COVID-19 Vaccine Moderna dispersion for injection | - | - | - | - | [1] 299 299 💬
|
| 1546 | COVID-19 Vaccines at a 3-month interval | - | - | - | - | [2] 46 46, 97 💬
|
| 1547 | COVID-19 Vaccines at a 6-month interval | - | - | - | - | [2] 46 46, 97 💬
|
| 1548 | COVID19 vaccine | - | - | - | - | [1] 13 13 💬
|
| 1549 | COX-2 inhibitor | - | - | - | - | [1] 165 165 💬
|
| 1550 | COYA 302 | - | - | - | - | [1] 2 2 💬
|
| 1551 | Cozaar | - | - | - | - | [1] 167 167 💬
|
| 1552 | Cozaar 50 | - | - | - | - | [1] 167 167 💬
|
| 1553 | COZAAR 50 mg comprimidos recubierto con pelicula | - | - | - | - | [1] 179 179 💬
|
| 1554 | COZAAR INICIO 12,5 mg comprimidos recubiertos con pelicula | - | - | - | - | [1] 167 167 💬
|
| 1555 | CP 690,550 | - | - | - | - | [1] 46 46 💬
|
| 1556 | CP 690550 MR | - | - | - | - | [1] 46 46 💬
|
| 1557 | CP- 690 550 | - | - | - | - | [1] 97 97 💬
|
| 1558 | CP-101 | - | - | - | - | [1] 97 97 💬
|
| 1559 | CP-195,543 | - | - | - | - | [1] 46 46 💬
|
| 1560 | CP-461 | - | - | - | - | [1] 96 96 💬
|
| 1561 | CP-529,414/Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 1562 | CP-690, 550 - 10 | - | - | - | - | [1] 46 46 💬
|
| 1563 | CP-690,500 5 mg | - | - | - | - | [1] 97 97 💬
|
| 1564 | CP-690,55-10 | - | - | - | - | [1] 46 46 💬
|
| 1565 | CP-690,550 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 1566 | CP-690,550 (tasocitinib) | - | - | - | - | [1] 46 46 💬
|
| 1567 | CP-690,550 (tofacitinib) | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [2] 46 46, 107 💬
|
| 1568 | CP-690,550 + methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 46 46 💬
|
| 1569 | CP-690,550 10 mg | - | - | - | - | [1] 97 97 💬
|
| 1570 | CP-690,550 – 10 | - | - | - | - | [1] 46 46 💬
|
| 1571 | CP-690,550-10 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 💬
|
| 1572 | CP-690-550 | - | - | - | - | [1] 46 46 💬
|
| 1573 | CP-690-550-10 | - | - | - | - | [1] 107 107 💬
|
| 1574 | CP-690-550-10 (DMID D1600180) | - | - | - | - | [1] 107 107 💬
|
| 1575 | CP690,550 | - | - | - | - | [2] 46 46, 97 💬
|
| 1576 | CPAP group: postoperative CPAP support, non-CPAP group: oxygen 3 liters per minute (L/min) either via mask for those who were extubated or through a T-piece for those with a trash | [1] Oxygen Oxygen | [1] Oxygen
Oxygen
💬
| - | - | [1] 330 330 💬
|
| 1577 | CPHC (carboxy pyrrolidine hexanoyl pyrrolidone carboxylate) | [2] Pyrrolidine Pyrrolidine, Pyrrolidone | - | - | - | [1] 28 28 💬
|
| 1578 | CPK850 | - | - | - | - | [1] 90 90 💬
|
| 1579 | CPL409116 | - | - | - | - | [1] 46 46 💬
|
| 1580 | CPL500036 | - | - | - | - | [1] 6 6 💬
|
| 1581 | CPL500036 - high dose | - | - | - | - | [1] 6 6 💬
|
| 1582 | CPL500036 - low dose | - | - | - | - | [1] 6 6 💬
|
| 1583 | CPSI-2364 | - | - | - | - | [1] 96 96 💬
|
| 1584 | CPTX2309 | - | - | - | - | [2] 46 46, 49 💬
|
| 1585 | CPV-104 | - | - | - | - | [1] 223 223 💬
|
| 1586 | CPX | - | - | - | - | [1] 299 299 💬
|
| 1587 | CR 1 | - | - | - | - | [1] 46 46 💬
|
| 1588 | CR 2 | - | - | - | - | [1] 46 46 💬
|
| 1589 | CR 3 | - | - | - | - | [1] 46 46 💬
|
| 1590 | CR002 | [1] CR002 CR002 | - | - | - | [1] 299 299 💬
|
| 1591 | CR002 Liquid API | [1] CR002 CR002 | - | - | - | [1] 299 299 💬
|
| 1592 | CR0686 | - | - | - | - | [1] 46 46 💬
|
| 1593 | Cr13C | - | - | - | - | [1] 113 113 💬
|
| 1594 | CR6086 | [1] CR6086 CR6086 | - | - | - | [1] 46 46 💬
|
| 1595 | CR6086Z | - | - | - | - | [1] 46 46 💬
|
| 1596 | CR845 1.0 mg | - | - | - | - | [1] 93 93 💬
|
| 1597 | Cranberry | [1] Cranberry Cranberry | - | - | - | [2] 13 13, 96 💬
|
| 1598 | Cranberry powder | [1] Cranberry Cranberry | - | - | - | [1] 96 96 💬
|
| 1599 | CRC (A3384) | - | - | - | - | [3] 93 93, 297, 338 💬
|
| 1600 | CRC01 | - | - | - | - | [1] 49 49 💬
|
| 1601 | CRC3357, ZK-355322, Leukoton | - | - | - | - | [1] 299 299 💬
|
| 1602 | CRD-TMH-001 | - | - | - | - | [1] 113 113 💬
|
| 1603 | CRD007 | - | - | - | - | [1] 113 113 💬
|
| 1604 | Creapure | - | - | - | - | [1] 50 50 💬
|
| 1605 | Creatine | [1] Creatine Creatine | - | - | - | [18] 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
|
| 1606 | Creatine Monohydrate | [1] Creatine Creatine | - | - | - | [5] 2 2, 8, 97, 113, 156 💬
|
| 1607 | Creatine-13C | [1] Creatine Creatine | - | - | - | [1] 113 113 💬
|
| 1608 | Creatinine | [1] Creatinine Creatinine | [1] Creatinine
Creatinine
💬
| - | - | [9] 2 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
|
| 1609 | Crefmirlimab | [1] Crefmirlimab Crefmirlimab | - | - | - | [4] 13 13, 25, 51, 53 💬
|
| 1610 | Crema de rapamicina al 1% y excipientes | - | - | - | - | [1] 157 157 💬
|
| 1611 | Crema placebo (excipiente) | - | - | - | - | [1] 157 157 💬
|
| 1612 | CREON | - | - | - | - | [2] 298 298, 299 💬
|
| 1613 | Creon 10.000, hårde enterokapsler | - | - | - | - | [1] 299 299 💬
|
| 1614 | Creon 10000 | - | - | - | - | [2] 298 298, 299 💬
|
| 1615 | CREON 10000 Capsules | - | - | - | - | [1] 299 299 💬
|
| 1616 | Creon 25.000, hårde enterokapsler | - | - | - | - | [1] 299 299 💬
|
| 1617 | Creon 25000 | - | - | - | - | [2] 298 298, 299 💬
|
| 1618 | Creon 40.000, hårde enterokapsler | - | - | - | - | [1] 299 299 💬
|
| 1619 | CREON IR | - | - | - | - | [1] 299 299 💬
|
| 1620 | Creon N | - | - | - | - | [1] 299 299 💬
|
| 1621 | CREON N 25000 | - | - | - | - | [1] 299 299 💬
|
| 1622 | Creon(Pancreatin Enteric-coated Capsules) | - | - | - | - | [1] 298 298 💬
|
| 1623 | Creon36™ | - | - | - | - | [1] 298 298 💬
|
| 1624 | Creon® | - | - | - | - | [1] 299 299 💬
|
| 1625 | Creon® (DR/GR) | - | - | - | - | [1] 299 299 💬
|
| 1626 | Creon® 25,000 | - | - | - | - | [1] 299 299 💬
|
| 1627 | Crestor | - | - | - | - | [3] 49 49, 79, 299 💬
|
| 1628 | CRESTOR 10 mg encapsulated tablet | - | - | - | - | [1] 79 79 💬
|
| 1629 | CRESTOR 20 mg encapsulated tablet (2x10 mg) | - | - | - | - | [1] 79 79 💬
|
| 1630 | CRESTOR 5 mg encapsulated tablet | - | - | - | - | [1] 79 79 💬
|
| 1631 | Crestor Film-Coated Tablet | - | - | - | - | [1] 79 79 💬
|
| 1632 | Crestor Tablets (calcium rosuvastatin) Film-Coated tablets | [2] Calcium Calcium, Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [1] 79 79 💬
|
| 1633 | CREXONT ER | - | - | - | - | [1] 6 6 💬
|
| 1634 | CRH | - | - | - | - | [1] 310 310 💬
|
| 1635 | Crinecerfont | [1] Crinecerfont Crinecerfont | [1] Crinecerfont
Crinecerfont
💬
| [1] CRHR1 CRHR1 💬
| [5] Cushing syndrome Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 81 81 💬
|
| 1636 | Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist. | [2] Corticotropin Corticotropin, Crinecerfont | [3] Corticotropin
Corticotropin
,
Corticotropin, repository
,
Crinecerfont
💬
| [2] CRHR1 CRHR1, MC2R 💬
| [7] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 81 81 💬
|
| 1637 | CrinecerfontProduct Code: NBI-74788 Pharmaceutical Form: Capsule, hardINN or Proposed INN: CrinecerfontCAS Number: 752253-39-7Current Sponsor code: NBI-74788Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: CapsuleRoute of administration of the placebo: Oral use | - | - | - | - | [1] 81 81 💬
|
| 1638 | Crisugabalin | [1] Crisugabalin Crisugabalin | - | - | - | [2] 6 6, 13 💬
|
| 1639 | Crizotinib | [1] Crizotinib Crizotinib | [1] Crizotinib
Crizotinib
💬
| [1] ALK ALK 💬
| [3] Non-small cell lung cancer Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer 💬 | [2] 2 2, 34 💬
|
| 1640 | CRN00808 | - | - | - | - | [1] 77 77 💬
|
| 1641 | CRN00808 - is an oral non-peptide small molecule somatostatin receptor 2 (SST2) | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1642 | CRN00808 is an oral non-peptide small molecule somatostatin receptor 2 (SST2) agonist | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1643 | CRN00808 è un agonista del recettore 2 della somatostatina (SST2), orale, non peptidico a piccole dimensioni molecolari | [1] Somatostatin Somatostatin | [1] Somatostatin
Somatostatin
💬
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬
| [5] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 77 77 💬
|
| 1644 | CRN00808.HCl | - | - | - | - | [1] 77 77 💬
|
| 1645 | Crocin | [1] Crocin Crocin | - | - | - | [1] 6 6 💬
|
| 1646 | Crocin and Apigenin | [2] Apigenin Apigenin, Crocin | - | - | - | [1] 6 6 💬
|
| 1647 | Crohn's Disease | - | - | - | - | [1] 96 96 💬
|
| 1648 | Crohn's disease exclusion diet | - | - | - | - | [1] 96 96 💬
|
| 1649 | Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 💬
|
| 1650 | Crohns Disease Exclusion Diet + PEN | - | - | - | - | [1] 96 96 💬
|
| 1651 | Cromoglicato disodico | - | - | - | - | [1] 85 85 💬
|
| 1652 | Cromolyn sodio (cromoglicato disodico, DSCG) | - | - | - | - | [1] 85 85 💬
|
| 1653 | Cromolyn Sodium | - | - | - | - | [1] 85 85 💬
|
| 1654 | Cromolyn Sodium (17.1 mg BID) | - | - | - | - | [1] 2 2 💬
|
| 1655 | Cromolyn Sodium (34.2 mg BID) | - | - | - | - | [1] 2 2 💬
|
| 1656 | Cromolyn sodium [Disodium Cromoglycate] | - | - | - | - | [1] 85 85 💬
|
| 1657 | Crono Five ambulatory pump | - | - | - | - | [1] 86 86 💬
|
| 1658 | Crovalimab | [1] Crovalimab Crovalimab | [1] Crovalimab
Crovalimab
💬
| [1] C5 C5 💬
| [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 48 48, 62, 109 💬
|
| 1659 | CrovalimabProduct Code: RO7112689/F03-10Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170-Product Name: CrovalimabProduct Code: RO7112689/F03-01Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: CROVALIMABCurrent Sponsor code: RO7112689Other descriptive name: C5 inh MAb, SKY59, RO/CH7092230Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 170- | - | - | - | - | [1] 109 109 💬
|
| 1660 | CROWN | - | - | - | - | [1] 96 96 💬
|
| 1661 | CRx-102 | - | - | - | - | [1] 46 46 💬
|
| 1662 | CRx-102 (2.7/180) | - | - | - | - | [1] 46 46 💬
|
| 1663 | CRx-102 (2.7/360) | - | - | - | - | [1] 46 46 💬
|
| 1664 | CRX-139 | [1] CRx-139 CRx-139 | - | - | - | [1] 46 46 💬
|
| 1665 | CRx-150 | - | - | - | - | [1] 46 46 💬
|
| 1666 | CRYOPRESERVED AUTOLOGOUS CD34+ CELLS TRANSDUCED WITH A LENTIVIRAL VECTOR CONTAINING HUMAN SGSH GENE | - | - | - | - | [1] 19 19 💬
|
| 1667 | Cryopreserved Autologous CD34+ cells transduced with pCCLCHIM-p47 | - | - | - | - | [1] 65 65 💬
|
| 1668 | Cryopreserved EFS-ADA LV transduced patient CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 1669 | Cryopreserved G2SCID lentiviral vector transduced patient CD34+ cells | - | - | - | - | [1] 65 65 💬
|
| 1670 | Cryopreserved myelin-derived peptide-loaded tolerogenic dendritic cells | - | - | - | - | [1] 13 13 💬
|
| 1671 | Cryostor CS10 | - | - | - | - | [1] 53 53 💬
|
| 1672 | Cryosupernatant plasma | - | - | - | - | [1] 64 64 💬
|
| 1673 | Crystalline Calcium Carbonate | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [1] 235 235 💬
|
| 1674 | Crystalline calcium supplements | [1] Calcium Calcium | - | - | - | [1] 235 235 💬
|
| 1675 | Crystalline cholesterol oil-based suspension | [1] Cholesterol Cholesterol | [1] Cholesterol
Cholesterol
💬
| - | - | [1] 310 310 💬
|
| 1676 | Crysvita (burosumab-twza) Treatment | [1] Burosumab Burosumab | [1] Burosumab
Burosumab
💬
| [1] FGF23 FGF23 💬
| [11] Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | [1] 238 238 💬
|
| 1677 | CS (corticosteroids) Only | - | - | - | - | [1] 97 97 💬
|
| 1678 | CS-0777 tablets | - | - | - | - | [1] 13 13 💬
|
| 1679 | CS0159 | - | - | - | - | [2] 93 93, 94 💬
|
| 1680 | CS1 | - | - | - | - | [1] 86 86 💬
|
| 1681 | CS1 Administration | - | - | - | - | [1] 86 86 💬
|
| 1682 | CS10BR05 | - | - | - | - | [1] 17 17 💬
|
| 1683 | CS20AT04 (allogenic bone marrow derived mesenchymal stem cell) | - | - | - | - | [1] 49 49 💬
|
| 1684 | Csa | - | - | - | - | [2] 49 49, 60 💬
|
| 1685 | CsA+ATG+Herombopag | - | - | - | - | [1] 60 60 💬
|
| 1686 | CsA+Herombopag | - | - | - | - | [1] 60 60 💬
|
| 1687 | CSCC_ASC(22) | - | - | - | - | [1] 53 53 💬
|
| 1688 | CsDMARD(s) | - | - | - | - | [1] 46 46 💬
|
| 1689 | CsDMARDs | - | - | - | - | [1] 46 46 💬
|
| 1690 | CSF collection by lumbar puncture (Optional) | - | - | - | - | [1] 13 13 💬
|
| 1691 | CSF sampling | - | - | - | - | [1] 13 13 💬
|
| 1692 | CSL312 | - | - | - | - | [2] 65 65, 85 💬
|
| 1693 | CSL312 garadacimab | [1] Garadacimab Garadacimab | [1] Garadacimab
Garadacimab
💬
| [1] F12 F12 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [2] 65 65, 85 💬
|
| 1694 | CSL787 | - | - | - | - | [1] 299 299 💬
|
| 1695 | CSL830 | - | - | - | - | [1] 65 65 💬
|
| 1696 | CSM allogéniques issues de cordons ombilicaux ( MTI-PP) | - | - | - | - | [1] 49 49 💬
|
| 1697 | CSs | - | - | - | - | [1] 107 107 💬
|
| 1698 | CST-103 | - | - | - | - | [1] 6 6 💬
|
| 1699 | CST-107 | - | - | - | - | [1] 6 6 💬
|
| 1700 | CST-139 | - | - | - | - | [1] 6 6 💬
|
| 1701 | CSTI-500 | - | - | - | - | [1] 193 193 💬
|
| 1702 | CT Scan | - | - | - | - | [1] 65 65 💬
|
| 1703 | CT- P10 | - | - | - | - | [1] 46 46 💬
|
| 1704 | CT-G20 | - | - | - | - | [1] 58 58 💬
|
| 1705 | CT-P10 | - | - | - | - | [1] 46 46 💬
|
| 1706 | CT-P13 | - | - | - | - | [4] 46 46, 96, 97, 271 💬
|
| 1707 | CT-P13 SC (Infliximab) | [1] Infliximab Infliximab | [1] Infliximab
Infliximab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 💬
|
| 1708 | CT-P13 SC Auto-Injector | - | - | - | - | [1] 46 46 💬
|
| 1709 | CT-P17 | - | - | - | - | [1] 46 46 💬
|
| 1710 | CT-P17 SC | - | - | - | - | [1] 46 46 💬
|
| 1711 | CT-P17 SC AI (adalimumab) | [1] Adalimumab Adalimumab | [1] Adalimumab
Adalimumab
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 💬
|
| 1712 | CT-P47 | - | - | - | - | [1] 46 46 💬
|
| 1713 | CT-P47 AI (tocilizumab) | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬
|
| 1714 | CT-P47 PFS (tocilizumab) | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 💬
|
| 1715 | CT-P53 | - | - | - | - | [1] 13 13 💬
|
| 1716 | CT103A | [1] CT103A CT103A | - | - | - | [4] 11 11, 13, 14, 16 💬
|
| 1717 | CT103A cells | [1] CT103A CT103A | - | - | - | [4] 11 11, 13, 14, 16 💬
|
| 1718 | CTH120 | - | - | - | - | [1] 206 206 💬
|
| 1719 | CTI-1601 | - | - | - | - | [1] 18 18 💬
|
| 1720 | CTLA4-IgG4m (RG2077) | - | - | - | - | [1] 49 49 💬
|
| 1721 | CTLA4Ig | - | - | - | - | [5] 46 46, 49, 96, 223, 271 💬
|
| 1722 | CTX | - | - | - | - | [1] 223 223 💬
|
| 1723 | CTX combined with Glucocorticoids | - | - | - | - | [1] 222 222 💬
|
| 1724 | CTX-4430 | - | - | - | - | [1] 299 299 💬
|
| 1725 | CTX112 | - | - | - | - | [3] 51 51, 61, 63 💬
|
| 1726 | CTX310 | - | - | - | - | [1] 79 79 💬
|
| 1727 | Cu(II)ATSM | - | - | - | - | [2] 2 2, 6 💬
|
| 1728 | Cu-64 DOTATATE | [1] Dotatate Dotatate | - | - | - | [1] 84 84 💬
|
| 1729 | CU104 | - | - | - | - | [1] 97 97 💬
|
| 1730 | Cudetaxestat | [1] Cudetaxestat Cudetaxestat | - | - | - | [1] 85 85 💬
|
| 1731 | Cudetaxestat (BLD-0409) | [1] Cudetaxestat Cudetaxestat | - | - | - | [1] 85 85 💬
|
| 1732 | Cufence | - | - | - | - | [2] 58 58, 171 💬
|
| 1733 | Cufence (trientine dihydrochloride) | [1] Triethylenetetramine Triethylenetetramine | [2] Trientine hydrochloride
Trientine hydrochloride
,
Trientine tetrahydrochloride
💬
| - | - | [1] 171 171 💬
|
| 1734 | CUG252 | - | - | - | - | [1] 49 49 💬
|
| 1735 | Cultivated oral mucosal epithelial sheet transplantation | - | - | - | - | [2] 38 38, 162 💬
|
| 1736 | Culture of lymphoblastoid line from blood sample | - | - | - | - | [1] 102 102 💬
|
| 1737 | Cultured allogeneic fibroblasts | - | - | - | - | [1] 36 36 💬
|
| 1738 | Cultured mesenchymal stem cells from bone marrow isolation | - | - | - | - | [1] 71 71 💬
|
| 1739 | Cultured Thymus Tissue | - | - | - | - | [1] 65 65 💬
|
| 1740 | Cultured Thymus Tissue for Implantation (CTTI) | - | - | - | - | [1] 65 65 💬
|
| 1741 | Cultured Thymus Tissue Implantation (CTTI) | - | - | - | - | [1] 65 65 💬
|
| 1742 | Cumulative corticosteroid exposure | - | - | - | - | [1] 49 49 💬
|
| 1743 | Cupping | - | - | - | - | [1] 70 70 💬
|
| 1744 | Cuprimine (penicillamine) | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [1] 51 51 💬
|
| 1745 | Cuprior | - | - | - | - | [1] 171 171 💬
|
| 1746 | Cuprior 150 mg | - | - | - | - | [1] 171 171 💬
|
| 1747 | Cuprior 150 mg film-coated tablets | - | - | - | - | [1] 171 171 💬
|
| 1748 | Cuprior 150mg film-coated tablets | - | - | - | - | [1] 171 171 💬
|
| 1749 | Cura-100 | - | - | - | - | [1] 46 46 💬
|
| 1750 | Curcuma | - | - | - | - | [1] 96 96 💬
|
| 1751 | Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg | - | - | - | - | [1] 299 299 💬
|
| 1752 | CURCUMA LONGA RHIZOMA | - | - | - | - | [1] 96 96 💬
|
| 1753 | Curcumin | [1] Curcumin Curcumin | - | - | - | [12] 2 2, 13, 34, 36, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
| 1754 | Curcumin (Longvida™) | [1] Curcumin Curcumin | - | - | - | [1] 46 46 💬
|
| 1755 | Curcumin Supplementation | [1] Curcumin Curcumin | - | - | - | [1] 97 97 💬
|
| 1756 | Curcumin, high phenolic extra virgin olive oil (HP-EVOO) | [2] Curcumin Curcumin, Olive oil | [1] Olive oil
Olive oil
💬
| - | - | [1] 34 34 💬
|
| 1757 | Curcumin-based photodynamic therapy | [1] Curcumin Curcumin | - | - | - | [1] 36 36 💬
|
| 1758 | Curie Artificial Intelligence (AI) cough monitor | - | - | - | - | [1] 299 299 💬
|
| 1759 | Curosurf | - | - | - | - | [1] 211 211 💬
|
| 1760 | CurQD (Curcumin + QingDai combination) | [1] Curcumin Curcumin | - | - | - | [1] 97 97 💬
|
| 1761 | Current lipid-lowering treatment | - | - | - | - | [1] 79 79 💬
|
| 1762 | Current marketed FLOLAN (epoprostenol sodium) | [1] Epoprostenol Epoprostenol | [2] Epoprostenol
Epoprostenol
,
Epoprostenol sodium
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 💬
|
| 1763 | Current standard of care treatment options | - | - | - | - | [1] 49 49 💬
|
| 1764 | Current treatment of AL-CM | - | - | - | - | [1] 28 28 💬
|
| 1765 | Currently available therapy in the community | - | - | - | - | [1] 51 51 💬
|
| 1766 | Cushing's syndrome confirmation | - | - | - | - | [1] 75 75 💬
|
| 1767 | Custom Device | - | - | - | - | [1] 6 6 💬
|
| 1768 | Customized microinjection device | - | - | - | - | [1] 6 6 💬
|
| 1769 | Cutaneous biopsy | - | - | - | - | [1] 162 162 💬
|
| 1770 | Cutaneous iontophoresis of treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 1771 | CUTAQUIG | - | - | - | - | [1] 65 65 💬
|
| 1772 | CUV1647 | - | - | - | - | [1] 254 254 💬
|
| 1773 | CUVITRU | - | - | - | - | [1] 65 65 💬
|
| 1774 | Cuvitru 200 mg/ml solution for subcutaneous injection | - | - | - | - | [1] 65 65 💬
|
| 1775 | CV-MG01 | [1] CV-MG01 CV-MG01 | - | - | - | [1] 11 11 💬
|
| 1776 | CVD00118-E | - | - | - | - | [1] 6 6 💬
|
| 1777 | CVL-751 | - | - | - | - | [1] 6 6 💬
|
| 1778 | CVN424 | - | - | - | - | [1] 6 6 💬
|
| 1779 | CVN424 150 mg | - | - | - | - | [1] 6 6 💬
|
| 1780 | CVN424 75 mg | - | - | - | - | [1] 6 6 💬
|
| 1781 | CVT-301 | - | - | - | - | [1] 6 6 💬
|
| 1782 | CVT-301 (Dose Level 1) | - | - | - | - | [1] 6 6 💬
|
| 1783 | CVT-301 (Dose Level 2) | - | - | - | - | [1] 6 6 💬
|
| 1784 | CVT-301 35mg | - | - | - | - | [1] 6 6 💬
|
| 1785 | CVT-301 50mg | - | - | - | - | [1] 6 6 💬
|
| 1786 | CVT-301 High Dose | - | - | - | - | [1] 6 6 💬
|
| 1787 | CVT-301 Low Dose | - | - | - | - | [1] 6 6 💬
|
| 1788 | CVT-301, LIP | - | - | - | - | [1] 6 6 💬
|
| 1789 | CVXL-0107 | - | - | - | - | [1] 6 6 💬
|
| 1790 | CX-016492 | - | - | - | - | [1] 245 245 💬
|
| 1791 | CX-017950 | - | - | - | - | [1] 245 245 💬
|
| 1792 | CX-4945 oral formulation | - | - | - | - | [1] 331 331 💬
|
| 1793 | CX-8998 | - | - | - | - | [1] 6 6 💬
|
| 1794 | Cx401 | - | - | - | - | [1] 96 96 💬
|
| 1795 | CX501 | [1] CX501 CX501 | - | - | - | [1] 36 36 💬
|
| 1796 | CX516 | [1] CX516 CX516 | - | - | - | [1] 206 206 💬
|
| 1797 | CX516 (Ampalex®) | [1] CX516 CX516 | - | - | - | [1] 206 206 💬
|
| 1798 | Cx601 | - | - | - | - | [1] 96 96 💬
|
| 1799 | CXA-10 | [1] CXA-10 CXA-10 | - | - | - | [2] 86 86, 222 💬
|
| 1800 | Cy | - | - | - | - | [1] 60 60 💬
|
| 1801 | Cy-ATG | - | - | - | - | [1] 60 60 💬
|
| 1802 | CYB704 | - | - | - | - | [1] 13 13 💬
|
| 1803 | CyberKnife | - | - | - | - | [1] 6 6 💬
|
| 1804 | CYC | - | - | - | - | [1] 40 40 💬
|
| 1805 | CYC202 | - | - | - | - | [1] 299 299 💬
|
| 1806 | Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence in situ hybridization (FISH) assay | - | - | - | - | [1] 28 28 💬
|
| 1807 | Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate | - | - | - | - | [1] 75 75 💬
|
| 1808 | Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly pamoate | - | - | - | - | [1] 77 77 💬
|
| 1809 | Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly di-aspartate | - | - | - | - | [1] 75 75 💬
|
| 1810 | Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly pamoate | - | - | - | - | [1] 77 77 💬
|
| 1811 | Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys pamoate | - | - | - | - | [1] 77 77 💬
|
| 1812 | Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate | - | - | - | - | [1] 75 75 💬
|
| 1813 | Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) pamoate | - | - | - | - | [1] 77 77 💬
|
| 1814 | Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) | - | - | - | - | [2] 75 75, 77 💬
|
| 1815 | CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL] | - | - | - | - | [1] 299 299 💬
|
| 1816 | Cyclophosfamide | - | - | - | - | [1] 13 13 💬
|
| 1817 | Cyclophosphamid | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 66 66, 223 💬
|
| 1818 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 1819 | Cyclophosphamide (CTX) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 28 28, 222 💬
|
| 1820 | Cyclophosphamide (CY) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
| 1821 | Cyclophosphamide (CY) (Plan 1) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 60 60, 65, 285 💬
|
| 1822 | Cyclophosphamide (CY) (Plan 2) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 60 60, 65, 285 💬
|
| 1823 | Cyclophosphamide (CYC) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 49 49, 221 💬
|
| 1824 | Cyclophosphamide (Cytoxan) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 65 65 💬
|
| 1825 | Cyclophosphamide (drug) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
| 1826 | Cyclophosphamide + pred | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 283 283 💬
|
| 1827 | Cyclophosphamide 100 mg/Kg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 19 19, 222 💬
|
| 1828 | Cyclophosphamide 100mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
| 1829 | Cyclophosphamide 1200 mg/Kg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 19 19, 222 💬
|
| 1830 | Cyclophosphamide 150mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
| 1831 | Cyclophosphamide 50mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
| 1832 | Cyclophosphamide 50Mg Oral Tablet | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 162 162 💬
|
| 1833 | Cyclophosphamide added to standard immunosuppressive therapy with herombopag | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
| 1834 | Cyclophosphamide and ATG | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
| 1835 | Cyclophosphamide and fludarabine | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [4] 11 11, 13, 14, 16 💬
|
| 1836 | Cyclophosphamide and steroids | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 222 222, 223 💬
|
| 1837 | Cyclophosphamide Dose Level 1 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 1838 | Cyclophosphamide Dose Level 2 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 1839 | Cyclophosphamide Dose Level 3 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 1840 | Cyclophosphamide Dose Level 4 | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 65 65, 284 💬
|
| 1841 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | [3] Azathioprine Azathioprine, Cyclophosphamide, Methotrexate | [6] Methotrexate
Methotrexate
,
Azathioprine
,
Cyclophosphamide
,
Methotrexate sodium
,
Azathioprine sodium
,
Cyclophosphamide
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 44 44 💬
|
| 1842 | Cyclophosphamide Injection 1g | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 50 50, 51, 52 💬
|
| 1843 | Cyclophosphamide LD | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 49 49 💬
|
| 1844 | CYCLOPHOSPHAMIDE MONOHYDRATE | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [4] 13 13, 60, 96, 256 💬
|
| 1845 | Cyclophosphamide post transplant | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 65 65 💬
|
| 1846 | Cyclophosphamide(CTX) | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 224 224 💬
|
| 1847 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone | [4] Azathioprine Azathioprine, Cyclophosphamide, Methylprednisolone, Prednisone | [7] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Methylprednisolone
,
Prednisone
,
Methylprednisolone acetate
,
Azathioprine sodium
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 💬
|
| 1848 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen | [3] Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | [6] Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Dexamethasone sodium phosphate
,
Bortezomib
,
Cyclophosphamide
,
Dexamethasone phosphate
💬
| [2] NR3C1 NR3C1, PSMB5 💬
| [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 💬
|
| 1849 | Cyclophosphamide, Fludarabine | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 285 285 💬
|
| 1850 | Cyclophosphamide, fludarabine , thymoglobulin | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬
|
| 1851 | Cyclophosphamide, Fludarabine, Rabbit ATG | [3] Cyclophosphamide Cyclophosphamide, Fludarabine, Rabbit | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬
|
| 1852 | Cyclophosphamide, Fludarabine, Thymoglobulin | [2] Cyclophosphamide Cyclophosphamide, Fludarabine | [4] Cyclophosphamide
Cyclophosphamide
,
Fludarabine phosphate
,
Cyclophosphamide
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [1] 60 60 💬
|
| 1853 | Cyclophosphamide,Campath IH and TBI | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 60 60 💬
|
| 1854 | Cyclophosphamide,cyclosporine A | [2] Cyclophosphamide Cyclophosphamide, Cyclosporine | [3] Cyclosporine
Cyclosporine
,
Cyclophosphamide
,
Cyclophosphamide
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬
|
| 1855 | Cyclophosphamide-prednisone-azathioprine | [3] Azathioprine Azathioprine, Cyclophosphamide, Prednisone | [5] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Prednisone
,
Azathioprine sodium
,
Cyclophosphamide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 49 49 💬
|
| 1856 | Cyclophosphamide/ATG | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 13 13 💬
|
| 1857 | Cyclophosphamide/azathioprine | [2] Azathioprine Azathioprine, Cyclophosphamide | [4] Azathioprine
Azathioprine
,
Cyclophosphamide
,
Azathioprine sodium
,
Cyclophosphamide
💬
| - | - | [1] 44 44 💬
|
| 1858 | Cyclophosphamide/Glatiramer acetate | [3] Acetate Acetate, Cyclophosphamide, Glatiramer | [3] Cyclophosphamide
Cyclophosphamide
,
Glatiramer acetate
,
Cyclophosphamide
💬
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬
| [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 💬
|
| 1859 | Cyclophosphamide/Rituximab | [2] Cyclophosphamide Cyclophosphamide, Rituximab | [3] Cyclophosphamide
Cyclophosphamide
,
Rituximab
,
Cyclophosphamide
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 💬
|
| 1860 | Cyclophosphamidum 500 mg | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 44 44 💬
|
| 1861 | Cycloserine | [1] Cycloserine Cycloserine | [1] Cycloserine
Cycloserine
💬
| - | - | [1] 2 2 💬
|
| 1862 | Cyclosphamine | - | - | - | - | [1] 85 85 💬
|
| 1863 | Cyclosporin | - | - | - | - | [6] 53 53, 60, 97, 222, 223, 274 💬
|
| 1864 | Cyclosporin (CSA) | - | - | - | - | [1] 60 60 💬
|
| 1865 | Cyclosporin A | - | - | - | - | [12] 46 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
|
| 1866 | Cyclosporin A (CsA) | - | - | - | - | [1] 60 60 💬
|
| 1867 | Cyclosporin A+Glucocorticoids | - | - | - | - | [2] 60 60, 62 💬
|
| 1868 | Cyclosporin Capsules | - | - | - | - | [1] 222 222 💬
|
| 1869 | Cyclosporin, low dose steroid | - | - | - | - | [2] 222 222, 223 💬
|
| 1870 | Cyclosporin, Methotrexate (GVHD prophylaxis) | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [1] 326 326 💬
|
| 1871 | Cyclosporine | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [39] 11 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
|
| 1872 | Cyclosporine (Ciclosporinium) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 1873 | Cyclosporine (CsA) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬
|
| 1874 | Cyclosporine (Gengraf ) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 💬
|
| 1875 | Cyclosporine (USAN) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1876 | Cyclosporine + BCX7353 | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 💬
|
| 1877 | Cyclosporine 0.09% Ophthalmic Solution | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 53 53 💬
|
| 1878 | Cyclosporine A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 19 19, 20, 36, 49, 50, 53, 58, 60, 107, 228, 234, 283 💬
|
| 1879 | Cyclosporine A (CsA) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 19 19, 60 💬
|
| 1880 | Cyclosporine A dry powder inhalation (Drug) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 1881 | Cyclosporine Capsule | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 1882 | Cyclosporine combine with mycophenolate mofetil | [2] Cyclosporine Cyclosporine, Mycophenolate mofetil | [3] Cyclosporine
Cyclosporine
,
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [7] IMPDH1 IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [35] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 283 283 💬
|
| 1883 | Cyclosporine Inhalation Solution | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 1884 | Cyclosporine Inhalation Solution (CIS) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 💬
|
| 1885 | Cyclosporine Injection (IV) | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 97 97 💬
|
| 1886 | Cyclosporine Oral Product | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 97 💬
|
| 1887 | Cyclosporine Pill | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 56 56 💬
|
| 1888 | Cyclosporine Soft Capsules | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 67 67 💬
|
| 1889 | CYCLOSPORINE VS INFLIXIMAB | [2] Cyclosporine Cyclosporine, Infliximab | [2] Cyclosporine
Cyclosporine
,
Infliximab
💬
| [6] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬
| [85] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 97 97 💬
|
| 1890 | Cyclosporine-A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 95 95 💬
|
| 1891 | Cyclosporins | - | - | - | - | [4] 53 53, 60, 65, 222 💬
|
| 1892 | CyCol | - | - | - | - | [1] 97 97 💬
|
| 1893 | CyCol™ | - | - | - | - | [1] 97 97 💬
|
| 1894 | CYKLOKAPRON | - | - | - | - | [1] 65 65 💬
|
| 1895 | Cyklokapron Tablets | - | - | - | - | [1] 65 65 💬
|
| 1896 | Cyklokapron® | - | - | - | - | [1] 46 46 💬
|
| 1897 | Cyklosporin A | - | - | - | - | [1] 54 54 💬
|
| 1898 | Cyltezo | - | - | - | - | [1] 96 96 💬
|
| 1899 | CYMBALTA | - | - | - | - | [3] 6 6, 13, 49 💬
|
| 1900 | CYP substrates | - | - | - | - | [1] 98 98 💬
|
| 1901 | CYR-064 | - | - | - | - | [1] 6 6 💬
|
| 1902 | Cystadane anhydrous | - | - | - | - | [1] 19 19 💬
|
| 1903 | CYSTADROPS | - | - | - | - | [1] 19 19 💬
|
| 1904 | CYSTADROPS 0.55% eye drops, solution | - | - | - | - | [1] 19 19 💬
|
| 1905 | CYSTAGON | - | - | - | - | [3] 8 8, 19, 299 💬
|
| 1906 | Cystagon (cysteamine bitartrate) immediate-release capsules | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 299 299 💬
|
| 1907 | Cystagon 150mg | - | - | - | - | [1] 19 19 💬
|
| 1908 | Cystagon 50mg | - | - | - | - | [1] 19 19 💬
|
| 1909 | Cystagon® | - | - | - | - | [1] 19 19 💬
|
| 1910 | Cystagon® (Cysteamine Bitartrate) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1911 | Cysteamine | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [4] 8 8, 19, 21, 299 💬
|
| 1912 | Cysteamine (mercaptamine) viscous solution | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1913 | Cysteamine Bitartrate | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [4] 8 8, 19, 21, 299 💬
|
| 1914 | Cysteamine bitartrate (Cystagon) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 299 299 💬
|
| 1915 | Cysteamine bitartrate (INN: mercaptamine bitartrate | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1916 | Cysteamine bitartrate (INN: mercaptamine bitartrate ) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1917 | Cysteamine bitartrate (INN: mercaptamine bitartrate) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1918 | Cysteamine Bitartrate Delayed-release Capsules | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1919 | Cysteamine Bitartrate Delayed-release Capsules (RP103) | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1920 | CYSTEAMINE HYDROCHLORIDE | [1] Cysteamine Cysteamine | [3] Cysteamine
Cysteamine
,
Cysteamine hydrochloride
,
Cysteamine bitartrate
💬
| - | - | [1] 19 19 💬
|
| 1921 | Cysteine | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [13] 6 6, 13, 19, 34, 60, 84, 85, 88, 90, 254, 296, 310, 337 💬
|
| 1922 | Cysteine hydrochloride | [1] Cysteine Cysteine | [2] L-Cysteine
L-Cysteine
,
Cysteine hydrochloride
💬
| - | - | [1] 254 254 💬
|
| 1923 | Cystic Fibrosis Ready to Use Supplemental Food | - | - | - | - | [1] 299 299 💬
|
| 1924 | Cystic fibrosis transmembrane conductance regulator | [1] Cystic fibrosis transmembrane conductance regulator Cystic fibrosis transmembrane conductance regulator | - | - | - | [1] 299 299 💬
|
| 1925 | Cystoscopic injection of Botox into the urinary bladder | - | - | - | - | [1] 6 6 💬
|
| 1926 | Cystoscopy | - | - | - | - | [1] 226 226 💬
|
| 1927 | CYT107 | - | - | - | - | [1] 25 25 💬
|
| 1928 | Cytarabine | [1] Cytarabine Cytarabine | [2] Cytarabine
Cytarabine
,
Cytarabine hydrochloride
💬
| - | - | [8] 11 11, 13, 14, 25, 34, 49, 60, 65 💬
|
| 1929 | Cytochrome P450 (CYP) Substrates | - | - | - | - | [2] 96 96, 97 💬
|
| 1930 | Cytokine essays | - | - | - | - | [2] 61 61, 63 💬
|
| 1931 | Cytokine-treated Veto Cells | - | - | - | - | [1] 60 60 💬
|
| 1932 | Cytolytic CD4+ T cells | - | - | - | - | [1] 13 13 💬
|
| 1933 | Cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant | - | - | - | - | [1] 62 62 💬
|
| 1934 | Cytotoxic Combination | - | - | - | - | [1] 56 56 💬
|
| 1935 | Cytoxan | - | - | - | - | [2] 60 60, 96 💬
|
| 1936 | CZP | - | - | - | - | [1] 46 46 💬
|
| 1937 | Cápsulas de Laquinimod 0.6 mg | [1] Laquinimod Laquinimod | [1] Laquinimod sodium
Laquinimod sodium
💬
| - | - | [1] 13 13 💬
|
| 1938 | Células madre mesenquimales | - | - | - | - | [1] 13 13 💬
|
| 1939 | Células madre mesenquimales de tejido adiposo autólogo | - | - | - | - | [1] 2 2 💬
|
| 1940 | Células madre mesenquimales haploidénticas derivadas de médula ósea | - | - | - | - | [1] 36 36 💬
|
| 1941 | Células Mesenquimales de tejido adiposo | - | - | - | - | [1] 2 2 💬
|
| 1942 | Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas | - | - | - | - | [1] 274 274 💬
|
| 1943 | Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada PEI nº 12-088) | - | - | - | - | [1] 274 274 💬
|
| 1944 | Células mesenquimales troncales adultas autólogas de medula ósea expandidas | - | - | - | - | [1] 117 117 💬
|
| 1945 | Células mesenquimales troncales adultas autólogas de médula ósea expandidas | - | - | - | - | [1] 117 117 💬
|
| 1946 | Células Mononucleares troncales adultas autólogas de médula ósea no expandidas | - | - | - | - | [1] 57 57 💬
|
| 1947 | Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea | - | - | - | - | [1] 2 2 💬
|
| 1948 | Células troncales mesenquimales autólogas derivadas de tejido adiposo expandidas (ASC) | - | - | - | - | [1] 97 97 💬
|